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Summary 
 
Response to DNA damage, lack of nutrients and other stress conditions are the 
essential properties of all living systems. The coordinated response includes DNA damage 
repair, DNA damage checkpoints, transcriptional alterations and the activation of alternate 
biochemical pathways, as well as drastic measures like cellular suicide which prevents 
proliferation of severely damaged cells. Transcriptional response of cells exposed to DNA 
damaging agents is a coordinated process which induces transcription of all necessary 
proteins which are not only involved in the repair process, but also in the general stress 
response and maintenance of internal homeostasis. The most important aspects of 
transcriptional modifications upon DNA damage are induction of the environmental stress 
response program (ESR), repression of genes involved in cell cycle progression and 
modulation of major energy metabolism pathways.  
Exposure of living organisms to smaller amounts of toxic agents and other adverse 
effects may be more common in natural environments than direct impact of highly cytotoxic 
doses of the same agents. Occurring over various time spans or as the consequence of 
repeated exposures, the accumulation of mutations may be as critical for the organism as the 
immediate cytotoxic effect. Therefore, cellular response to the treatment with DNA-damaging 
substances at low concentrations which are genotoxic but do not have a strong cytotoxic 
effect are of special interest. In addition, environmental variations that influence growth 
conditions, e.g. different media, and individual fitness, e.g. different strains, are likely to 
influence and modulate the adverse effects of individual DNA-damaging substances. 
  Investigating the transcriptional response of S.cereveisiae to low doses of the 
alkylating agent methylmethane sulfonate (MMS) we observed that cellular sensitivity to 
MMS directly depends on their ability to immediately induce the basic, stereotypical stress 
response program called ESR. Transcriptional response of cells cultivated in nutrient rich 
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medium significantly differed from those cultivated in minimal medium. In the full medium 
MMS treatment triggered induction of the ESR programme in a dose and time dependent 
manner. In contrast, expression of many genes involved in ESR was already elevated when 
cells are cultivated in minimal, nutrient deprived medium. Additional treatment of those cells 
with MMS led to the transcriptional regulation of genes more specific and necessary for DNA 
damage repair, cell cycle arrest or detoxification.  
Comparing the response to low level treatment with MMS of two different yeast 
strains, FF18984 and BY4742, we found that BY4742 is more sensitive to MMS than 
FF18984. While FF18984 showed an immediate strong adaptation in transcription including a 
higher and stronger activation of ESR, the response of the BY4742 strain did not result in the 
transcriptional regulation of many genes. In particularly genes involved in protein 
biosynthesis, mRNA processing and transcriptional regulation were not affected in the same 
manner as observed in the FF18984 strain. Among the genes induced in BY4742 not more 
than three belonged to one functional group. These results led us to the conclusion that in the 
BY4742 strain more time may be required to response to MMS. Persistent proliferation of this 
strain during the first hours of MMS treatment most probably leads to a higher accumulation 
of mutations, conversion of primary lesions to double strand breaks (DSB) and in 
consequence to a higher sensitivity to the toxic agent.  
 Modulation of basic metabolic pathways and induction of diauxic shift are other 
factors that directly contributed to the increased resistance of the FF18984 strain to MMS. 
Metabolic adaptation and pre-induction of ESR resulting from nutrient deprivation helped this 
strain to cope better with the toxic effect of genotoxic agents applied later such as MMS. Our 
results showed that the major stimulus that triggers the adaptive response and the induction of 
ESR genes upon MMS treatment is an alteration in glucose utilization. These results point to 
an important correlation between metabolic pathways and the ability of living organisms to 
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cope with adverse environmental conditions. Moreover, the induction of ESR seemed to be 
the most important prerequisite for a proper and fast cellular response to DNA damage. 
Expression of the key enzyme of gluconeogenesis fructose-1,6-bisphosphatase (FBP1) 
was clearly up-regulated by MMS in glucose-rich medium. Interestingly, deletion of FBP1 
led to reduced sensitivity to MMS, but not to other DNA damaging agents such as 4-
nitroquinoline (4-NQO) or phleomycin. The reduced sensitivity of the Δfbp1 mutant was the 
result of better recovery of this mutant after a long-term treatment with MMS. Reintroduction 
of FBP1 in the knockout strain restored the wild-type phenotype while overexpression 
increased MMS-sensitivity of wild-type. The fact that terminally GFP-tagged Fbp1p restored 
the lack of Fbp1p on non-fermentable carbon source, but not wild-type MMS-sensitivity in 
Δfbp1 cells, implicated that the function of FBPase in cellular growth on media with 
alternative carbon sources could be independent, at least in part, from its role in response to 
MMS treatment. 
The connection between Fbp1p and one of the most important DNA damage 
signalling cascade that starts with the Mec1/Tel1 damage sensors was investigated with the 
RNR2-GFP reporter assay. These experiments revealed that the deletion of FBP1 had no 
effect on induction through the RNR2 promoter while overexpression of FBP1 significantly 
increased the activity of the RNR2 promoter. These results indicated that the increased 
intracellular level of Fbp1p after DNA damage caused by MMS probably acts as a signal that 
mediates cellular response to this toxic agent. 
 Deletion of FBP1 reduced the production of reactive oxygen species (ROS) in 
response to MMS and in untreated aged cells. The mutant cells showed delayed production of 
ROS in the first fifteen days in aging culture what resulted in better viability in full medium. 
In minimal medium the lack of Fbp1p was no advantage for cellular survival. In these 
conditions aged Δfbp1 mutants survived even less and accumulated similar levels of ROS. 
Elevated amounts of Fbp1p shortened life-span, but did not have any influence on ROS 
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accumulation. These results showed that Fbp1p is an important factor that modulates ROS 
production in response to MMS treatment and aging. However, in media with limited 
nutrients Fbp1p is a critical factor for cellular survival and its lack is rather a disadvantage. 
Based on the above observations, we concluded that FBP1 influences the connection 
between DNA damage, aging and oxidative stress either through direct signalling or an 
intricate adaptation in energy metabolism. In consequence, the tight regulation of FBP1 
expression and age-associated changes in glucose metabolism are not only crucial for the 
control of gluconeogenesis but also for an appropriate response to aging and DNA damage. 
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Zusammenfassung 
 
Die Fähigkeit auf DNA Schädigungen, das Fehlen von Nährstoffen oder andere 
Stressfaktoren zu reagieren, ist eine wichtige Eigenschaft aller lebenden Systeme. Dies 
beinhaltet sowohl die Reparatur von DNA Schäden, DNA-Schädigung abhängige Kontrolle 
des Zellzyklus, die Änderung der Transkription und die Aktivierung alternativer 
biochemische Prozesse, als auch drastischere Maßnahmen, wie zum Beispiel zellulären 
Selbstmord, der eine Proliferation schwer beschädigter Zellen verhindert. Zellen, die DNA 
schädigenden Substanzen ausgesetzt werden, reagieren mit einem aufeinander abgestimmten 
Prozess, der auch die Regulation der Transkription aller benötigter Proteine beinhaltet. Diese 
Proteine spielen nicht nur bei der Reparatur der DNA, sondern auch bei der allgemeinen 
Antwort der Zelle auf Stress und der Aufrechterhaltung des inneren Gleichgewichts eine 
entscheidende Rolle. Die wichtigsten Schritte bei der Anpassung der Transkription nach einer 
DNA Schädigung sind die Induktion der allgemeine Stress-Antwort (ERS), die verminderte 
Expression von Genen, die den Zellzyklus steuern, und eine Modulation wichtiger Gene des 
Energiemetabolismus.  
In einer natürlichen Umgebung ist zu vermuten, dass lebende Organismen kleineren 
Mengen toxischer Agenzien ausgesetzt sind, die nicht direkt zum Zelltod führen. Die 
Akkumulation von Mutationen, die durch die Einwirkung des toxischen Agens auf die Zellen 
über längere Zeitspannen oder durch eine wiederholte Exposition zustande kommen, kann für 
den Organismus genauso kritisch sein, als ein sofortiger zytotoxischer Effekt. Deshalb ist die 
zelluläre Antwort auf die Behandlung mit DNA schädigenden Substanzen in niedrigen 
Konzentrationen, in denen sie einen genotoxischen, jedoch keinen stark zytoxischen Effekt 
besitzen, von besonderem Interesse. Zusätzlich könnten Veränderungen der Umwelt, die 
einen Einfluss auf Wachstumsbedingungen haben, wie z.B. unterschiedliche Medien und die 
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individuelle Fitness z.B. verschiedener Stämme, die nachteiligen Effekte einzelner DNA 
schädigender Substanzen beeinflussen und regulieren. 
Bei der Untersuchung der transkriptionalen Antwort von S. cereveisiae auf kleine 
Dosen des alkylierenden Agens Methylmethansulfonat (MMS) haben wir beobachtet, dass die 
Empfindlichkeit der Zellen gegenüber MMS direkt von ihrer Fähigkeit abhängt, unmittelbar 
die grundlegende allgemeine Stressantwort (ESR) einzuleiten. Die transkriptionale Antwort 
von Zellen, die in nährstoffreichem Medium kultiviert werden, unterscheidet sich signifikant 
von denen, die in Minimalmedium kultiviert werden. In Vollmedium leitet eine MMS 
Behandlung die Induktion der allgemeinen Stressantwort ESR in einer dosis- und 
zeitabhängigen Weise ein. Im Gegensatz dazu wurde die Expression vieler Gene, die Teil der 
ESR sind, erhöht, wenn die Zellen in Medium, dem Nährstoffe entzogen wurden, kultiviert 
wurden. Eine weitere Behandlung dieser Zellen mit MMS führt zu einer transkriptionalen 
Regulation von spezifischeren Genen, die für die Reparatur von DNA-Schäden, die 
Zellzykluskontrolle und die Entgiftung nötig sind. 
Beim Vergleich der Antwort zweier unterschiedlicher Stämme auf eine Behandlung 
mit MMS in niedrigen Konzentrationen zeigte der Stamm BY4742 eine höhere 
Empfindlichkeit auf MMS als der Stamm FF18984. Während FF18984 eine sofortige starke 
Anpassung der Transkription, einschließlich einer stärkeren Aktivierung der ESR, zeigte, war 
im Stamm BY4742 keine transkriptionale Regulation vieler Gene zu beobachten. Besonders 
Gene, die an der Proteinbiosynthese, der mRNA Prozessierung und der 
Transkriptionsregulation beteiligt sind, wurden nicht auf die gleiche Weise, wie im Stamm 
FF18984 beeinflusst. Unter den Genen, die in BY4742 induziert wurden, gehören weniger als 
drei zu einer funktionellen Gruppe. Diese Ergebnisse führen uns zu der Schlussfolgerung, 
dass BY4742 für eine ähnliche Antwort mehr Zeit benötigt als FF18984. Die andauernde 
Proliferation dieses Stammes während der ersten Stunden der MMS Behandlung führt 
wahrscheinlich zu einer größeren Ansammlung von Mutationen, zur Umwandlung primärer 
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Veränderungen zu Doppelstrangbrüchen (DSB) und auf diese Weise zu einer höheren 
Empfindlichkeit gegenüber toxischen Agenzien.  
Die Anpassung der grundlegenden Metabolismuswege und die Induktion des „Diauxic 
Shifts“ sind weitere Faktoren, die direkt an der gesteigerten Widerstandskraft des Stammes 
FF18984 gegenüber MMS beteiligt sind. Die durch eine Entziehung von Nährstoffen 
vermittelte Induktion der ESR und die damit verbundene metabolische Anpassung ermöglicht 
es den Zellen mit toxischen Effekten genotoxischer Agenzien, die wie MMS später zugefügt 
werden, zurechtzukommen. Unsere Ergebnisse zeigen, dass der wichtigste Stimulus für eine 
angepasste Antwort und die Induktion der ESR Gene auf eine MMS Behandlung, eine 
Änderung in der Glukosenutzung ist. Diese Ergebnisse führen zu einer wichtigen Beziehung 
zwischen den metabolischen Signalwegen und der Fähigkeit lebender Organismen mit 
ungünstigen Umweltbedingungen umzugehen. Des Weiteren scheint die Induktion der ESR 
die wichtigste Bedingung für eine korrekte und schnelle zelluläre Antwort auf DNA Schäden 
zu sein.  
 Die Expression des Schlüsselenzyms der Glukoneogenese Fructose-1,6-
bisphosphatase (FBP1) wird durch eine Behandlung mit MMS in glukosereichem Medium 
hochreguliert. Interessanter Weise führt das Fehlen von FBP1 zu einer Verringerung der 
Sensitivität gegenüber MMS, nicht aber gegenüber anderen DNA schädigenden Substanzen, 
wie 4-Nitroquinolin (4-NQO) oder Phleomycin. Die verringerte Sensitivität des Δfbp1 
Mutanten ist das Ergebnis einer besseren Erholung dieses Mutanten nach einer 
Langzeitbehandlung mit MMS. Das Wiedereinführen von FBP1 in einen Knockoutstamm 
stellt den Phenotyp des Wildtyps wieder her, wohingegen die Überexpression von FBP1 zu 
einer gesteigerten MMS Sensitivität des Wildtyps führt. Die Expression eines Fbp1-
Fusionsproteins mit terminalem GFP reicht aus, um im Knockoutstamm das Wachstum auf 
nicht fermentierbaren Kohlenstoffquellen zu ermöglichen; die Empfindlichkeit gegen MMS 
in Δfbp1 Zellen kann aber nicht wiederhergestellt werden. Dies impliziert, dass die Funktion 
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der FBPase für das Zellwachstum auf alternativen Kohlenstoffquellen, unabhängig sein 
könnte von seiner Funktion bei der Antwort auf eine MMS Behandlung. 
 Die Verbindung zwischen Fbp1p und einer der wichtigsten Signalkaskaden bei DNA 
Schäden, die mit den Mec1/Tel1 Sensoren beginnt, wurde mit Hilfe des RNR2-GFP 
Reporterassays untersucht. Diese Experimente offenbaren, dass die Deletion von FBP1 
keinen Einfluss auf die Induktion des RNR2 Promotor hat, während eine Überexpression von 
FBP1 zu einem signifikanten Anstieg der Aktivität des RNR2 Promotors führt. Dieses 
Ergebnis deutet auf die Schlussfolgerung hin, dass der ansteigende zelluläre Fbp1p Spiegel 
nach einer DNA- Schädigung, durch MMS möglicher Weise als ein Signal fungiert, das die 
Antwort der Zelle auf dieses toxische Agens vermittelt. 
 Die Deletion von FBP1 vermindert die Bildung von Reaktiven Sauerstoff Spezies 
(ROS) als Antwort auf MMS oder in gealterten unbehandelten Zellen. In Vollmedium zeigten 
Mutanten eine verzögerte ROS Produktion in den ersten fünfzehn Tagen einer alternden 
Kultur, was zu einer besseren Lebensfähigkeit führte. In Minimalmedium ist das Fehlen vom 
Fbp1p kein Vorteil für das Überleben der Zellen. Unter diesen Bedingungen überlebten sogar 
weniger Δfbp1 Mutanten und sie akkumulierten ähnliche ROS Spiegel. Erhöhte Mengen 
Fbp1p verkürzten die Lebenszeit, hatten jedoch keinen Einfluss auf die Ansammlung von 
ROS. Diese Ergebnisse zeigen, dass Fbp1p ein bedeutender Faktor ist, der die Produktion von 
ROS als Antwort auf eine MMS Behandlung und das Altern moduliert. In Medien mit 
eingeschränktem Nährstoffangebot ist Fbp1p jedoch ein kritischer Faktor für das Überleben 
der Zellen und sein Fehlen ist eher ein Nachteil. 
 Auf Grundlage dieser Beobachtungen kommen wir zu dem Schluss, dass FBP1 die 
Verbindung zwischen der Schädigung der DNA, dem Altern und oxidativem Stress, entweder 
über einen direkten Signalweg oder durch eine komplexe Anpassung im 
Energiemetabolismus, beeinflusst. Als Folge sind die enge Regulation der FBP1 Expression 
und die mit dem Alter verknüpften Veränderungen im Glukosestoffwechsel nicht nur für die 
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Kontrolle der Gukoneogenese, sondern auch für eine passende Reaktion auf das Altern und 
die Schädigung von DNA entscheidend. 
      1. Introduction 
 1
1. Introduction 
 
All eukaryotic cells are constantly exposed to exogenous or endogenous agents that 
damage DNA. DNA is highly reactive and easily altered either by normal cell processes or by 
exogenous factors. One estimate is that a mammalian genome undergoes about 100,000 
modifications per day, each bearing a finite probability of residual damage (Friedberg et al., 
1995). Whether DNA damage is only a simple base change or more complex like deletions, 
fusions, translocations, or aneuploidy, accumulation of unrepaired DNA damage increases 
genetic instability that can lead, among other things, to elevation of intracellular levels of 
reactive oxygen species (ROS) or facilitate tumor promotion and progression. Mutational 
changes of proto-oncogenes which are involved in normal cellular functions can generate an 
oncogene. The examples are oncogenes derived from the c-ras family. Each of the c-ras proto-
oncogenes can give rise to a transforming oncogene by a single base mutation. Moreover, 
almost any mutation at either position 12 or 61 can convert a c-ras proto-oncogene into an 
active oncogene (see Lewin, 2000). Increased genetic instability can also lead to activation of 
proto-oncogenes by elevated insertion, translocation or amplification events in the cell. One 
such example is the bcr-abl fusion protein derived from reciprocal translocation of the 5000 kb 
region from the end of chromosome 9, carrying c-abl, to the bcr gene of chromosome 22. This 
fusion protein appears to activate the Ras pathway for transformation. Depending on the 
breakpoint in the bcr gene the consequence of this translocation is developing of either chronic 
myelogenous leukemia (CML) or acute lymphoblastic leukaemia (ALL). The translocation can 
be detected by the presence of the Philadelphia (PH1) chromosome in patients with CML or 
ALL (see Lewin, 2000).  
To ensure that the potentially irreparable damage will not give rise to viable mutants 
with an instable genome, both prokaryotic and eukaryotic cells developed a complex network 
to detect and eliminate such changes, known as the DNA damage response. The fact that just a 
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single double strand DNA brake (DSB) can facilitate cell cycle arrest and subsequently trigger 
apoptosis (Rich et al., 2000) can illustrate the importance of genome stability maintenance and 
the need to develop an elaborate mechanism to monitor and keep this stability. Therefore, it is 
not surprising that these mechanisms and their components have been conserved throughout 
the evolution from unicellular to mammalian organisms. Thus, budding yeast, Saccharomyces 
cerevisiae, as a model organism provides an exciting possibility of discovering genes that play 
important role in the DNA damage response.  
 DNA damage response is a hierarchical process which includes subsequent activation 
of signalling pathways that culminate in activation of four response pathways: DNA repair, 
DNA damage checkpoints, transcriptional response, and apoptosis. These pathways may 
function independently, but frequently a protein primarily involved in one response participates 
in other responses. Defects in any of these pathways may cause genomic instability (Sancar et 
al, 2004). The magnitudes of these responses and, especially, cell fate choice are proportional 
to the dose, time and type of damaging agent applied. All of these four processes orchestrate 
together.  DNA damage checkpoints ensure cell cycle arrest giving the repair mechanisms 
enough time to fix the damage. The transcriptional response induces transcription of proteins 
involved in the repair process, but also of the general stress response. Moreover, it is also 
required to maintain the internal homeostasis of cells. Eventually, if the damage cannot be 
repaired apoptosis is induced to remove the seriously damaged cells. 
  
1.1. DNA lesions and structures that elicit DNA response reactions and DNA 
damage recognition 
DNA molecules, like all other biomolecules, can be damaged in numerous ways. 
Spontaneous damage due to replication errors, deamination, depurination and oxidation is 
compounded in the real world by the additional effects of radiation and environmental 
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chemicals. DNA lesions and structural alterations that induce DNA damage response and 
binding of recognition factors include (Fig.1): 
• Replication, recombination, and repair intermediates that include fork structures, 
bubbles, Holliday structures, and other nonduplex DNA forms (Cox et al., 2000). 
• DNA base damages produced by different agents include chemical modifications and 
photodamage. Chemical modifications imply deamination, reduction, oxidation, or 
bases fragmentation. Deamination includes conversion of primary amino groups to 
keto groups, adenine to hypoxanthine, guanine to xanthine, and 5-methyl cytosine to 
thymine. The agents that lead to chemical modifications of DNA are, for instance, 
reactive oxygen species (ROS), alkylating agents like methyl methanesulfonate 
(MMS), N-methyl-N´-nitro-N-nitrosoguanidine (MNNG) and 1,3-bis(2-chloroethyl)-1-
nitrosourea (BCNU), or 4-nitroquinoline 1-oxide (4-NQO) that produce quinoline-
purine monoadducts, the so called “bulky adducts”. Photodamage could be induced by 
ultraviolet radiation (UV) that leads to formation of pyrimidine dimers (most frequent 
are cyclobutane pyrimidine dimers) and pyrimidine (6-4) pyrimidone photoproducts 
(6-4PPs) causing extensive distortion of the normal DNA structure (Sancar et al., 
2004). Nearly half of chemotherapeutic drugs, including cisplatin, mitomycin C, 
psoralen, nitrogen mustard, and adriamycin, make different base adducts. In addition 
to the impact of exogenous chemicals, normal metabolism frequently leads to 
alkylation. It has been shown that S-adenosylmethionine, the normal biological methyl 
group donor, reacts accidentally with DNA to produce alkylated bases like 3-
methyladenine at a rate of several hundred per day per mammalian haploid genome 
(Rydberg and Lindahl, 1982). 
• DNA backbone damages include abasic sites and single- and double-strand DNA 
breaks. Abasic sites (apurinic/apyrimidinic (AP) sites) are generated spontaneously, 
by the formation of unstable base adducts or by base excision repair. Within a typical 
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mammalian cell, several thousand purines and several hundred pyrimidines are 
spontaneously lost per haploid genome per day (Smith, 1992). Single-strand breaks 
are produced directly by damaging agents or as intermediates of base and nucleotide 
excision repair. Double-strand breaks are formed by ionizing radiation (IR) and other 
DNA-damaging agents, but they are also essential intermediates in recombination.  
• Cross-links that can be produced by bifunctional agents such as cisplatin, nitrogen 
mustard, mitomycin D or psoralen, but could also be an effect of UV and IR. 
Bifunctional alkylating agents and radiation can also create crosslinks between DNA 
and protein molecules. 
 
             Figure 1. DNA lesions and structures that elicit DNA response reactions. Some of the base 
backbone lesions and noncanonical DNA structures that elicit DNA response reactions are shown. O6 MeGua 
indicates O6-methyldeoxyguanosine, T__T indicates a cyclobutane thymine dimer, and the cross-link shown is 
a cisplatin G-G interstrand cross-link (from Sancar et al., 2004). 
 
Based on the type of DNA lesion and of proteins that recognise corresponding 
structural alterations, DNA damage sensors can utilize several strategies to recognise damage 
and initiate DNA damage response. The simplest way is a direct recognition based on 
complementarity of a particular DNA damage and a cognate protein, usually an enzyme. 
Photolyase and DNA glycosylase illustrate the enzymes that can directly recognise DNA 
damage. Photlyase is a monomeric protein of 55–65 kDa with two chromophore cofactors, a 
pterin in the form of methenyltetrapydrofolate and a flavin in the form of FADH-. This 
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enzyme is able to directly repair UV-induced cyclobutane pyrimidine dimers and 
photoproducts using blue-light photons as an energy source, but it is absent in many species, 
including humans (Sancar, 2003).  
The second very important way of DNA damage recognition is a multistep recognition 
which includes molecular matchmakers and combinatorial recognition. A molecular 
matchmaker is a protein that by itself is not directly involved in the repair process, but rather 
promotes association of other repair proteins into a complex bound to the damage site and 
than dissociates from the complex. Those proteins usually utilise energy from ATP 
hydrolysis. An example for a molecular matchmaker is the eukaryotic replication factor C 
(RFC) that loads PCNA (Proliferating Cell Nuclear Antigen) onto DNA and then dissociates, 
allowing PCNA to act as a DNA polymerase clamp and confer high processivity upon the 
polymerase (Sancar et al., 2004).  
Combinatorial recognition implies a synergistic action of two or more proteins for 
promoting DNA repair (Naar et al., 2001). The example are three human damage recognition 
proteins, RPA, XPA, and XPC that cooperatively act in nucleotide excision repair in order to 
achieve a high-specificity in recognition. Each of these is a DNA-binding protein with some 
preference for damaged DNA. RPA is the most abundant factor, while XPC has the highest 
specific and non-specific constant. The moderate specificity of cooperative binding of these 
factors is amplified by the kinetic proofreading function of the transcription/repair factor 
TFIIH with 3’ to 5’ and 5’ to 3’ helicase activities. TFIIH is recruited by three damage 
recognition factors. Together they form a preincision complex 1 (PIC1) and the DNA is 
unwound by about 20 bp at the assembly site. If they assemble at a non-damaged site, ATP 
hydrolysis by TFIIH leads to the disassembly of the complex (kinetic proofreading). PIC1 
formed at a damage site is more stable, and the unwound DNA constitutes a high-affinity 
binding site for XPG which is followed by disassociation of XPC from the complex and 
formation of PIC2. Finally, association of XPF•ERCC1 with the complex form PIC3, that 
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result in irreversible dual incisions and release of the excised oligomer (reviewed in Sancar et 
al., 2004).   
In some cases, proteins that are not part of DNA repair machinery provide so called 
proxy mechanism of recognition. One of them is RNA polymerase that simply arrests at the 
damage site and thus helps recruit the repair proteins (Friedberg, 1996). Moreover, DNA 
repair intermediates generated by one repair pathway could initiate another repair mechanism. 
A gap created by nucleotide excision repair, for instance, could be recognised and further 
repaired by homologous recombination (Cox, 2001). 
 
1.2. DNA repair pathways  
To handle genotoxic stress, cells have evolved a number of mechanisms to either 
repair or tolerate DNA damage. These pathways include direct repair (DR), base excision 
repair (BER), nucleotide excision repair (NER), mismatch repair (MR), homologous 
recombination (HR), nonhomologous end-joining (NHEJ) mechanisms and translation bypass 
synthesis (TBS) (Fig.2).  
1.2.1. Direct repair 
Although it might seem that direct reversal of damage would be the simplest way to 
correct the damage, in most cases the reverse reaction is not possible for thermodynamic or 
kinetic reasons (Kao et al., 2005; Zang et al., 2005).  Beside the aforementioned DNA 
photolyase which repairs UV-induced cyclobutane pyrimidine dimers, the other enzyme 
involved in direct repair methylguanine, DNA methyltransferase, has nearly universal 
distribution in nature. This enzyme recognizes damage by three-dimensional diffusion and 
forms a low-stability complex with the DNA. O6-methyldeoxyguanosine (O6MeGua) is than 
flipped-out into the active site cavity, wherein the methyl group is transferred to an active site 
cysteine. This C-S bond of methylcysteine is stable, and therefore, after one catalytic event 
the enzyme becomes inactivated (Sancar et al., 2004). To accomplish this, in E.coli and 
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perhaps in other organisms, the alkylated version of the protein induces increased 
transcription of the gene encoding the protein (Teo et al., 1984). Another example in humans 
is oxidative methyl transferase (hABH1–3), an alpha-keto-glutarate-dependent and iron-
dependent oxygenases (aKG-Fe(II)-oxygenases), which use iron-oxo intermediates to oxidize 
chemically inert compounds.  hABH1–3 is capable of repairing 1-methyladenine and 3-
methylcytosine (Sancar et al., 2004). 
1.2.2. Base excision repair (BER) 
All three excision mechanisms: base excision repair, nucleotide excision repair and 
mismatch repair cut out and replace damages present in one strand by using the 
complementary strand as template. The first, base excision repair pathway, for instance, 
removes incorrect bases present in one strand by employing three common steps. In the first 
step DNA N-glycosylase removes the damaged base and creates an AP site. This step is 
followed by cleavage at the abasic site by an apurinic/apyrimidinic (AP) endonuclease and 
subsequently, extension of the 3'-OH terminus by a DNA polymerase, accompanied by 
excision of the AP site. In the end, human DNA ligase III and XRCC1 protein ligate the gap 
(Rich et al., 2000).  
A large number of DNA N-glycosylases have been identified that specifically 
recognise different types of incorrect bases: uracil (uracil-DNA glycosylase), alkylated 
purines (methyl- purine glycosylase), oxidized/reduced pyrimidines (homologues of E. coli 
endonuclease III), or oxidized purines (homologs of E. coli Fapy glycosylase or 8-oxoguanine 
glycosylase) (Sancar et al., 2004). The general principle of damage recognition by DNA 
glycosilase is pinching the DNA while scanning it. The result is that the DNA kinks at 
positions of instability caused by mismatching and binds to the enzyme (Mol et al., 1999). 
Some DNA glycosylases in addition to glycosilase activity cleave off the base by a lyase 
mechanism and catalyze a subsequent AP lyase reaction. The major polymerase used for base 
excision repair in mammalian cells is polymerase beta, which has two distinct enzymatic 
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activities: polymerase activity and deoxyribose phosphatase activity used to excise the 
deoxyribose phosphate moiety in a case where glycosylase lack lyase activity (Prasad et al., 
1998).  
E. coli Mammals Yeast Substrates Other functions 
 
XTH APE1 (HAP, APE, 
hAPE, ref-1) 
Absent AP sites, 3´phosphate, 
3´phosphoglycolate 
Redox activation of transcription 
factors and 
bioreductive drugs, activation of 
p53, 3´ 
diesterase activity ~100-fold less 
than 
endonuclease activity, 
3´mismatch 
exonuclease 
 
no homologue 
 to date 
APE2 APN2 AP sites, 3´phosphate, 
3´phosphoglycolate 
 
NFO no homologue 
 to date 
APN1 AP sites, 3´phosphate, 3´ 
phosphoglycolate 
3´diesterase activity = 
endonuclease activity 
 
NTH1 NTH1 no homologue  
to date 
Thymine glycol, 5-hydroxy- and 6-
hydroxy-dihydrothymine (DHT), 
uracil glycol, 5-hydroxycytosine, 
5-hydroxyuracil, β- 
ureidoisobutyric acid, urea 
 
 
no homologue 
 to date 
no homologue  
to date 
NTG1 and NTG2 
(endo III homologues) 
Thymine glycol, 5-hydroxy-6-
hydrothymine, 5-hydroxy-6-
hydrouracil, 
5-hydroxy-5-methylhydantoin, 5-
hydroxyuracil, 5,6-dihydrouracil, 
5-hydroxycytosine, DHT, urea, 
uracil glycol, 
Formamdiopyrimidine 
G (FapyG), Fapy A, 8- oxoG:G 
 
NEI NEIL1 Absent Same as NTH1. In addition, endo 
VIII also recognize 8-oxoG, in 
particular when 8-oxoG is paired 
with A or G. 
 
UNG  UNG UNG Uracil in both single and double 
stranded DNA 
 
MUG  DUG Absent Uracil and thymine (in T/G 
mismatch) in double stranded 
DNA. 
Ethenocytosine 
 
FPG OGG1 OGG1 8-oxoG:C, 8-oxoG:G, 8-oxoG:T, 
FapyG, FapyA 
 
Mut Y MYH Absent 8-oxoG:A  
Mut T MTH Absent 8-oxo-dGTPase  
 
Table 1. Comparison of BER enzymes in E. coli, yeast, and mammals 
 
The 1-nucleotide replacement pathway is called a short-patch base excision repair, the 
alternative mechanism being a long-patch base excision repair. In general, base excision 
repair initiated by glycosylases is a short patch initiated by AP sites resulting from 
“spontaneous hydrolysis”, while oxidative base loss is a long patch (Sancar et al., 2004). 
Another difference is that human long patch pathway, for instance, employs enzymes of DNA 
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replication, DNA polymerase delta and epsilon in combination with PCNA, FEN1 and DNA 
ligase 1. This mechanism involves synthesis of a new stretch, usually 2-10 nucleotides long, 
which results in displacement of the strand terminated by deoxyribosephosphate group made 
by APE1 (Sancar et al., 2004). Although BER pathway in S.cerevisiae shares some 
homologues with the mammalian one, their main players are remarkably divergent (Table 1). 
1.2.3. Nucleotide excision repair (NER) 
NER is the major repair system for removing bulky DNA lesions formed by exposure 
to radiation or chemicals, or by protein addition to DNA. It recognizes damaged regions based 
on their abnormal structure as well as on their abnormal chemistry. The basic steps of 
nucleotide excision repair are (a) damage recognition, (b) dual incisions of the damaged 
strand to form a 12–13-nt oligomer in prokaryotes or a 24–32-nt oligomer in eukaryotes, (c) 
release of the excised oligomer, (d) repair synthesis to fill in the resulting gap, and (e) ligation 
(Sancar et al., 2004).  
In both prokaryotes and eukaryotes, the excision follows a similar path: an ATP-
independent, low-specificity recognition complex (XPC/HR23B in humans) recognise the 
damage, which is followed by an ATP-dependent DNA unwinding by two subunits of 
transcription factor TFIIH (XPB and XPD in humans) and formation of a long-lived DNA-
protein complex (stabilised by three additional proteins XPA, RPA and XPG in humans), and, 
finally, dual incisions by two nucleases (XPG and ERCC1/XPF in humans) (Petit and Sancar, 
1999). The damage-containing oligonucleotide is displaced concomitant with the binding of 
replicative gap-repair proteins (humans RFC, PCNA, DNA polymerase delta or epsilon) and 
the final nick is sealed by DNA ligase I. Mutation in any of NER genes give rise to human 
DNA repair diseases, like Xeroderma pigmentosum (XP), Cockayne’s syndrome or 
trichothiodystrophy. XP is characterized by a very high incidence of light-induced skin 
cancer, Cockayne’s syndrome by growth retardation, photosensitivity, premature aging and 
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early death, while hallmarks of trichothiodystrophy are hair dysplasia and numerous 
symptoms affecting mainly organs derived from the neuroectoderm (Cleaver, 2005).  
Tanscription-coupled NER and BER are special types of excision repair. They utilise 
the stalling of RNA polymerase at damaged site of transcribed strain for damage recognition 
(Mellon, 2005). Generally, removal of certain types of DNA damage is more rapid and more 
efficient from the transcribed strands of expressed genes in comparison to the non-transcribed 
strands. 
1.2.4. Double-strand break repair 
Double-strand DNA breaks are repaired either by homologous recombination (HR) or 
nonhomologous end-joining (NHEJ) mechanisms. Homologous recombination obtains 
instructions from the sister chromatide or homologous chromosome for proper repair of 
breaks consisting of three major steps: strand invasion, branch migration, and Holliday 
junction formation (Wyman et al., 2004; Krogh and Symington, 2004). Strand invasion and 
branch migration are initiated by Rad51 in eukaryotes or RecA in prokaryotes. In eukaryotes, 
Rad52, Rad54, Rad55, Rad57, BRCA1, and BRCA2 are also involved in homologous 
recombination, but the precise roles of these proteins are unclear. The Mre11/Rad50/NBS1 
(M/R/N) complex (Mre11/Rad50/Xrs2 complex in yeast) performs the nucleolytic processing 
of DSBs before initiation of strand invasion by Rad51. The MUS81-MMS4 heterodimer 
resolves the Holliday junctions or the topologically equivalent four-strand intermediates 
arising from replication fork regression.  
A transitional pathway between HR and NHEJ is the so-called single-strand annealing 
(SSA) repair mechanism. In this case, the ends of the duplex are digested by an exonuclease, 
possibly the M/R/N complex (Paull and Gellert, 1998), until some of homology regions 
(usually short repeat sequences are abundant in mammals) on the two sides of the break are 
exposed and paired. Considering that nonhomologous tails are cut away, loss of information 
is inevitable.  
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NHEJ permits joining of ends even if there is no sequence similarity between them. In 
NHEJ the Ku heterodimer (encoded by HDF1 and HDF2 in yeast) binds to the two ends of a 
double-strand break and recruits DNA-PKcs (not present in yeast)  and the ligase4-XRCC4 
heterodimer (Lig4/Lif1 complex in yeast), which then ligates broken dsDNA molecules after 
their ends have been properly processed. (Hefferin and Tomkinson, 2005). DNA-PK 
phosphorylate a special protein Artemis (absent in yeast) which by its endonuclease activity 
creates blunt double-stranded structures that are good ligase substrates. The M/R/N complex 
may also participate in NHEJ, particularly when this pathway is utilized for V(D)J 
recombination, a site-specific DNA rearrangement process which assembles the variable 
regions of immunoglobulin and T-cell receptor genes from multiple germline V, (D) and J 
gene segments (Roth, 2000).  
There are indications that HR is important for the recovery of collapsed replication 
forks, while, NHEJ is essential for V(D)J recombination and is thought to be the major 
pathway for repair of double-strand breaks induced by ionizing radiation and radiomimetic 
agents (Sancar et al., 2004). Despite its inaccuracy, mammals seem to favour NHEJ as their 
repeat-ridden genomes make sequence alignment tricky, while HR is dominant double strand 
break repair pathway in yeast (Rich et al., 2000).  
      1. Introduction 
 12
 
Figure 2. DNA repair mechanisms (from Rich et al., 2000; see text for the detailed explanation). 
 
1.2.5. Mismatch repair 
Mismatch repair pathway corrects mismatched nucleotides and small loops. Most of 
the mismatches occur due to replication errors that result in double helix distortion. Because 
neither nucleotide is damaged or modified, it is not obvious which strand carries the correct 
genetic information and which carries the error; thus, the mismatch repair cannot be 
accomplished by a mechanism such as BER or NER, which simply excise the damaged base, 
or a short DNA fragment containing the damage, respectively (Stojic et al., 2004). In the 
initial step of mismatch repair in E.coli MutS recognizes mismatches in the DNA and binds to 
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them. This is followed by binding of second protein MutL that stabilizes the complex 
(Schofield and Hsieh, 2003). Distinction between old and newly synthesized (presumably 
incorrect) strand is made based on methylation at GATC sequences of the old strand in E.coli, 
and single-strand nicks in eukaryotes (the presence of gaps between Okazaki fragments on the 
lagging strand or the free 3´-terminus on the leading strand; Stojic et al., 2004). The MutS-
MutL complex activates further MutH which in cooperation with UvrD nicks the newly 
synthesized strand. Missing nucleotides are resynthesized by polymerase II and ligated at the 
end of the repair process.   
Although lacking the homologous of MutH and UvrD, eukaryotic organisms possess 
numerous homologous of MutS and MutL, like MSH2-6 (homologous of MutS), PMS1-2, 
MLH1-3 (both homologous of MutL). Interestingly, the eukaryotic homologous all function 
as heterodimers. In eukaryots several other proteins are needed for this repair: PCNA, RPA, 
replication factor C and DNA polymerase delta in humans (Stojic et al., 2004).  
1.2.6. DNA damage bypass 
In some cases, during the replication damage encountered in template, the strand may 
not be reparable. In these situations damage could become simply bypassed. In S.cerevisiae 
RAD6 epistasis group is responsible for this process (Broomfield et al., 2001). The major 
alternative bypass pathway, translesion synthesis, can be either non-mutagenic or mutagenic, 
depending on the type of damage and the repertoire of translesion polymerases available to 
the cell. In yeast polymerases zeta and eta are involved in this process.  
Various repair pathways may share certain enzymes and reaction intermediates. 
Conversely, particular lesions might be repaired by more than one pathway, in which case, 
they might compete for the same substrate, interfering with one another’s function, or 
cooperating in removing the lesion. Likewise, it is unclear whether a particular damage-
specific binding protein can act as a nucleation site for more than one repair pathway. 
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1.3. DNA Damage Cell Cycle Checkpoints 
Progression through the cell cycle is tightly controlled by cell cycle checkpoint 
mechanisms. During the transition from one cell cycle phase to another, checkpoint proteins 
control the integrity of macromolecules, like DNA and proteins, as well as the successful 
completion of cellular processes prior the initiation of the next cell cycle phase. If the 
macromolecular damage, especially DNA damage is sensed, checkpoint response mediates 
cell cycle arrest, DNA damage repair and transcriptional induction of certain genes involved 
in the general stress response and DNA damage repair. Growth arrest represents an adaptive 
and integrated part of the cellular stress response. It ensures preservation of energy and 
reducing equivalents necessary for macromolecular stabilization and repair, and, what is also 
very important, gives enough time for the repair process. Proliferating cells that actively 
undergo DNA replication and mitosis are more prone to suffer stress-induced damage to 
macromolecules than the cells in a resting state (Kültz, 2005). Therefore, the activation of cell 
cycle checkpoints is the key mechanism in prevention of further cellular damage. 
In yeast, there are four checkpoints in the cell cycle in which cellular division could be 
ceased (Fig.3): at the G1/S transition (the G1 checkpoint), during the S phase to prevent DNA 
replication (the S-phase progression checkpoint) and mitosis (the S/M checkpoint), and at the 
G2/M boundary (the G2/M checkpoint) (reviewed in Elledge, 1996; Longhese et al., 1998; 
Weinert, 1998). Which checkpoint will be activated depends on the type of DNA lesion, as 
well as on the consequences of the damage. For example, ionizing radiation triggers G2/M 
arrest, preventing loss of DNA fragments during division (Weinert and Hartwell, 1989), 
whereas base modifications that inhibit DNA replication activate the S-phase progression 
checkpoint (Paulovich and Hartwell, 1995).  
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Figure 3. The cell cycle phases in Saccharomyces cerevisiae, periodicity of cyclins and DNA damage 
cell cycle checkpoints. Cyclins are grouped according to suggested times of action during the cell cycle and 
mRNA periodicity. As indicated by *, CLN3 is the exception to the rule in that its mRNA levels remain constant 
throughout the cell cycle.  
.  
The DNA damage checkpoint conceptually has three components (Fig.4; Table 2): 
sensors, signal transducers, and effectors. However, various components of the checkpoint 
could serve at the same time in several steps. For example, the damage sensor, ATM, also 
functions as a signal transducer. Moreover, the fourth class of checkpoint mediator proteins, 
placed between sensors and signal transducers, has been identified. In humans this class 
includes BRCA1, Claspin, 53BP1, and MDC1. These mediator proteins also appear to 
participate in more than one step of the checkpoint response (Sancar et al., 2004).  
Checkpoint-specific damage sensors can be classified into two groups: 
phosphoinositide 3-kinase-like kinase (PIKK) family members, presented with ATM (for 
ataxia telangiectasia mutated) and ATR (ataxia telangiectasia Rad3 related), and the 
RFC/PCNA (clamp loader/polymerase clamp)-related Rad17- RFC/9-1-1 complex (Melo and 
Toczyski, 2002). ATM is a sensor and transducer responding to double-strand breaks and 
ATR serves an analogous role for base damages, at least from UV irradiation. In both S. 
cerevisiae and S. pombe, the ATR homologous (scMec1 and spRad3, respectively) were 
      1. Introduction 
 16
shown to be in a complex with scDdc2 and spRad26 (Edwards et al., 1999, Paciotti et al., 
2000) (low homology protein ATRIP was identified in mammalian cells; Zou and Elledge, 
2003). The Rad17-RFC complex is a checkpoint specific structural homolog of the replication 
factor, RFC. The 9-1-1 (Rad9-Rad1-Hus1) complex is the checkpoint counterpart of PCNA, a 
homotrimer with a ring-like structure (Lindsey-Boltz et al., 2001). In vivo biochemical 
experiments show that in budding yeast the 9-1-1 complex equivalent (scDdc1- scRad17-
scMec3) is recruited to double-strand breaks introduced by HO endonuclease independently 
of recruitment of scMec1 (Kondo et al., 2001).  
 
Figure 4. Components of the DNA damage checkpoints in human cells. The damage is detected by 
sensors that, with the aid of mediators, transduce the signal to transducers. The transducers, in turn, activate or 
inactivate other proteins (effectors) that directly participate in inhibiting the G1/S transition, S-phase 
progression, or the G2/M transition (from Sancar et al., 2004; see text for the detailed explanation). 
Mutations in any of damage sensors cause chromosome instability, increase risk for 
tumor development and lead to many immune deficiency diseases. For example, mutations in 
ATM damage sensor give rise to Ataxia–telangiectasia (A–T), a human autosomal recessive 
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disorder characterized by progressive neurodegeneration, immunodeficiency and cancer 
predisposition (Sedgwick and Boder, 1991). The A–T cellular phenotype includes 
chromosomal instability, radiosensitivity and failure to adequately activate cell cycle 
checkpoints (Lavin and Shiloh, 1997).   
Protein function Mammals S.pombe S.cerevisiae 
Sensors 
RFC-like Rad17 Rad17 Rad24 
PCNA-like Rad9 Rad9 Ddc1 
 Rad1 Rad1 Rad17 
 Hus1 Hus1 Mec3 
PI3-Kinases (PIKK) ATM Tel1 Tel1 
 ATR Rad3 Mec1 
PIKK binding partner ATRIP Rad26 Ddc2/Lcd1/Pie1 
Mediators 
 MDC1   
 53BP1   
 TopBP1 Cut5 Dpb11 
 Claspin Mrc1 Mrc1 
 BRCA1 Crb2/Rph9 Rad9 
Transducers 
Kinase Chk1 Chk1 Chk1 
 Chk2 Cds1 Rad53 
 
Table 2.  DNA damage checkpoint proteins in mammals, S.pombe and S.cerevisiae. 
 
Checkpoint mediators simultaneously associate with damage sensors and signal 
transducers at certain phases of the cell cycle and as a consequence help to provide signal 
transduction specificity. In S.cerevisiae the Rad9 protein functions along the signal 
transduction pathway from scMec1 (ATR) to scRad53 (Chk2) (Vialard et al., 1998). Another 
mediator, Mrc1 (mediator of replication checkpoint), found in both S.cerevisiae and S.pombe 
(Alcasabas et al., 2001; Tanaka and Russell, 2001), is expressed only during the S phase and 
is essential for S-phase checkpoint signalling from scMec1/spRad3 to scRad53/spCds1. There 
are three checkpoint mediators identified in humans: the p53 binding protein, 53BP1 (Wang 
et al., 2002); the topoisomerase binding protein, TopBP1 (Yamane et al., 2002); and the 
mediator of DNA damage checkpoint 1, MDC1 (Stewart et al., 2003). In addition, other 
proteins such as H2AX, BRCA1, the M/R/N complex, and SMC1 (structural maintenance of 
chromatin 1), play essential roles in the activation of checkpoint kinases (Sancar et al., 2004). 
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Signal transducers are two S/T kinases, Chk1 and Chk2 (yeast Rad53), that transduce 
the double-strand break signal sensed by ATR and UV-damage signal sensed by ATM, 
respectively (Sancar et al., 2004).  
In humans, three phosphotyrosine phosphatases, Cdc25A, -B, and -C serve as effector 
proteins downstream from the signal transducers. They dephosphorylate the cyclin-dependent 
kinases that act on proteins directly involved in cell-cycle transitions. Phosphorylation of 
these Cdc25 proteins by the checkpoint kinases creates binding sites for the 14-3-3 adaptor 
proteins, which inactivates the Cdc25 proteins by excluding them from the nucleus, or 
causing proteolytic degradation. Because active Cdc25 proteins promote the G1/S transition 
by dephosphorylating Cdk2 or G2/M transition by dephosphorylating Cdc2 phosphotyrosine, 
its inactivation directly arrests the cell cycle in G1 or G2 phase, respectively (Bartek and 
Lukas, 2001). In S.cerevisiae there are few effectors downstream from Rad53 and Chk1 
signal transducers (Wahl and Carr, 2001). Rad53p mediates phosphorylation of Swi6, a part 
of the SCB (Swi4/6 cell-cycle box) binding factor (SBF) and MCB (MluI cell-cycle box) 
binding factor (MBF). MBF is required to transcribe a range of genes required for S phase 
entry and DNA replication. Rad53 also phosphorylates Cdc5 (a polo-like kinase that regulates 
the anaphase-promoting complex), whereas Chk1 phosphorylates Pds1, an inhibitor of sister 
chromosome separation and anaphase. 
 
1.4. Transcriptional response to DNA-damaging agents in yeast 
An important aspect of each cellular response to DNA damage is the reorganization of 
gene expression. The first works that monitor transcriptional response of yeast cells to the 
DNA damage induced by MMS, revealed that ~30% of mRNA species could be regulated by 
MMS treatment in dose and time dependent manner (Jelinsky and Samson, 1999; Jelinsky et 
al., 2000). Transcriptional alteration after DNA damage is a coordinate process initiated by 
damage sensors, like ATR or ATM proteins. Gasch et al. (2001) showed that ATM homolog 
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Mec1 regulates transcription of the whole set of genes in response to DNA damage (Fig.5). 
Mec1 signalling pathway activates two checkpoint kinases, Rad53 and Chk1. Signal 
transduced through Chk1 leads to the regulation of cell cycle specific genes and cell cycle 
arrest. Kinase cascade Mec1-Rad53-Dun1 induce transcription of transcriptional factors, like 
Msn2 and Msn4, involved in expression of genes part of environmental stress  response 
(ESR). This cluster involves more than 900 genes whose expression is stereotypically altered 
in response to different stress conditions (Gasch et al., 2000). The group of genes whose 
transcription is induced in the ESR includes those that encode proteins involved in 
carbohydrate metabolism, protein folding and degradation, oxidative stress defence, 
autophagy, cytoskeletal reorganisation, DNA-damage repair. Genes that are repressed in the 
ESR are mostly those required for ribosome synthesis and processing, RNA polymerase I- 
and III-dependent transcription and protein translation. The proposed role of transcriptional 
regulation triggered by DNA damage is energy conservation and maintenance of internal 
osmolarity, oxidation-reduction potential and integrity of cellular structures. The global and 
coordinated activation of yeast stress response genes is enabled by bimodal transcriptional 
regulation of yeast genome. Namely, Huisinga and Pugh (2004) showed that genome of 
S.cerevisiae is divided into genes preferentially targeted by SAGA (Spt-Ada-GCN5-
acetyltransferase) transcriptional complex (~10% of the genome) and genes preferentially 
targeted by the TFIID transcriptional complex (~90% of the genome). Many SAGA-regulated 
genes are stress inducible, whereas most TFIID regulated genes have housekeeping functions.   
Undoubtedly, DNA-damaging agents damage not only DNA, but also other cellular 
macromolecules, and organelles as well. Those agents that affect protein structure and result 
in protein unfolding or misfolding induce transcription of genes encoding protein chaperones 
and proteasome subunits (Fig.5). Moreover, many of DNA-damaging agents alter the cellular 
redox potential and create high oxidative stress through formation of free radicals.  Therefore, 
these agents often induce transcription of cellular redox sensors, like AP-1 (yeast Yap1) and 
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its targets, e.g. genes encoding: proteins involved in glutathione synthesis and conjugation, 
putative transporters required for resistance to various drugs, and proteins involved in thiol 
oxidation and reduction (Kültz, 2005).  
 
Figure 5. Summary of genomic responses to MMS and ionizing radiation. This diagram summarizes 
the functional features of the genomic expression responses: observed in the study from Gasch et al. (2001) 
(purple), transcription factors (blue) and protein kinases (yellow) that have been implicated in those genomic 
responses, and the hypothetical cellular signals that trigger the responses (orange) (from Gasch et al., 2001). 
 
In addition, reactive oxygen and nitrogen species (ROS, RNS) are employed as second 
messengers that carry signals about alterations of cellular redox potential or DNA damage 
(Mikkelsen and Wardman, 2003). Salmon et al. (2004) showed that in yeast, just like in 
mammalian cells, ROS are important second messengers in response to DNA damage. 
Elevated amount of ROS in the cell, referred to as oxidative burst, triggers induction of many 
genes involved in oxidative stress defence and cell cycle arrest, but could also lead to 
activation of apoptotic program or senescence.  Thus, increased concentrations of free radicals 
are rather beneficial for cellular stress sensing and signalling, because they enable proper 
cellular stress response and suicide of seriously damaged cells.  
Very important aspect of the DNA damage response is the modulation of major 
pathways of energy metabolism, which may be closely linked to the oxidative burst in cells 
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exposed to stress. Induction of many key enzymes involved in glycolysis, pentose phosphate 
pathway, or the Krebs (citrate) cycle may be necessary for generating reducing equivalents 
(NADH, NADPH) that are needed for cellular antioxidant systems (Kültz, 2005). The 
elevated transcription of glycerol-3-phosphate dehydrogenase (G3PDH), 6 phosphogluconate 
dehydrogenase (6PGDH), enolase, citrate synthase, and isocitrate dehydrogenase (IDH) were 
observed in response to many stress conditions or DNA damage (Jelinsky and Samson, 1999; 
Jelinsky et al., 2000; Gasch et al., 2001). Moreover, growth arrest results in redirection of 
NADPH/NADH and ATP utilization from proliferative processes to macromolecular 
stabilization and repair (Kültz, 2005). Therefore, another potential reason for inducing these 
metabolic pathways lies in the energetic requirements of protein degradation, protein 
chaperoning, and DNA repair.  
It is very important to underline that few, if any genes encoding proteins involved in 
repairing the various potentially lethal DNA lesions, are induced in response to exposure to 
the agents that produce these lesions (Birrell et al., 2002). Only a small cluster of 9 genes, 
among many considered as specific signature of DNA damage, was identified in the work of 
Gasch et al. (2001) and Jelinsky et al. (2000). These include two genes involved in 
homologous recombination (RAD51 and RAD54) as well as the ribonucleotide reductase 
subunit genes RNR2 and RNR4. This implicate that endogenous levels of various proteins 
involved in protecting against DNA damage are at sufficient levels to provide full, immediate 
and fast response to the lesions produced by the agents used.  
Cellular sensitivity to different DNA damaging agents varies widely, depending on 
species, cell type and differentiation state. It is very well known that cells that were exposed 
to low doses of certain agent become more resistant to higher doses of the same agent applied 
later. Further, cells treated with one agent show increased tolerance to another one. These two 
phenomena, the so called stress-hardening and cross-tolerance, are common and significant 
(Gasch and Werner-Washburne, 2002; Kültz, 2005). The activation and induction of a 
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common set of stress proteins is the molecular basis of both phenomena. Depending on 
species, cell type, history of prior stress exposure, gene-environment interactions during 
development, and stress severity, proteins activated by one stress remain active/elevated for a 
certain period, conferring resistance to many different types of stress. Those proteins are 
usually involved in general aspects of cellular protection like protein stabilization, DNA 
repair, and free radical scavenging.  
 
1.5. The role of apoptosis in the DNA damage response 
Apoptosis is a critical tumour suppressive mechanism. It serves to remove from the 
cellular population the cells in which damage of macromolecules or organelles is not likely to 
be efficiently and accurately repaired. The induction of apoptosis is the base of the therapeutic 
effect of many antitumor drugs, including those that damage DNA or inhibit DNA replication 
(reviewed in Ding and Fisher, 2002). Therefore, defect in apoptosis can lead to drug 
resistance (reviewed in Johnstone et al., 2002).  
Apoptotic cell death induced by DNA damage is a mitochondrial mediated process 
that results in realising of cytochrome c (Green and Evan, 2002; Wolf and Green, 2002). The 
release of cytochrome c and other apoptosis inducing factors from mytochondria is the initial 
step in activation of apoptosome. The final outcome of this process is a programmed cell 
death (Fig.6). The transmision of the damage signal to the apoptosome is under control of 
checkpoint sensors, ATM, ATR and DNA-PK. These sensors have a critical role in the DNA 
damage response system as they provide an opportunity to monitor the appropriateness of 
suicide over repair (Rich et al., 2000). They catalyse phosphorylation cascade which transmits 
damage signal to repair proteins and checkpoints, but also activates tumor suppressors. 
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Figure 6. The role of the mitochondria in DSB-specific apoptosis. Some of the principal activities 
required for regulating DSB-specific apoptosis are shown. Multi-domain Bcl-2 family members (red indicates 
pro-apoptotic and green pro-survival) are shown at the mitochondrial surface. DSB triggered apoptosis 
ultimately results in activation of pro-apoptotic or inhibition of pro-survival Bcl-2 family members, as indicated. 
The resulting release of mitochondrial factors such as cytochrome c and Smac/DIABLO (an inhibitor of IAPs, 
inhibitors of apoptosis proteins) effectively amplifies the apoptotic signal by driving apoptosome formation and 
activation of the caspase cascade (from Bree et al., 2004). 
  
How the decision between apoptosis and other fates can be made is well illustrated by 
human p53 tumor suppressor. This very important transcriptional factor in the DNA damage-
induced apoptosis is mutated in 50% of all human tumors (Halazonetis, 2004). After DNA 
damage is sensed, p53 becomes phosphorylated by ATM kinase and regulate further 
transcription of pro-survival genes involved in the cell cycle arrest and DNA damage repair, 
as well as pro-apoptotic genes (Bcl-2 family members) (Bree et al., 2004). Which cellular fate 
will be chosen depends on the levels of p53 expression. Low levels of this protein are known 
to have anti-apoptotic activity while high levels promote apoptosis (Chen et al., 1996). In 
addition, a portion of activated p53 can translocate to the mitochondria and by forming a 
complex with Bcl-XL and Bcl-2 proteins induces permeabilisation of mitochondrial outer 
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membrane (Mihara et al., 2003). p53 also promote release of histone H1.2 from damaged 
hromatin and its translocation into the cytosol, where it further induces release of cytochrome 
c (Konishi et al., 2003). The two other human proteins, involved in regulation of cell cycle 
checkpoint and apoptosis induction following DNA damage, are E2F-1 and c-Abl. These 
proteins are also phosphorylated by ATM and DNA-PK, and they function independently 
from p53 (Rich et al., 2000).  
The first correlation between DNA damage and apoptosis in yeast was shown by 
Blanchard and colleges (2002), where exposure of S.cerevisiae to lethal levels of DNA-
damaging antitumor agent caused the proteasome-dependent destruction of the DNA 
replication initiation protein Cdc6. Also other DNA damage response genes, like MEC1 or 
RAD9, have been implicated in programmed cell death in yeast (reviewed in Burhans et al., 
2003), linking yeast apoptosis to two major signalling molecules involved in DNA-damage 
repair. Yeasts were also shown to induce an apoptotic phenotype by UV irradiation (Del 
Carratore et al., 2002) or by inactivation of the yeast telomere binding protein Cdc13p (Qi et 
al., 2003). The latter results in abnormal telomeres and in the activation of the DNA damage 
checkpoint. Budding yeast cells harbouring the orc2-1, the mutation in the origin recognition 
complex required for initiation of DNA replication, also show typical apoptotic features 
(Watanabe et al., 2002). Salmon and colleagues (2004) presented that DNA damage can 
trigger an increase in ROS production suggesting that ROS may function as a signal 
mediating cellular response to unprepared DNA damage. Therefore, despite the lack of many 
pro-apoptotic proteins, like caspases and Bcl-2 family, yeast cells might contain an intrinsic 
cell death pathway. Indeed, yeast cells do undergo an apoptotic program in response to many 
external stimuli other than DNA damage: treatment with acetic acid (Ludovico et al., 2002), 
hydrogen peroxide (Madeo et al., 1999) or high levels of mating pheromone (Severin and 
Hyman, 2002).  
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The important role of ROS in the regulation of yeast apoptosis indicates the origin and 
primary purpose of the suicide process in unicellular organisms. Cells that continue 
proliferation even with the seriously damaged DNA endanger genetic stability of the 
population. In a case of unicellular organisms cells are mostly clonal relatives. Therefore, 
committing suicide in this kind of populations would save resources for neighbouring cells 
and enable the healthiest cells to survive (Herker et al., 2004). Via the p53 system higher 
eukaryotes evaluate cell damage to decide whether suicide is advisable. In a case of 
unicellular organisms, which miss such a complex system and lack p53 tumor supressor, 
chemical reactivity of ROS themselves may have been used to trigger cellular suicide. With 
this simple signalling system that triggers apoptosis, yeast offers the opportunity to easily 
screen for the substances that are directly involved in committing the programmed cell death 
without being diverted by a complex upstream network.     
 
 1.6. Objectives     
Considering that DNA damage is not only associated with immediate cytotoxicity, the 
response to substances that cause DNA damage is of particular interest. At sub-cytotoxic 
levels, DNA damaging substances play an important role in the accumulation of genomic 
mutations. In longer living organisms, like humans and other mammals, exposure to DNA 
damaging substances over extended period of time is a critical factor that contributes to the 
development of various diseases and in particular of tumors (Vogelstein and Kinzler, 1993). 
In previous studies analyzing gene expression profiles of yeast cells in response to DNA 
damaging agents, including methyl methane sulfonate (MMS), strong cytotoxic 
concentrations in short-term treatment (up to 2h) were used (Jelinsky and Samson, 1999; 
Jelinsky et al., 2000; Gasch et al., 2001). Also, in all these studies influence of nutrient 
availability, aging and strain background on cellular sensitivity and transcriptional response to 
damaging agent were not taken in consideration. However, exposure of living organisms to 
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smaller amounts of toxic agents and other adverse effects may be more common in natural 
environments. Occurring over various time spans or as the consequence of repeated exposures 
the accumulation of mutations may be as critical for the organism as the immediate cytotoxic 
effect. Therefore, cellular response to treatment with DNA-damaging substances at low 
concentrations which are genotoxic but do not have a strong cytotoxic effect are of special 
interest. In addition, environmental variations that influence growth conditions, e.g. different 
media, and individual fitness, e.g. different strains, are likely to influence and modulate the 
adverse effects of individual DNA damaging substances. 
Methyl methanesulfonate (MMS) is a methylating agent that methylates DNA at 7-
deoxyguanine and 3-deoxyadenine. The resulting 3-methyladenine (3MeA) and 7-
methylguanine cause base mispairing and replication blocks which activate DNA damage 
repair pathways and cell cycle arrest (Evensen and Seeberg, 1982). The major repair pathways 
involved in the repair of DNA alkylation damage are predominantly base excision repair 
(BER) and repair by DNA alkyltransferases (Lindahl and Wood, 1999), but all three radiation 
repair pathways are involved in this process as well (Friedberg, 1988). In yeast Mag1p (3MeA 
DNA glycosylase) removes the damaged base, than Apn1p (apurinic/apyrimidinic 
endonuclease) cleaves the DNA strand at the abasic site for subsequent repair (Friedberg et 
al., 1995). Overexpression of MAG1 causes a mutator phenotype (Frosina, 2000) as does 
mutation of APN1 (Ramotar et al., 1991), suggesting that this AP site produced by Apn1p is 
the first product of lesion processing that can be converted to a potentially lethal double 
strand brakes (DSB) and check-point activation (Frosina, 2000). In addition, MMS was 
shown to cause oxidative cell injury that follows the depletion of intracellular glutathione 
(GSH) (Mizumoto et al., 1993). A decrease in the intracellular pool of reduced GSH results in 
an increase of ROS levels. The latter of course depends on the balance of ROS production 
versus ROS scavenging. However, MMS is not expected to directly cause intracellular ROS 
formation (Salmon et al., 2004). More likely, ROS may function as a signal which mediates 
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cellular response to unprepared DNA damage. Therefore, cellular response to MMS treatment 
includes a complex network of proteins involved in DNA repair, cell cycle control, oxidative 
stress response and apoptosis. The magnitude of response will, of course, depend on the dose 
and time of treatment.   
The aim of our work was to study how strain background and growth conditions 
influence respond to DNA damage caused by low doses of MMS and which part of these 
changes is responsible for their sensitivity to toxic conditions. We analyzed sensitivity of two 
yeast strains FF18984 and BY4742 to MMS in media with limited and full nutrient 
availability, as well as in a respiratory induced medium. We also tried to find out if the 
sensitivity to MMS is influenced by aging and what are the differences in MMS sensitivity in 
yeast cells that were aged in different media. Furthermore, we analyzed and compared 
transcriptional response of two yeast strains to short-term treatment with low doses of MMS, 
as well as of yeast strains growth in full and minimal media. The MMS concentrations used 
were selected based on their relative toxic effect: either for a selective genotoxic effect 
(0.00125% MMS); or with a slightly cytotoxic effect (0.0125% MMS) at which nevertheless 
more than 50% of the cells are viable and continue proliferation. Finally, we investigated the 
role of glucose metabolism, particularly the key enzyme in gluconeogenesis fructose -1,6-
bisphosphatase (Fbp1p) in cellular response to DNA damage and aging.   
  2. Materials and methods 
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2. Materials and methods    
 
2.1. Materials 
2.1.1. Bacterial and yeast strains 
E.coli strain 
DH5α chemically competent cells (Invitrogen) 
Saccharomyces cerevisiae strains 
Strains Plasmid Genotype Source 
FF 18984 (WT)  MATa leu2-3,112 ura3-52, lys2-1, his7-1 
Provided by 
Prof.Dr. 
R.Walmsley, 
Manchester, UK 
Δfbp1  MATa leu2-3,112 ura3-52, lys2-1, his7-1;fbp1::KanMX4 This study 
Δhap4  MATa leu2-3,112 ura3-52, lys2-1, his7-1;hap4::KanMX4 ___ ’’ ___ 
Δmig1  MATa leu2-3,112 ura3-52, lys2-1, his7-1;mig1::KanMX4 ___ ’’ ___ 
Δrad9  MATa leu2-3,112 ura3-52, lys2-1, his7-1;rad9::KanMX4 
Provided by 
Prof.Dr. 
R.Walmsley, 
Manchester, UK 
BY4742  MATα ; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0 
EUROSCARF 
yeast strain 
collection 
Transformed 
 strains 
FF 18984 (WT) pRS426 as FF18984 and  URA3 This study 
FF 18984 (WT) pGen ACT as FF18984 and  URA3 ___ ’’ ___ 
FF 18984 (WT) pRS426 FBP1 as FF18984 and FBP1, URA3 ___ ’’ ___ 
FF 18984 (WT) pUMGP5 as FF18984 and GFP controled by RNR2 promoter, URA3 ___ ’’ ___ 
FF 18984 (WT) pRS425 +  pUMGP5 
as FF18984 and LEU2, URA3, and GFP controlled by 
RNR2 promoter, 
___ ’’ ___ 
FF 18984 (WT) pRS425 FBP1 +  pUMGP5 
as FF18984 and LEU2, URA3, FBP1 and GFP controlled 
by RNR2 promoter,  
___ ’’ ___ 
Δfbp1 pRS426 as Δfbp1 and URA3 ___ ’’ ___ 
Δfbp1 pGen ACT as Δfbp1 and URA3 ___ ’’ ___ 
Δfbp1 pRS426 + FBP1 as Δfbp1 and FBP1, URA3 ___ ’’ ___ 
Δfbp1 pGen ACT + FBP1-GFP as Δfbp1 and FBP1-GFP, URA3 ___ ’’ ___ 
Δfbp1 pUMGP5 as Δfbp1 and GFP controled by RNR2 promoter, URA3 ___ ’’ ___ 
Δfbp1 pRS425 +  pUMGP5 
as Δfbp1and LEU2, URA3, and GFP controlled by RNR2 
promoter, 
___ ’’ ___ 
Δfbp1 pRS425 FBP1 +  pUMGP5 
as Δfbp1and LEU2, URA3, FBP1 and GFP controlled by 
RNR2 promoter,  
___ ’’ ___ 
Δrad9 pUMGP5 as Δrad9  and GFP controlled by RNR2 promoter, URA3 ___ ’’ ___ 
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2.1.2. Plasmids used in this study 
Plasmid Selection marker in yeast  promoter Cloned DNA Source 
pRS425 GPD LEU2 GPD - Provided by Dr. T.Munder, Jena, Germany 
pRS426 GPD URA3 GPD - Provided by Dr. T.Munder, Jena, Germany 
pGen ACT URA3 ACT GFP Provided by Prof.Dr. R.Walmsley, Manchester, UK 
pRS425 GPD+ 
FBP1 LEU2 GPD FBP1 This study 
pRS426 GPD+ 
FBP1 URA3 GPD FBP1 This study 
pGen ACT + 
FBP-GFP URA3 ACT FBP1-GFP This study 
pUMGP5  URA3 RNR2 GFP Provided by Prof.Dr. R.Walmsley, Manchester, UK 
pUG6 - - Kan MX Template for PCR, EUROSCARF 
 
2.1.3. Primers used in this study 
Gene Forward primer Reverse primer Fragment 
RT_PCR primers 
ACT cat cta tcg tcg gta gac ttc tac cgg aag agt aca 348 bp 
FBP1 tcg agc acc aga agc aat agt ctc gtt cca gta gag 614 bp 
YAP1 agg ata gcg agc aac cga tat cag tgc tac cag tgc 1068 bp 
YCF1 ctg agg ata gag cat tga gtg tca gct ctc gca taa 658 bp 
Plasmid construction primers 
FBP1 
overexpression 
tgc aga cca cta gta tgc caa ctc 
tag taa atg g 
tgc aga ccc tcg agc tac tgt gac ttg 
cca ata tgg - 
FBP1-GFP fusion tgc aga cct taa tta agc caa ctc tag taa atg gac c 
tgc aga cct taa tta a ct gtg act tgc 
caa tat ggt - 
Gene disruption primers 
FBP1 disruption 
cta aca aat gta cgt ata tat atg 
gag caa caa gta gtg cca gct gaa 
gct tcg tac gc 
cgc gat cat tga act act gtg act tgc 
caa tat ggt cta agc ata ggc cac tag 
tgg atc tg 
- 
MIG1 disruption 
tgt aac tac acg aga gtt gag tat 
agt gga gac gac ata cca gct gaa 
gct tcg tac gc 
tga ttt atc tgc acc gcc aaa aac ttg 
tca gcg tat cag tgc ata ggc cac tag 
tgg atc tg 
- 
HAP4 disruption 
ggt ctc cta gta cat caa aga gca 
ttt taa tgg gtt gct gca gct gaa 
gct tcg tac gc 
aag gaa aag gac gcc taa gca ggc 
gaa gaa tac tat cat tgc ata ggc cac 
tag tgg atc tg 
 
- 
 All primers were purchased from MWG-Biotech AG (Germany).
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2.1.4. Media 
F1 Medium     Amino acids: 
Salts:      L-Lysine HCl  100 mg/l 
(NH4)2SO4  3.13 g/l   L-Leucine   100 mg/l 
KH2PO4  2.00 g/l  L-Histidine   100 mg/l 
MgSO4 * 7 H2O 0.55 g/l  Other components:  
CaCl2 * 2H2O  0.09 g/l  Glucose   20 g/l 
NaCl   0.10 g/l  Uracil    20 mg/l  
Trace elements:    YPD Medium (Ready-made “YEPD 
ZnSO4 * 7 H2O 0.07 mg/l   Broth” – Invitrogen) 
FeCl3 * 6H2O  0.05 mg/l  gives medium with: 
CuSO4 * 5 H2O 0.01 mg/l  Yeast extracts   10 g/l 
H3BO3   0.01 mg/l  Peptone   20 g/l 
KI   0.01 mg/l   Glucose   20 g/l 
Vitamins:      for plates: 2% agar 
Inositol  31 mg/l  selection: 300 µg/ml G418 
Thiamine-HCl  14 mg/l  SD Medium 
Pyridoxine  4 mg/l   Yeast nitrogen base  6.7 g/l 
Ca-Pantothenat 4 mg/l   Glucose   20 g/l 
Biotin   0.3 mg/l  L-Lysine HCl  100 mg/l 
Phosphate buffer:    L-Histidine   100 mg/l 
Na2HPO4  13.8 g/l  L-Leucine   100 mg/l 
KH2PO4  9.08 g/l  Uracil    20 mg/l 
      For plates: 2% agar 
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YPKG Medium    SDEG Medium 
Yeast extracts   10 g/l   Yeast nitrogen base  6.7 g/l 
Peptone  20 g/l   Glycerol   2% 
Potassium acetate  10 g/l   Ethanol  2% 
Glucose   5 g/l   L-Lysine HCl  100 mg/l 
L-Histidine   100 mg/l  
L-Leucine   100 mg/l  
Uracil    20 mg/l  
For plates: 2% agar  
LY medium for growth of E.coli 
Bacto-Trypton  10 g/l 
Yeast extracts  5 g/l 
NaCl    5 g/l 
For plates: 2% agar 
For selection: ampicillin 100 µg/ml of medium 
 
2.1.5. Buffers       
TES solution     Denaturing solution 
Tris-HCl  10 mM   NaOH    1 M  
EDTA    10 mM   EDTA   10 mM  
SDS    0.5%      
pH 7.5 
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Hybridisation buffer    Wash buffer I 
SDS    7%   SDS    1% 
EDTA    1 mM    EDTA    1 mM 
Sodium phosphate  0.5 M   Sodium phosphate  40 mM 
BSA    1%    pH 7.2 
Herring Sperm DNA  500 μg   Wash buffer II 
Yeast t-RNA   250 μg   Sodium phosphate  100 mM 
 pH 7.2     pH 7.2 
Stripping buffer  
Sodium phosphate  5 mM  
SDS    0.1%  
pH 7.2 
Phosphate-buffered saline (PBS) 
Na2HPO4·7 H2O  4.3 mM 
KH2PO4  1.4 mM 
NaCl    137 mM 
KCl   2.7 mM 
pH 7.4 
 
2.1.6. Other reagents and chemicals  
Tag Polymerase (Qiagen) 
Herring Sperm DNA (Sigma) 
QIAquickGel Extraction Kit (Qiagen) 
Plasmid Mini Kit (Qiagen) 
Methyl methanesulfonate (MMS; Sigma-Aldrich) 
[α-33P]dATP (2500 Ci/mmol; Amersham Pharmacia) 
  2. Materials and methods 
 33
(dT)18 primer (MWG-Biotech, Germany) 
p(dN6) random primer (Roche) 
Super ScriptTMII (Invitrogen) 
NucleoSpin Extraction Columns (Clontech Laboratories, Inc) 
Imaging Plates (FUJIFILM Medical Systems USA, Inc) 
AMV Reverse Transcriptase (Promega) 
G-50 Sephadex columns (Amersham Pharmacia) 
Fluorescein diacetate (FDA; ICN Biomedicals, Inc.) 
Propidium iodide (PI; Sigma-Aldrich) 
Restriction enzymes (New England Biolabs) 
FM 4-64 (Molecular Probes) 
Dihydroethidium (DHE; Molecular Probes) 
DNase I, RNase free (Roche) 
3,3,5,5,-tetramethyl-pyrroline N-oxide (TMPO; Sigma-Aldrich) 
Yeast t-RNA (Invitrogen) 
G418 disulfate (Sigma-Aldrich) 
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2.2 Methods 
2.2.1. Gene disruption  
Gene disruption was performed as described by Güldener et al. (1996) and Lorenz et 
al. (1995) using the KanMX4 marker from the plasmid pUG6. Briefly, KanMX4 cassette was 
amplified by PCR using the primers with 40 bp homologue sequences up- and down-stream 
from the disrupted gene. PCR reaction mix contained polymerase buffer (Qiagen) at 1x 
concentration, 3 mM magnesium chloride, 0.2 mM deoxyribonucleotides, 100 pmol PCR 
primers and 2.5 units Tag polymerase in total volume of 50 µl. The PCR cycling was 
performed using an Eppendorf Mastercycler. The PCR reaction was denatured at 95°C for 2 
min, followed by 40 cycles of 30 s denaturation at 95°C, 30 s annealing at 54°C, and 90 s 
extension at 72°C. PCR products were separated by electrophoresis in 1% agarose gels 
containing ethidium bromide (EtBr; 0.5 mg/ml) and visualised by UV transillumination. 
Disruption cassettes were extracted from the gel by using the Gel Extraction Kit (Qiagen). For 
the gene disruption protocol wild-type cells were grown until mid-log phase (OD600 0.6-0.8), 
cells were harvested, washed once with sterile water and resuspended in 100 mM lithium 
acetate. Cells were incubated for 20 min at 30°C with shaking. 100 µl of cells were mixed 
with 0.5-1 µg of disruption cassette and 5 µg of herring sperm DNA (denatured for 10 min at 
98°C). After 20 min incubation at 30°C 600 µl of 100 mM lithium acetate/40%PEG 3350 
solution was added and tubes were incubated at 30°C for additional 20 min. 71 µl of 100% 
DMSO was added and heat shock was performed at 42° for 15 min. Cells were harvested and 
resuspended in YPD medium and grown for 3h at 30°C. At the end cells were harvested and 
plated on selective medium, YPD with 300 µg/ml of G418. To prove correct gene 
replacement colony PCR was performed with flanking region and internal primers.   
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2.2.2. Low-level treatment with MMS and RNA isolation 
  YPD and F1 media were inoculated with overnight pre-cultures and grown at 30°C to 
mid log-phase (OD600 0.6 to 0.8). Cultures were split into three parts: the first aliquot was 
mock-treated and used as control; the second and third aliquots were treated with low 
concentration of MMS (0.00125% and 0.0125%). All cultures were incubated at 30° C. 
Samples were collected after 30 min and 1h incubation. Cells were pelleted, frozen in liquid 
nitrogen and stored at -80°C until RNA preparation.  
Total RNA was isolated with the hot-phenol method described by Schmitt et al. 
(1990). Cell pellets were resuspended in 400 μl TES solution and 400 μl acidic phenol. 
Samples were incubated at 65°C for 1h. The upper phase was extracted twice with one 
volume of chloroform and subsequently ethanol precipitated. Samples were digested with 
DNAse and ethanol precipitated again. RNA pellet was dissolved in RNAse free water and 
stored at –20°C. 
 
2.2.3. Hybridisation probe synthesis  
Probes were generated by a first-strand cDNA synthesis. 4 μg of total RNA was mixed 
with 100 pmol (dT)18 and p(dN6) random primer and heated at 70°C for 5 min. Reverse 
transcription was performed in a total volume of 20 μl using Super ScriptTMII (Invitrogen) and 
25 μCi of [α-33P]dATP (2500 Ci/mmol; Amersham, UK) and incubated at 42° for 1.5 h. 
Subsequently, probes were denatured with 1/10 volume denaturing solution at 68°C for 20 
min and afterwards neutralized with 1M NaH2PO4, pH 7.0 at 68°C for 10 min The 
unincorporated nucleotides were removed using Atlas NucleoSpin Extraction Columns 
(Clontech).  
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2.2.4. Hybridisation and image analysis  
All hybridisations were performed using complementary DNA arrays produced with 
PCR fragments of 6116 open reading frames (ORFs) of Saccharomyces cerevisiae spotted 
onto nylon membranes (Hauser et al., 1998). Arrays were pre-hybridised for 2h at 68° in 
hybridisation buffer. Probe hybridisation was done in the same buffer at 68° for 16-20 h in 5 
ml. Subsequently, filters were washed 5 times at 68° with Wash buffer I and 3 times at room 
temperature with Wash buffer II. Filters were stripped washing twice with boiled stripping 
buffer (5mM sodium phosphate, pH 7.2, 0.1% SDS), rinsing membranes in 200 mM KOH for 
1h and repeated washing for three times with boiled stripping buffer. Samples from the same 
medium and the same time point, but different treatments (mock-treated; 0.00125%; 0.0125% 
MMS) were hybridized on the same membrane (membranes were stripped in between two 
hybridizations).  
Signals were detected by exposition to Imaging Plates (Fuji) for 16h and scanning on 
Storm 860 Phosphor Imager (Molecular Dynamics, USA). All images were analyzed with the 
AIDA Image Analyser Software version 3.22 (Raytest, Germany). Data analysis was 
performed for each set of results from one filter separately. Datasets from one experiment 
were ranked and compared in a rank intensity plot (Kroll and Wölfl, 2002). The curves varied 
as expected not only in scaling but as well in an additional offset. The real offset cannot be 
determined, so the average intensity of each rank was calculated. To this curve all pooled 
experiments were mapped rank wise (Kroll and Wölfl, 2002; Bolstad et al., 2003). After 
normalization, spots with hybridization signals at least two times higher than the maximal 
background level were selected for further analysis. Changes in expression of particular gene 
after MMS treatment, greater than 3-fold were considered significant. Using these stringent 
criteria the changes in gene expression subscribed solely to MMS-induction were determined. 
Genes with significantly changed expression were grouped according to their function and 
pathway they belong to (according to Saccharomyces Genome Database – SGD). 
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2.2.5. Semi-quantitative RT-PCR 
Reverse transcription was performed using AMV Reverse Transcriptase (Promega). 
10 μg of total RNA was mixed with 100 pmol (dT)18 and 100 pmol random hexamer primer 
and heated at 70°C for 5 min. Master mix, containing 5 μl AMV RT 5x buffer, 2.5 μl 10 mM 
dNTP’s and 2.5 μl AMV Reverse Transcriptase (300 u/μl), was added, volume was adjusted 
with RNAsee free water to 25 μl and probes were incubated at 42° for 1.5 h. cDNA was 
purified with G-50 Sephadex columns (Amersham Pharmacia), measured on 
spectrophotometer and concentrations were equalised. Semi-quantitative RT-PCR protocol 
was performed as described by Halford et al. (1999) and Spadoni et al. (2003). Briefly, 5-fold 
or 10-fold serial dilutions of cDNA, prepared from total RNA, were used as RT-PCR 
templates. One twentieth volume of the resulting dilutions was subjected to PCR 
amplification using polymerase buffer (Qiagen) at 1x concentration containing 1.5 mM 
magnesium chloride, supplemented with 0.2 mM dNTP’s, 50 pmol PCR of each primer and 
2.5 units Tag polymerase (Qiagen) in total volume of 50 µl. The PCR cycling was performed 
using an Eppendorf Mastercycler. The cDNA mixture was denatured at 95°C for 2 min, 
followed by 25 or 30 cycles (as described in the text) of 30 s denaturation at 95°C, 30 s 
annealing at the temperature specific for each primer set, and 45 s extension at 72°C. PCR 
products were separated by electrophoresis in 1% agarose gels containing EtBr (0.5 mg/ml) 
and visualised by UV transillumination. As an internal control of cDNA, PCR was performed 
on the same cDNA using primers for ACT1. For every RNA sample three separate cDNA 
preparations were performed and analysed by PCR amplifications with each set of primers.  
 
2.2.6. Drug sensitivity assay  
Strains were grown in YPD, SD, SD-URA or YPKG medium (as indicated in the text) 
until mid log phase (OD600 = 0.6-0.8) or stationary phase (one or six days old). OD600 was 
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adjusted to 0.5 and five additional 5-fold serial dilutions were made. Four microliters of each 
serial dilution were spotted onto the indicated media and incubated at 30°C for 3 days.  
 
2.2.7. Survive test and viability staining  
Cells cultures were started at time point zero with equal number of cells (OD600 0.2), 
grown until mid log phase at 30°C, split and treated with MMS (concentrations are indicated 
in the text).  Samples were taken after 2h, 4h, 24h and 48 h. OD was adjusted to 0.5 and 0.1 
ml from 10-fold serial dilutions (10-4 dilutions for control samples or 10-2 dilutions for MMS 
treated samples) were plated on YPD or SD-URA in triplicate. After 2 days numbers of 
colonies were scored and calculated according to the dilution factor. For viability test aliquots 
of the same samples were stained with fluorescein diacetate (FDA) in concentration of 0.04 
µg per 100 µl of cell culture and propidium iodide (PI) in concentration of 25 µg per 100 µl of 
cell culture according to the protocol described in Nikolova et al. (2000-2002). Cells were 
incubated for 15 min at room temperature in the dark, washed and resuspended in PBS. 
Fluorescence was monitored by fluorescence microscope (AxioCam HR/Axioplan 2, Carl 
Zeiss, Germany) or stained cells were counted using a FACS® Calibur (Becton Dickinson) 
and CellQuest Pro analysis software. Excitation and emission settings were 488 nm and 525–
550 nm (FL1 filter) for FDA and 488 nm and 564–606 nm (FL2 filter) for PI staining, 
respectively.  
 
2.2.8. Plasmid construction and overexpression assay  
Full-length FBP1 (1070-bp) was amplified by PCR using the sense primer containing 
the SpeI site upstream the start codon and the antisense primer with XhoI site downstream the 
stop codon. The PCR product was digested with SpeI/XhoI and the resulting product was 
ligated into the SpeI/XhoI sites of the pRS426 or pRS425 plasmids with GPD promoter 
(Mumberg et al., 1995; kindly provided by Thomas Munder). Competent E.coli DH5α cells 
were used for cloning. Plasmids were isolated from bacteria cells grown in selective LB 
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medium using Qiagen plasmid purification kit. Sequencing of obtained plasmids was done by 
JenaGen (Jena, Germany). Resulting plasmids, encoding FBP1 under the control of the GPD 
promoter as well as the “empty” pRS426 and pRS425 plasmids were transformed into wild-
type and Δfbp1 mutant strains using the lithium acetate protocol and URA3 or LEU2 as 
selection markers, respectively.  
 
2.2.9. RNR2 reporter plasmid assay  
Wild-type, Δfbp1 and  Δrad9 mutants were transformed with only pUMGP5 RNR2 
reporter plasmid (Walmsley et al., 1983) or with both pUMGP5 RNR2 reporter plasmid and 
either pRS425 empty plasmid (Mumberg et al., 1995) or pRS425 containing the FBP1 
cassette under the control of the GPD promoter (this work). Cells were grown until mid log 
phase in selective F1 (F1-URA for transformants with only reporter plasmid or F1-URA-LEU 
for double transformants). F1 is a minimal medium optimised for fluorescence measurements 
(Afanassiev et al., 2000). Afterwards, cells were resuspended in F1 medium containing 
increasing MMS concentrations (0%-0.045%) to final OD600 of 0.1 and grown at 30°C for 
16h. Every sample was run in triplicate. For all experiments we used black 96-well microtiter 
plates with transparent bottoms (Greiner). Fluorescence intensity was measured at 0h and 16h 
of treatment using the Tecan Ultra plate reader (Tecan, Germany) with excitation and 
emission at 485 nm and 535 nm, respectively. Absorbance values were measured using the 
same plate reader through a 620 nm filter. For every MMS-treated sample each fluorescence 
value was normalised by the absorption value and the normalised fluorescence of the non-
treated sample.  
 
2.2.10. Expression of GFP fused proteins  
Full-length (excluding start and stop codon) FBP1 (1070-bp) was amplified by PCR 
using primers with PacI sites on both ends. The PCR products were digested with PacI and 
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the resulting products were ligated after start codon into PacI site of pGen ACT plasmid with 
actin promoter (2µ plasmid with upstream non-coding DNA sequence of the S.cerevisiae 
ACT1 promoter, Walmsley et al., 1997, kindly provided by Richard Walmsley). Competent 
E.coli DH5α cells were used for cloning. Plasmids were isolated from bacteria cells grown in 
selective LB medium using Qiagen plasmid-purification kit. Sequencing of obtained plasmids 
was done by JenaGen (Jena, Germany). The constructs were used to transform wild-type and 
Δfbp1 strains using the lithium acetate protocol. The integration resulted in the expression of 
an Fbp1-GFP fusion protein.  
 
2.2.11. Fluorescence microscopy and vacuolar staining 
Intracellular localisation of fused proteins was monitored by fluorescence microscopy 
(AxioCam HR/Axioplan 2, Carl Zeiss, Germany) in cells grown until mid-log phase in 
selective SD-URA medium before and after 1h treatment with 0.03% MMS. For vacuolar 
staining aliquots from the same cultures were incubated with 30 µM FM 4-64 (Molecular 
Probes) for 30 min at 4°C, washed with PBS and further incubated at room temperature for 
1h.  
 
2.2.12. Detection of ROS production  
Cells were grown in YPD or SD-URA medium until mid log phase and treated with 
0.03% MMS for 1h. Samples collected before and after MMS treatment were incubated for 10 
min with dihydroethidium added to the medium (DHE; Molecular Probes) at final 
concentration of 5 µg/ml. Cells were washed and resuspended in PBS. ROS production was 
quantified with a laser-scanning cytometer (LSC; Olympus) and visualised by fluorescence 
microscopy (AxioCam HR/Axioplan 2, Carl Zeiss, Germany).  
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2.2.13. Chronological aging experiment 
Cells from overnight culture were diluted to the same density in full (YPD) or 
selective minimal (SD-URA) medium and incubated at 30°C. Every day (SD-URA) or every 
third day (YPD) aliquots of the cultures were adjusted to OD600 0.5 and 0.1 ml of 10-4 and 10-3 
dilutions were plated on YPD or SD-URA plates in triplicate. After 2 days numbers of 
colonies were scored and calculated according to the dilution factor. The number of colonies 
on day 0 (SD-URA) or day 3 (YPD) is considered to denote 100% survival. The assay was 
performed for 12 (SD-URA) or 21 (YPD) days (described in Bitterman et al., 2003). Aliquots 
of cells were taken and incubated with dihydroethidium for 10 min as described above. ROS 
accumulation was analyzed with flow cytometry by using a FACS® Calibur (Becton 
Dickinson). Excitation and emission settings were 488 nm and 564–606 nm (FL2 filter), 
respectively. 
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3. Results 
 
3.1. Cytotoxicity of low doses of MMS  
Sensitivity of yeast cells to the metylating agent MMS was tested by spotting serial 
dilution of cells onto YPD medium containing different concentrations of MMS. The 
concentrations used were chosen based on those that were used in the work of Gasch et al. 
(2001), where 0.02% of MMS was producing significant transcriptional changes of >750 
genes after 15 min of treatment. Therefore, we tested the cellular sensitivity to concentrations 
between 0.02 and 0.03%. All experiments were performed in parallel with cells of two 
Saccharomyces cerevisiae strains, FF18984 and BY4742 grown to mid-log phase. The results 
showed a strong cytotoxic effect of MMS concentrations starting from 0.025% in the 
FF18984 strain and from 0.02% in the BY4742 strain (Fig.7). Also, strong differences in 
sensitivity to MMS between the two strains were observed. The BY4742 strain was much 
more sensitive to MMS than the FF18984 strain showing reduced biomass yield already on 
plates with 0.02% of MMS. The sensitivity test is performed with constant exposure of cells 
to toxic agent and thus can indicate the percentage of cells that can continue proliferation and 
form colonies in the constant presence of strong cytotoxic agents. In the natural environment 
a more important issue could be: how many cells survive short or repeated treatment with 
toxic agents and are they able to recover and continue proliferation. 
 
  
Figure 7. Sensitivity of FF18984 and BY4742 strains to MMS. Cultures were grown in YPD 
overnight at 30°C. Serial 5-fold dilutions were spotted onto YPD or YPD + MMS and incubated for 48h at 30°C. 
Reduced growth at higher dilutions reflects higher sensitivity of BY4742 to MMS. 
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To address this question we measured the survival rate of cells that were treated with 
MMS and afterwards released from treatment and plated on full medium without toxic agent. 
The time-course MMS treatment was done in liquid medium in which the access of toxic 
agents to the cells is much easier than on plates. Therefore, we used lower MMS 
concentrations than used for the sensitivity assay on plates, the higher 0.0125% and the 
second ten times lower 0.00125%. Cells from mid-log phase were treated for 72h and samples 
were taken at 0h, 2h, 24h and 48h. We also measured the growth rate of these cultures during 
the 72h time-course. In addition to the two strains used before, FF18984 and BY4742, we also 
tested the survival of the Δrad9 mutant (FF18984 Δrad9). The Δrad9 mutant is impaired for 
checkpoint-induced cell cycle arrest but able to process primary lesions (Toh and Lowndes, 
2003). Thus, DNA damage induced by a genotoxic substance will persist through the cell 
cycle and accumulate, and in turn will lead to an enhanced cytotoxicity in the Δrad9 mutant. 
Both doses of MMS reduced biomass yield in all strains measured as cell density (Fig. 8A).  
With the lower MMS concentration (0.00125%) both wild-type strains showed reduced 
proliferation but reached 80-100% of the cell density of the mock-treated culture after 48h. At 
the higher MMS concentration (0.0125%) the block of proliferation was more efficient and 
cultures reached only 50-60% density of the mock-treated reference. Proliferation of the 
Δrad9 mutant was impaired even in medium without MMS. This strain stopped proliferation 
after approximately 24h in all conditions. Treatment of the Δrad9 mutant with the higher 
MMS concentration also significantly reduced the cell density, while treatment with the lower 
concentration did not considerably influence growth. 
Colony forming capacity was assessed after plating aliquots of cells on MMS free 
YPD plates and calculated as percentage of colonies from the untreated culture at time point 
zero (0 h). Amounts of viable cells were lower in all strains treated with the higher 
concentration of MMS (Fig.8B). The number of viable cells in the FF18984 strain strongly 
decreased already after 2h of treatment, while in the BY4742 strain a clear decrease occurred 
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only after 24h. Only 10% of the Δrad9 mutant cells formed colonies after 2h of treatment, 
while there were no viable cells after 24h of treatment. With the lower MMS concentration 
the number of viable cells was significantly reduced in both wild-type strains. Interestingly, 
after 2h only FF18984 showed a sharp drop in viability.  After 24h viability was comparably 
reduced in both strains, while after 48h survival was significantly reduced in all untreated 
cells showing no additional effect of the lower MMS concentration. Apparently, at this time 
point nutrient deprivation and relatively high culture density severely reduced the number of 
viable cells even in untreated cultures.  
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Figure 8. Cytotoxic effect of 0.00125% and 0.0125% of MMS. FF18984, BY4742 and FF18984 rad9 mutant were treated with 0.00125% or 0.0125% MMS in 
YPD medium during a 72h time course (control indicates mock-treated sample).  (A) Optical densities of the cultures (OD600) measured after 2h, 24h, 48h or 72h. (B) Survival 
of MMS treated cells. Sample aliquots were taken at 0h, 2h, 24h and 48h, ODs were adjusted to 0.5 and 0.1 ml of 10-4 dilutions was plated on YPD in triplicate. After 2 days 
the numbers of colonies were scored. Relative survival was estimated as the percentage of cells capable of forming colonies in reference to the time point zero from control 
sample. The results are presented as logarithmic mean values.  Standard deviations are indicated. Experiment was repeated three times with similar results at every repetition.  
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3.2. Transcriptional response after treatment with low doses of MMS 
In the survival experiment both concentrations of MMS (0.0125% and 0.00125%) had 
a clear genotoxic effect and showed a high potential to inhibit cellular proliferation. The 
sensitivity assay showed that higher doses are needed for a clear cytotoxic effect. Therefore, 
treatment with these doses can be considered as a low level treatment and used to investigate 
sensing and first line response to non-cytotoxic concentrations of the DNA damaging agent 
MMS. To identify genes that are immediately regulated in response to MMS treatment, we 
analyzed gene expression profile of the FF18984 strain after 30 min and 1 h treatment with 
0.00125% and 0.0125% MMS. Experiments were done in full (YPD) and minimal medium 
(F1) in order to include the effect of growth conditions on the response. In the following 
analysis only genes with hybridization signals at least two times higher than maximum 
background and a greater than 3-fold change in one comparison were considered significant. 
Classification of these ORFs into functional groups is based on their molecular function and 
biological process in which they are involved according to the Saccharomyces Genome 
Database (SGD). Significantly induced/down-regulated ORFs with unknown function and 
without any homology to known eukaryotic genes are not presented in this work.  
The lower 0.00125% of MMS induced significant changes in transcription only in 
YPD medium after 1h. At this time point we observed significant up-regulation of genes 
involved in carbohydrate metabolism and fermentation, which implicates that even such a 
small dose of MMS provokes metabolic adaptation in the cell (Table 3). However, there was 
no up-regulation of genes from this functional group in F1 medium. The next large up-
regulated gene groups include those that encode proteins involved in: protein biosynthesis 
(with some translation elongation factors, EFT1, EFT2 and TEF1 and ribosomal proteins), as 
well as protein folding and degradation (like heat shock proteins SSA1 and SSA2 and 
proteasome genes DOA1 and SHP1). The induction of protein chaperons and proteasome 
subunits is a result of MMS induced protein damage and was already observed in the work of 
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Jelinsky et al. (2000) and Gasch et al. (2001). However, in their work the higher doses of 
MMS that were used rather down-regulated the transcription of protein biosynthesis genes. 
Connected with these functional groups is also the up-regulation of some genes involved in 
regulation of transcription and RNA processing as well as induction of some amino acid 
synthesis genes. With this MMS concentration we also identified induction of genes 
responsible for cell wall biosynthesis and organization. In between are some mannoproteins, 
glycoproteins and ergosterol biosynthesis genes, as well as induction of some membrane 
transporters, like regulators of cytoplasmic pH and multidrug resistance genes. These groups 
of genes may prevent the alkylating agent from entering the cells and reacting with target 
molecules. With exception of the LRP1 gene, there were no other genes directly involved in 
DNA repair which were induced with this MMS concentration. Basically, most of the 
functional groups whose genes are induced and down-regulated in this experiment belong to 
the big superfamily of genes stereotypically regulated by different stress conditions called 
environmental stress response (ESR; Gasch et al., 2000). In the group of down-regulated 
genes with exception of a protein biosynthesis group with 5 genes, other groups did not 
include more than two genes the transcription of which was reduced by 0.00125% of MMS 
and therefore, we did not consider those as significantly down-regulated processes in the cell 
(Table 4). However, the important down-regulation was detected for two cell cycle genes, 
CDC53 and KEL2, and two protein sorting genes, YIP4 and WSC4. It seems that this modest 
down-regulation of gene expression serves to slow-down cellular division until alkylation 
exposure is diminished.  
  The higher MMS concentration, 0.0125%, caused a much stronger response in both 
induced and down-regulated groups of genes, as well as in both media (Table 5, Table 6). 
Certain important facts regarding this treatment should be underlined. First of all, cells grown 
in F1 medium elicited faster and stronger response which was observed already after 30 min 
of treatment. In YPD medium 30 min treatment was not sufficient to produce significant 
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transcriptional response of the cells. Second, in F1 medium MMS partially promoted response 
of different functional groups or, if the same groups were involved in response as in YPD 
medium, in many cases different genes represented those groups. Third, what could be at least 
observed in F1 medium, the global changes in transcript abundance were largely transient. 
Most of the genes regulated after 30 min of treatment were not regulated any longer after 1h. 
An explanation could be that as soon as the protein level of the important components of 
cellular defence machinery is adjusted to a new steady-state level, the transcription of these 
genes is again reduced to basal one. In the group of up-regulated genes in YPD medium we 
could detect the same functional groups as in the treatment with 0.00125% of MMS: genes 
involved in carbohydrate metabolism and fermentation, amino acid metabolism, protein 
biosynthesis regulation of transcription and RNA processing, cell wall biosynthesis and 
organisation, protein folding and degradation, membrane transporters. This time more genes 
part of these functional groups were involved in cellular response. An important fact is also 
that from the 46 genes up-regulated in YPD medium after 30 min of treatment with 0.00125% 
MMS 33 of them showed similar regulation with 0.0125% of MMS. Interestingly, it was only 
in F1 medium that the higher MMS concentration after 30 min of treatment induced 
transcription of many genes involved in DNA synthesis/repair (the exceptions are RNR2 and 
MAG2 up-regulated also in YPD medium and RNR4 up-regulated only in YPD), stress 
response/detoxification, cell cycle control (with the exception of CDC39 up-regulated also in 
YPD after 30 min of treatment) as well as in the mitochondrial biogenesis and aerobic 
respiration. Additionally, some important stress induced transcription factors, like POL2, 
YAP1 and YRR1, were only up-regulated in F1 medium. In contrast, in cells cultivated in F1 
medium we again could not detect induction of genes that are part of carbohydrate 
metabolism and fermentation group. As already mentioned, some of the functional groups 
were presented with different genes in F1 and YPD media. This especially stands for the 
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signalling kinases/phosphatases, membrane transporters, and genes involved in protein 
sorting, folding and degradation.  
With 0.0125% MMS treatment in F1 we found only 24 down-regulated genes after 
either 30 min or 1h of treatment, while in YPD medium this number reached 60 genes (Table 
6). The functional groups that were included in this response belong to those involved in 
protein biosynthesis, regulation of transcription and RNA processing, cell wall biogenesis and 
organisation, protein folding and degradation, protein sorting, chromosomes maintenance, 
mitochondrial biogenesis and aerobic respiration. Out of the 25 down-regulated genes with 
0.00125% of MMS in YPD medium after 30 min of treatment, 13 of them were regulated in a 
similar way with the 10-fold higher MMS concentration.  
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Table 3. ORFs whose transcripts are induced in FF18984 strain by 3-fold by 0.00125% MMS in F1 and/or YPD media (n=52) 
F1 
0.00125% 
YPD  
0.00125% 
F1 
0.00125% 
YPD  
0.00125% Up-regulated  
ORFs 
Gene  
short name 30 min 30 min 1h 1h 
Molecular function Biological process 
Carbohydrate metabolism and fermentation, pentose phosphate shunt (9 ORFs) 
YOL086C ADH1 n.d. n.d. n.d.  4.53 Alcohol dehydrogenase Fermentation 
YMR083W ADH3 n.d. n.d. n.d.  5.06 Alcohol dehydrogenase isoenzyme III Fermentation 
YGR254W ENO1  2.05 n.d. n.d.  6.13 Enolase I Glycolysis  
YKL060C FBA1 n.d. n.d. n.d.  3.98 Aldolase Glycolysis  
YLR134W PDC5 n.d. n.d.  2.36  6.18 Pyruvate decarboxylase Ethanol fermentation 
YBR196C PGI1 n.d. n.d. n.d.  3.68 Phosphoglucoisomerase Glycolysis  
YHR163W SOL3  3.43 n.d. n.d. n.d. Weak multicopy suppressor of los1 1 Pentose phosphate shunt, oxidative branch 
YJL052W TDH1 n.d. n.d. n.d.  3.53 Glyceraldehyde 3 phosphate dehydrogenase 1 Glycolysis  
YGR192C TDH3 n.d. n.d. n.d.  4.87 Glyceraldehyde 3 phosphate dehydrogenase 3 Glycolysis  
DNA synthesis/repair (1 ORF) 
YHR081W LRP1  2.91 n.d. n.d.  3.45 Substrate-specific nuclear cofactor for exosome activity in the processing of stable RNAs  Double-strand break DNA repair 
Signaling/kinases/phosphatases (1 ORF) 
YHR005C GPA1 n.d. n.d. n.d.  5.94 Involved in the mating pheromone signal transduction pathway 
Signal transduction of mating signal (sensu 
Saccharomyces) 
Amino acid metabolism (3 ORFs) 
YLR089C ALT1  4.49 n.d. n.d. n.d. Putative alanine transaminase  Biological process unknown 
YJR016C ILV3 n.d. n.d.  2.23  3.04 Dihydroxy-acid dehydratase activity Branched chain family amino acid biosynthesis 
YBR263W SHM1 n.d. n.d. n.d.  6.97 Serine hydroxymethyltransferase, mitochondrial Serine and glycine biosynthesis 
Protein biosynthesis (8 ORFs) 
YOR133W EFT1 n.d. n.d. n.d.  5.19 Translation elongation factor 2 (EF 2) Protein synthesis elongation 
YDR385W EFT2 n.d. n.d. n.d.  6.47 Translation elongation factor 2 (EF 2) Protein synthesis elongation 
YNL069C RP23 n.d. n.d. n.d.  3.28 Homology to rat ribosomal protein L13a Protein biosynthesis 
YLR344W RPL33A  3.56 n.d. n.d. n.d. Homology to rat L26 Protein biosynthesis 
YIL018W RPL5A n.d. n.d. n.d.  3.61 Homology to rat L8 and E. coli L2 Protein biosynthesis 
YPL081W RPS13B n.d. n.d. n.d.  3.05 Homology to rat S9 and E.coli S4 Protein biosynthesis  
YNL209W SSB2 n.d. n.d. n.d.  3.09 Stress seventy subfamily B Protein biosynthesis 
YPR080W TEF1 n.d. n.d. n.d.  3.91 Translational elongation factor EF 1 alpha Protein synthesis elongation 
Regulation of transcription, RNA metabolism and processing (8 ORFs) 
YKR036C CAF4 n.d.  2.01 n.d.  3.12 CCR4 associated factor Regulation of transcription 
YHR187W IKI1 n.d. n.d. n.d.  5.00 RNA polymerase II Elongator associated protein Regulation of transcription from RNA polymerase II promoter 
       3. Results                                                                                                          
 51
F1 
0.00125% 
YPD  
0.00125% 
F1 
0.00125% 
YPD  
0.00125% Up-regulated  
ORFs 
Gene  
Short name 30 min 30 min 1h 1h 
Molecular function Biological process 
YBR167C POP7 n.d. n.d. n.d.  12.98 Processing of Precursors rRNA processing  
YLR039C RIC1 n.d. n.d. n.d.  3.41 Involved in transcription of ribosomal protein genes and ribosomal RNA Regulation of transcription from Pol II promoter  
YJL148W RPA34  3.96 n.d. n.d. n.d. RNA polymerase I subunit, not shared (A34.5) Transcription from Pol I promoter 
YGR013W SNU71  2.04 n.d. n.d.  5.31 Associated with U1 snRNP  mRNA splicing 
YKL058W TOA2 n.d. n.d.  2.18  3.66 Transcription factor IIA, small chain Transcription initiation from Pol II promoter 
YHR196W UTP9  9.29 n.d. n.d. n.d. Part of small (ribosomal) subunit (SSU) processosome (contains U3 snoRNA) Processing of 20S pre rRNA 
Cell wall biosynthesis and organisation (8 ORFs) 
YLR110C CCW12 n.d. n.d. n.d.  4.87 Cell wall mannoprotein Agglutination during conjugation with cellular fusion 
YBR078W ECM33 n.d. n.d. n.d.  4.43 Extra Cellular Mutant GPI anchored protein  
YGL012W ERG4 n.d. n.d. n.d.  3.07 Sterol C 24 reductase Ergosterol biosynthesis 
YJL159W HSP150 n.d. n.d. n.d.  5.89 Heat shock protein, secretory glycoprotein Cell wall organization and biogenesis 
YJL062W LAS21  3.27 n.d. n.d. n.d. 
Involved in the attachment of 
glycosylphosphatidylinositol (GPI) anchors to 
proteins. 
Integral plasma membrane protein  
YOR298W MUM3 n.d. n.d. n.d.  3.12 Acyltransferase activity Phospholipid biosynthesis 
YDR077W SED1 n.d. n.d.  2.01  4.36 Putative cell surface glycoprotein Cell wall organization and biogenesis 
YOR247W SRL1 n.d. n.d. n.d.  3.19 Suppressor of Rad53 null Lethality Mannoprotein that exhibits a tight association with the cell wall 
Protein folding, degradation and translocation (6 ORFs) 
YKL213C DOA1 n.d. n.d. n.d.  3.06 Required for normal rates of proteolysis of ubiquitin dependent proteolytic substrates in vivo Ubiquitin dependent protein degradation 
YPL240C HSP82 n.d. n.d. n.d.  3.91 82 kDa heat shock protein; homolog of mammalian Hsp90 Stress response  
YKL201C MNN4 n.d. n.d. n.d.  3.93 Involved in mannose metabolism Protein amino acid glycosylation 
YBL058W SHP1 n.d. n.d. n.d.  3.13 Protein phosphatase type 1 regulator activity Proteasomal ubiquitin dependent protein catabolism 
YAL005C SSA1 n.d. n.d. n.d.  6.51 Stress seventy subfamily A Protein folding  
YLL024C SSA2 n.d. n.d. n.d.  5.64 Member of 70 kDa heat shock protein family Protein folding  
Membrane transport (5 ORFs) 
YGL008C PMA1 n.d. n.d. n.d.  8.13 Major regulator of cytoplasmic pH Regulation of pH 
YPL036W PMA2 n.d.  2.05 n.d.  6.72 Plasma membrane H+-ATPase, isoform of Pma1p Regulation of pH 
YEL0171 PMP2 n.d. n.d. n.d.  8.00 
Proteolipid associated with plasma membrane H(+)-
ATPase (Pma1p); regulates plasma membrane 
H(+)-ATPase activity 
Cation transport 
YLL048C YBT1 n.d. n.d. n.d.  3.03 Yeast bile transporter, similar to mammalian bile transporter Bile acid transport 
YDR135C YCF1 n.d. n.d. n.d.  3.09 
Metal resistance protein with similarity to human 
cystic fibrosis protein CFTR and multidrug 
resistance proteins 
Bilirubin transport  
Protein sorting (1 ORF)        
YCL001W RER1 n.d. n.d. n.d.  5.59 Protein involved in retention of membrane proteins in the ER ER to Golgi transport 
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F1 
0.00125% 
YPD  
0.00125% 
F1 
0.00125% 
YPD  
0.00125% Up-regulated  
ORFs 
Gene  
Short name 30 min 30 min 1h 1h 
Molecular function Biological process 
Chromatin arrangement, chromosomes maintenance (1 ORF) 
YFR031B SMC2 n.d. n.d. n.d.  5.64 Component of the condensin complex Mitotic chromosome condensation 
Others (1 ORF) 
YJL039C NUP192  3.27 n.d. n.d. n.d. Large yeast nucleoporin Nuclear pore complex subunit 
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Table 4. ORFs whose transcripts are repressed in FF18984 strain by 3-fold by 0.00125% MMS in F1 and/or YPD media (n=25) 
F1  
0.00125% 
YPD 
0.00125% 
F1  
0.00125% 
YPD 
0.00125% Down-regulated  
ORFs 
Gene  
short name 30 min 30 min 1h 1h 
Molecular function Biological process 
Signaling/kinases/phosphatases (1 ORFs)     
YKL048C ELM1 n.d. n.d. n.d. -3.10 Serine/threonine protein kinase that regulates cellular morphogenesis, septin behavior, and cytokinesis  Cell morphology 
DNA synthesis/repair (2 ORFs)      
YLR245C CDD1 -2.32 n.d. -5.42 -4.36 Involved in cytidine and deoxycytidine metabolism Ribose and deoxyribose phosphate metabolism 
YHR164C DNA2 n.d. n.d. -3.80 n.d. DNA replication helicase DNA repair  
Protein biosynthesis (5 ORFs)      
YLR069C MEF1 -2.24 n.d. -5.42 -2.16 Mitochondrial elongation factor G-like protein Protein synthesis elongation 
YDL184C RPL47A n.d. n.d. n.d. -3.50 Homology to human L41 Protein biosynthesis 
YLR333C RPS31B n.d. n.d. n.d. -4.01 Homology to rat S25; belongs to the S25E family of ribosomal proteins Protein biosynthesis 
YOR294W RRS1 n.d. n.d. n.d. -4.05 Regulator for ribosome synthesis Ribosome biogenesis 
YDL191W SOS1 -2.55 -3.60 n.d. n.d. Homology to rat L35 Protein biosynthesis 
Regulation of transcription, RNA metabolism and processing (3 ORFs)     
YLR068W FYV7 n.d. n.d. -5.75 n.d. involved in processing the 35S rRNA primary transcript to generate the 20S and 27SA2 pre-rRNA transcripts Processing of 20S pre-rRNA 
YPL082C MOT1 -3.30 n.d. n.d. n.d. Involved in TBP (TATA-binding protein) regulation Transcription 
YLR335W NUP2 n.d. n.d. -4.35 -5.60 Probably functions in transport through nuclear pore mRNA-nucleus export  
Cell wall biosynthesis and organisation (2 ORFs)     
YKL096W CWP1 -3.49 n.d. n.d. n.d. Cell wall protein, involved in O and N glycosylation, acceptor of B1-6 glucan. Cell wall organization and biogenesis 
YKR004C ECM9 n.d. n.d. -7.37 n.d. Extra Cellular Mutant Not yet annotated 
Protein sorting (2 ORFs) 
YGL198W YIP4 n.d. n.d. n.d. -3.67  Protein that interacts with Rab GTPases Possible role in vesicle-mediated transport  
YHL028W WSC4 n.d. n.d. n.d. -7.19 
ER membrane protein involved in the translocation of soluble 
secretory proteins and insertion of membrane proteins into the 
ER membrane 
SRP-dependent cotranslational protein targeting to 
membrane, translocation 
Chromatin arrangement, chromosomes maintenance (1 ORFs)    
YLR357W RSC2 n.d. n.d. n.d. -3.03 RSC2 is a member of RSC complex, which remodels the structure of chromatin Chromatin modelling 
Cell cycle (2 ORFs)       
YDL132W CDC53 n.d. n.d. n.d. -4.27 Acts together with Cdc4p and Cdc34p to control the G1-S phase transition Ubiquitin-dependent  protein degradation  
YGR238C KEL2 n.d. n.d. n.d. -4.36 Protein that functions in a complex with Kel1p to negatively regulate mitotic exit 
Protein that functions in a complex with Kel1p to 
negatively regulate mitotic exit 
Mitochondrial biogenesis, maintance and aerobic respiration (1 ORF) 
YGR028W MSP1 n.d. n.d. n.d. -4.77 Mitochondrial protein involved in sorting of proteins in the mitochondria; putative membrane-spanning ATPase  Mitochondrial translocation 
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Molecular function Biological process 
Others (6 ORFs)       
YHR146W CRP1 n.d. n.d. n.d. -4.55 Crucifo-rm DNA Binding Protein 1 Protein that binds to cruciform DNA structures 
YHR055C CUP1B n.d. n.d. n.d. -3.20 Copper-binding metallothionein Copper sensitivity/resistance 
YDL227C HO n.d. n.d. n.d. -3.73 Homothallic switching Mating-type switching/recombination  
YGL197W MDS3 n.d. n.d. n.d. -3.85 Mck1 Dosage Suppressor 3; negative regulator of early meiotic gene expression Meiosis 
YGL211W NCS6 n.d. n.d. n.d. -3.14 Protein with a role in urmylation and in invasive and pseudohyphal growth Biological process unknown 
YER009W NTF2 n.d. n.d. n.d. -3.13 
May coordinate the Ran-dependent (GSP1/GSP2) association 
and disassociation reactions of nuclear import; human 
homolog complements yeast mutants 
Nuclear envelope protein 
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Table 5. ORFs whose transcripts are induced in FF18984 strain by 3-fold by 0.0125% MMS in F1 and/or YPD media (n=146) 
F1 
0.0125% 
YPD 
 0.0125% 
F1 
0.0125% 
YPD 
 0.0125% Up-regulated  
ORFs 
Gene  
short name 30 min 30 min 1h 1h 
Molecular function Biological process 
Carbohydrate metabolism and fermentation, pentose phosphate shunt (12 ORFs) 
YOL086C ADH1 n.d. n.d. 2.74 5.64 Alcohol dehydrogenase Fermentation 
YMR303C ADH2 n.d. n.d. 2.09 17.89 Alcohol dehydrogenase II Fermentation 
YMR083W ADH3 n.d. n.d. n.d. 5.03 Alcohol dehydrogenase isoenzyme III Fermentation 
YPL061W ALD6 3.20 n.d. n.d. n.d. Aldehyde dehydrogenase activity Glucose fermentation 
YGR254W ENO1 n.d. n.d. n.d. 9.69 Enolase I Glycolysis  
YHR174W ENO2 n.d. n.d. n.d. 3.21 Enolase Glycolysis  
YKL060C FBA1 n.d. n.d. n.d. 4.35 Aldolase Glycolysis  
YLR134W PDC5 n.d. n.d. n.d. 6.86 Pyruvate decarboxylase Ethanol fermentation 
YCR012W PGK1 n.d. n.d. n.d. 25.29 3 phosphoglycerate kinase Glycolysis  
YJL052W TDH1 n.d. n.d. n.d. 6.37 Glyceraldehyde 3 phosphate dehydrogenase 1 Glycolysis  
YGR192C TDH3 n.d. n.d. n.d. 4.27 Glyceraldehyde 3 phosphate dehydrogenase 3 Glycolysis  
YLR070C XYL2 4.25 n.d. n.d. n.d. Xylitol dehydrogenase Monosaccharide metabolism 
DNA synthesis/repair (11 ORFs) 
YGR061C ADE6 13.52 n.d. n.d. n.d. 5' phosphoribosylformyl glycinamidine synthetase Purine nucleotide biosynthesis 
YCL050C APA1 16.16 2.01 n.d. n.d. Diadenosine 5',5''' P1,P4 tetraphosphate phosphorylase I Nucleotide metabolism 
YLR245C CDD1 8.49 n.d. n.d. n.d. Involved in cytidine and deoxycytidine metabolism Cytidine catabolism  
YLR233C EST1 4.85 n.d. n.d. n.d. Telomere elongation protein  Telomere maintenance 
YLR427W MAG2 6.55 4.02 n.d. n.d. DNA 3 methyladenine glycosidase II that catalyzes of the hydrolysis of alkylated DNA  DNA dealkylation 
YLR154C RNH203 3.32 n.d. n.d. n.d. Ribonuclease H2 subunit  DNA replication 
YJL026W RNR2 2.25 3.98 4.39 8.06 Small subunit of ribonucleotide reductase DNA replication 
YGR180C RNR4 n.d. n.d. n.d. 3.57 Ribonucleotide reductase, small subunit (alt) DNA replication 
YLR135W SLX4 4.88 n.d. n.d. n.d. 
Subunit of a complex, with Slx1p, that hydrolyzes 
5' branches from duplex DNA in response to 
stalled or converging replication forks 
DNA replication 
YKR031C SPO14 3.50 n.d. n.d. n.d. Phospholipase D activity Phospholipid metabolism 
YKR010C TOF2 4.34 n.d. n.d. n.d. Topoisomerase I interacting factor 2 DNA topological change 
Signaling/kinases/phosphatases (4 ORFs) 
YHR005C GPA1 n.d. n.d. n.d. 5.50 Involved in the mating pheromone signal transduction pathway  Signal transduction of mating signal  
YHR082C KSP1 n.d. n.d. n.d. 3.68 Serine/threonine kinase similar to casein kinase II  Protein amino acid phosphorylation 
YFL033C RIM15 3.28 n.d. n.d. n.d. Involved in signal transduction during cell proliferation in response to nutrients Meiosis 
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 0.0125% Up-regulated  
ORFs 
Gene  
short name 30 min 30 min 1h 1h 
Molecular function Biological process 
YJR066W TOR1 9.89 5.90 n.d. n.d. Phosphatidylinositol 3-kinase activity  Signal transduction 
Amino acid metabolism (13 ORFs) 
YDR127W ARO1 7.23 3.09 n.d. n.d. 
Pentafunctional arom protein, catalyzes steps 2 
through 6 in the biosynthesis of chorismate, which 
is a precursor to aromatic amino acids 
Phenylalanine, tyrosine and tryptophan biosynthesis 
YPR145W ASN1 n.d. n.d. n.d. 4.82 Asparagine synthetase Asparagine biosynthesis 
YAL012W CYS3 n.d. n.d. 4.73 3.20 
Catalyzes one of the two reactions involved in the 
transsulfuration pathway that yields cysteine from 
homocysteine  
Sulfur amino acid metabolism 
YJR139C HOM6 n.d. n.d. n.d. 3.15 Catalyzes third step in common pathway for methionine and threonine biosynthesis Homoserine biosynthesis 
YJR016C ILV3 n.d. n.d. 3.13 3.72 Dihydroxy-acid dehydratase activity Branched chain family amino acid biosynthesis 
YCL009C ILV6 n.d. n.d. n.d. 3.35 Acetolactate synthase regulatory subunit Branched chain family amino acid biosynthesis 
YLR451W LEU3 6.01 n.d. n.d. n.d. Regulates genes involved in branched chain amino acid biosynthesis and in ammonia assimilation Leucine biosynthesis 
YBR115C LYS2 13.90 3.99 n.d. n.d. Involved in the key step in fungal biosynthesis of lysine Amino acid biosynthesis 
YNL076W MKS1 6.80 n.d. n.d. n.d. 
Pleiotropic regulatory factor involved in Ras 
CAMP and lysine biosynthetic pathways and 
nitrogen regulation 
Regulation of nitrogen utilization 
YER099C PRS2 13.12 n.d. n.d. n.d. Ribose phosphate pyrophosphokinase 2 Histidine biosynthesis  
YBR263W SHM1 n.d. n.d. n.d. 6.39 Serine hydroxymethyltransferase One-carbon compound metabolism 
YHR025W THR1 3.51 n.d. n.d. n.d. Homoserine kinase Threonine and methionine biosynthesis 
YBR166C TYR1 n.d. n.d. n.d. 4.79 Step of tyrosine biosynthesis pathway Tyrosine metabolism 
Protein biosynthesis (11 ORFs) 
YOR133W EFT1 n.d. n.d. n.d. 7.49 Translation elongation factor 2 (EF 2) Protein synthesis elongation 
YDR385W EFT2 n.d. n.d. 2.23 10.07 Translation elongation factor 2 (EF 2) Protein synthesis elongation 
YLR069C MEF1 10.50 n.d. n.d. n.d. Mitochondrial elongation factor G like protein Protein synthesis elongation 
YGR076C MRPL25 14.49 6.68 n.d. n.d. Mitochondrial ribosomal protein MRPL25 (YmL25) Protein biosynthesis 
YLR048W NAB1B n.d. n.d. n.d. 3.49 
Required for translation and contributes to the 
assembly and/or stability of the 40S ribosomal 
subunit 
Protein biosynthesis  
YBR079C RPG1 4.72 n.d. n.d. n.d. Sequence similarity with a subunit of the mammalian translation initiation factor 3 Protein synthesis initiation 
YIL018W RPL5A n.d. n.d. n.d. 3.96 Homology to rat L8 and E. coli L2 Protein biosynthesis 
YDL229W SSB1 17.39 n.d. n.d. n.d. Involved in translation, perhaps by guiding the nascent chain through the ribosome Protein biosynthesis 
YPR080W TEF1 n.d. n.d. n.d. 4.05 Translational elongation factor EF 1 alpha Protein synthesis elongation 
YKL081W TEF4 n.d. n.d. n.d. 3.13 Translation elongation factor EF 1gamma Protein synthesis elongation 
YKR059W TIF1 n.d. 2.27 n.d. 3.27 Translation initiation factor eIF4A Protein synthesis initiation 
Regulation of transcription, RNA metabolism and processing (20 ORFs) 
YPL217C BMS1 3.13 n.d. n.d. n.d. 
Essential conserved nucleolar GTP-binding 
protein required for synthesis of 40S ribosomal 
subunits and for processing of the 35S pre-rRNA 
35S primary transcript processing  
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ORFs 
Gene  
short name 30 min 30 min 1h 1h 
Molecular function Biological process 
YKR036C CAF4 n.d. n.d. n.d. 3.64 CCR4 associated factor Regulation of transcription 
YKL011C CCE1 n.d. n.d. 2.69 3.35 Cruciform cutting endonuclease tRNA processing 
YLR323C CWC24 3.12 n.d. n.d. n.d. Complexed with Cef1p; spliceosome complex  Biological_process unknown 
YFL031W HAC1 n.d. n.d. n.d. 3.31 
Transcription factor that is required for the 
unfolded protein response pathway; binds to CRE 
motif; homologous to ATF/CREB 1 
Regulation of transcription from Pol II promoter  
YHR187W IKI1 n.d. n.d. n.d. 9.87 RNA polymerase II Elongator associated protein Regulation of transcription from RNA polymerase II promoter 
YJR042W NUP85 n.d. n.d. n.d. 3.15 May function in nuclear envelope integrity; may also be involved in tRNA biogenesis mRNA nucleus export  
YML107C PML39 12.99 n.d. n.d. n.d. Protein required for nuclear retention of unspliced pre mRNAs along with Mlp1p and Pml1p mRNA nucleus export 
YNL262W POL2 4.43 n.d. n.d. n.d. DNA polymerase II Lagging strand elongation  
YBR167C POP7 n.d. n.d. n.d. 11.31 Processing of Precursors rRNA processing  
YOR207C RPC128 8.45 n.d. n.d. n.d. Second largest subunit of RNA polymerase III Transcription from Pol III promoter 
YLR141W RRN5 3.18 n.d. n.d. n.d. Involved in transcription of rDNA by RNA polymerase I.  Transcription from Pol I promoter 
YML049C RSE1 5.31 n.d. n.d. n.d. RNA splicing and ER to Golgi transport Nuclear mRNA splicing, via spliceosome 
YGR013W SNU71 2.10 n.d. n.d. 5.00 Associated with U1 snRNP  mRNA splicing 
YLR316C TAD3 3.21 n.d. n.d. n.d. tRNA specific adenosine 34 deaminase subunit Tad3p tRNA processing 
YAL001C TFC3 4.62 n.d. n.d. n.d. Transcription factor tau (TFIIIC) subunit 138 Transcription initiation from Pol III promoter 
YKL058W TOA2 n.d. n.d. 3.32 4.81 Transcription factor IIA, small chain Transcription initiation from Pol II promoter 
YMR093W UTP15 3.71 n.d. n.d. n.d. Part of small (ribosomal) subunit (SSU) processosome (contains U3 snoRNA) Processing of 20S pre-rRNA 
YML007W YAP1 7.96 6.47 n.d. n.d. Jun like transcription factor Response to oxidative stress 
YOR162C YRR1 4.68 n.d. n.d. n.d. Zn2-Cys6 zinc-finger transcription factor that activates genes involved in multidrug resistance 
Positive regulation of transcription from RNA polymerase II 
promoter 
Cell wall biosynthesis and organisation (15 ORFs) 
YLR110C CCW12 n.d. n.d. n.d. 5.68 Cell wall protein, mutants are defective in mating and agglutination Agglutination during conjugation with cellular fusion 
YLR391W CCW14 n.d. n.d. n.d. 3.68 Covalently linked cell wall glycoprotein, present in the inner layer of the cell wall  Cell wall organization and biogenesis 
YKL046C DCW1 n.d. n.d. 2.42 3.09 
Putative mannosidase, GPI-anchored membrane 
protein required for cell wall biosynthesis in bud 
formation 
Cell wall biosynthesis 
YBL043W ECM13 7.78 n.d. n.d. n.d. Extra Cellular Mutant Not yet annotated 
YLR436C ECM30 4.49 2.02 n.d. n.d. Extra Cellular Mutant Not yet annotated 
YBR078W ECM33 n.d. n.d. n.d. 6.55 GPI-anchored protein of unknown function, has a possible role in apical bud growth Not yet annotated 
YBR177C EHT1 5.80 n.d. n.d. n.d. Alcohol acyl transferase Lipid metabolism 
YKL182W FAS1 7.95 2.65 n.d. n.d. 
Pentafunctional enzyme consisting of the 
following domains : acetyl transferase, enoyl 
reductase, dehydratase and malonyl/palmityl 
transferase 
Fatty acid biosynthesis 
YMR306W FKS3 7.55 n.d. n.d. n.d. 
Protein of unknown function, has similarity to 1,3-
beta-D-glucan synthase catalytic subunits Fks1p 
and Gsc2p 
Not yet annotated 
       3. Results                                                                                                          
 58
F1 
0.0125% 
YPD 
 0.0125% 
F1 
0.0125% 
YPD 
 0.0125% Up-regulated  
ORFs 
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short name 30 min 30 min 1h 1h 
Molecular function Biological process 
YML075C HMG1 5.87 n.d. n.d. n.d. 3 hydroxy 3 methylglutaryl coenzyme A (HMG CoA) reductase isozyme Ergosterol biosynthesis 
YJL159W HSP150 n.d. n.d. n.d. 3.95 Heat shock protein, secretory glycoprotein Cell wall organization and biogenesis 
YGR166W KRE11 14.06 7.71 n.d. n.d. Involved in biosynthetic pathway for cell wall beta glucans ER to Golgi transport 
YGR014W MSB2 14.07 7.08 n.d. n.d. Putative integral membrane protein Establishment of cell polarity (sensu Saccharomyces) 
YHR102W NRK1 3.53 n.d. n.d. n.d. 
Protein kinase of the PAK/Ste20 kinase family, 
required for cell integrity possibly through 
regulating 1,6-beta-glucan levels in the wall 
Cellular morphogenesis during vegetative growth 
YER093C TSC11 13.24 n.d. n.d. n.d. 
Subunit of TORC2 (Tor2p Lst8p Avo1 Avo2 
Tsc11p Bit61p), a membrane associated complex 
that regulates actin cytoskeletal dynamics during 
polarized growth and cell wall integrity 
Establishment and/or maintenance of actin cytoskeleton 
polarity 
Protein folding, degradation and translocation (10 ORFs) 
YDL141W BPL1 6.09 n.d. n.d. n.d. Biotin:apoprotein ligase Protein modification 
YMR186W HSC82 n.d. n.d. n.d. 4.41 Constitutively expressed heat shock protein Stress response  
YDR258C HSP78 4.37 n.d. n.d. n.d. Involved in folding of some mitochondrial proteins Stress response  
YPL240C HSP82 n.d. n.d. 2.81 6.36 82 kDa heat shock protein; homolog of mammalian Hsp90 Stress response  
YKL201C MNN4 n.d. n.d. n.d. 4.57 Involved in mannose metabolism Protein amino acid glycosylation 
YGR199W PMT6 9.19 n.d. n.d. n.d. 
Transfers mannose residues from dolichyl 
phosphate D mannose to specific serine/threonine 
residues of proteins in the secretory pathway 
O linked glycosylation 
YAL005C SSA1 n.d. n.d. n.d. 12.78 Stress seventy subfamily A Protein folding  
YLL024C SSA2 n.d. n.d. 2.13 6.65 Member of 70 kDa heat shock protein family Protein folding  
YJR045C SSC1 n.d. n.d. n.d. 3.15 
Nuclear encoded mitochondrial protein; acts as a 
chaperone for protein import across the inner 
membrane 
Protein folding  
YLR024C UBR2 3.68 n.d. n.d. n.d. Ubiquitin protein ligase (E3) Polyubiquitination  
Membrane transport (11 ORFs) 
YNL270C ALP1 3.96 n.d. n.d. n.d. Basic amino acid transporter, involved in uptake of cationic amino acids Basic amino acid transport 
YLL052C AQY2 7.19 2.03 n.d. n.d. Aquaporin water channel in yeast Water transport 
YOR011W AUS1 5.83 n.d. n.d. n.d. ABC(ATP binding cassette) protein involved in uptake of sterols Sterol transport 
YGR217W CCH1 7.28 n.d. n.d. n.d. Calcium channel Calcium ion transport 
YHR175W CTR2 n.d. n.d. n.d. 4.25 Putative low affinity copper transport protein Copper ion import 
YGL008C PMA1 n.d. n.d. 3.39 12.65 Major regulator of cytoplasmic pH Regulation of pH 
YPL036W PMA2 n.d. n.d. 2.01 5.45 Plasma membrane H+-ATPase, isoform of Pma1p Regulation of pH 
YEL0171 PMP2 n.d. n.d. n.d. 6.11 
Proteolipid associated with plasma membrane 
H(+)-ATPase (Pma1p); regulates plasma 
membrane H(+)-ATPase activity 
Cation transport 
YKR050W TRK2 7.13 n.d. n.d. n.d. Membrane protein; low affinity potassium transport Potassium ion homeostasis 
YLL048C YBT1 n.d. n.d. n.d. 3.28 Yeast bile transporter, similar to mammalian bile transporter Bile acid transport 
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YDR135C YCF1 n.d. n.d. n.d. 4.23 
Metal resistance protein with similarity to human 
cystic fibrosis protein CFTR and multidrug 
resistance proteins 
Bilirubin transport  
Protein sorting (6 ORFs) 
YCL001W RER1 n.d. n.d. n.d. 10.28 Protein involved in retention of membrane proteins  in the ER ER to Golgi transport 
YKL002W DID4 3.05 n.d. n.d. n.d. 
Required for sorting of integral membrane 
proteins into lumenal vesicles of multivesicular 
bodies 
Golgi retention 
YDL145C RET1 3.46 n.d. n.d. n.d. Alpha subunit of the coatamer complex; gamma alpha COP Retrograde transport, Golgi to ER 
YBR214W SDS24 n.d. n.d. n.d. 3.13 May play an indirect role in fluid phase endocytosis Biological_process unknown 
YNR006W VPS27 3.27 n.d. n.d. n.d. 
Required for recycling Golgi proteins, forming 
lumenal membranes and sorting ubiquitinated 
proteins destined for degradation 
Golgi retention 
YLR181C VTA1 n.d. n.d. 2.14 3.48 Multivesicular body (MVB) protein involved in endosomal protein sorting Late endosome to vacuole transport 
Stress response/detoxification (5 ORFs) 
YPR128C ANT1 4.95 n.d. n.d. n.d. Adenine nucleotide transporter Peroxisome organization and biogenesis  
YJL101C GSH1 4.42 n.d. n.d. n.d. 
Gamma glutamylcysteine synthetase, catalyzes the 
first step in the gamma-glutamyl cycle for 
glutathione (GSH) biosynthesis 
Glutathione biosynthesis 
YML014W TRM9 5.95 n.d. n.d. n.d. 
tRNA methyltransferase, catalyzes the 
esterification of modified uridine nucleotides in 
tRNAs  
Stress response 
YBR216C YBP1 5.37 n.d. n.d. n.d. Protein required for oxidation of specific cysteine residues of the transcription factor Yap1p Response to oxidative stress 
YGR234W YHB1 n.d. n.d. n.d. 3.40 Nitric oxide oxidoreductase, flavohemoglobin involved in nitric oxide detoxification Stress response 
Chromatin arrangement, chromosomes maintenance (3 ORFs) 
YOR304W ISW2 4.37 n.d. n.d. n.d. Nitric oxide oxidoreductase, flavohemoglobin involved in nitric oxide detoxification Chromatin silencing at telomere 
YFR031c SMC2 n.d. n.d. n.d. 5.13 
Component of the condensin complex, essential 
SMC chromosomal ATPase family member that 
forms a complex with Smc4p to form the active 
ATPase 
Mitotic chromosome condensation 
YGR002C SWC4 6.95 2.26 n.d. n.d. Component of the Swr1p complex that incorporates Htz1p into chromatin Chromatin remodeling 
Cell cycle (6 ORFs) 
YDL220C CDC13 8.08 n.d. n.d. n.d. Required for the G2/M transition in mitosis Telomere capping 
YAR019C CDC15 6.35 n.d. n.d. n.d. Required for mitosis and sporulation, cell division cycle blocked at 36 degrees Cell cycle 
YDR168W CDC37 3.24 n.d. n.d. n.d. Cell cycle protein necessary for passage through START Regulation of cell cycle  
YCR093W CDC39 15.97 3.89 n.d. n.d. Required for Start B in mitosis and spindle pole body separation at meiosis I Regulation of cell cycle  
YCR094W CDC50 4.90 n.d. n.d. n.d. Cell division cycle mutant, transcription regulator activity G1 phase of mitotic cell cycle 
YGR098C ESP1 4.78 n.d. n.d. n.d. 
Esp1 promotes sister chromatid separation by 
mediating dissociation from the chromatin of the 
cohesin Scc1 
Regulation of exit from mitosis 
        
       3. Results                                                                                                          
 60
F1 
0.0125% 
YPD 
 0.0125% 
F1 
0.0125% 
YPD 
 0.0125% Up-regulated  
ORFs 
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short name 30 min 30 min 1h 1h 
Molecular function Biological process 
Mitochondrial biogenesis, maintance and aerobic respiration (7 ORFs) 
YPL170W DAP1 5.20 n.d. n.d. n.d. Heme binding protein involved in regulation of cytochrome P450 protein Erg11p  Biological_process unknown 
YPL040C ISM1 7.09 n.d. n.d. n.d. Nuclear encoded mitochondrial isoleucyl tRNA synthetase Isoleucyl-tRNA aminoacylation 
YLR163C MAS1 5.39 n.d. n.d. n.d. Mitochondrial processing protease subunit Mitochondrial processing 
YMR177W MMT1 4.68 n.d. n.d. n.d. Protein involved in mitochondrial iron accumulation Iron homeostasis 
YPR100W MRPL51 6.65 n.d. n.d. n.d. Mitochondrial ribosomal protein of the large subunit  Aerobic respiration 
YNL055C POR1 n.d. n.d. n.d. 3.06 Outer mitochondrial membrane porin (voltage dependent anion channel, or VDAC) Transport 
YGR181W TIM13 4.71 2.03 n.d. n.d. 
Translocase of the inner membrane; mitochondrial 
intermembrane space protein mediating import 
and insertion of polytopic inner membrane 
proteins 
Protein import into mitochondrial inner membrane 
Others (11 ORFs) 
YJL020C BBC1 5.04 n.d. n.d. n.d. Protein possibly involved in assembly of actin patches Actin cytoskeleton organization and biogenesis 
YDL238C GUD1 4.85 6.32 n.d. n.d. 
Guanine deaminase, a catabolic enzyme of the 
guanine salvage pathway producing xanthine and 
ammonia from guanine 
Hydrolase activity, acting on carbon-nitrogen (but not 
peptide) bonds, in linear amides 
YMR207C HFA1 9.92 n.d. n.d. n.d. 
Mitochondrial acetyl coenzyme A carboxylase, 
catalyzes the production of malonyl CoA in 
mitochondrial fatty acid biosynthesis 
Fatty acid biosynthesis 
YLR347C KAP95 3.05 n.d. n.d. n.d. Required for the docking of import substrate to the nuclear membrane/pore Protein import into nucleus 
YNR008W LRO1 3.15 n.d. n.d. n.d. Lecithin cholesterol acyl transferase (LCAT) Related Orf Triacylglycerol biosynthesis 
YGL183C MND1 7.41 2.43 n.d. n.d. 
Forms a complex with Hop2p, which is involved 
in chromosome pairing and repair of meiotic 
double-strand breaks 
Meiotic recombination 
YLR315W NKP2 3.87 n.d. n.d. n.d. Non essential Kinetochore Protein Biological_process unknown 
YDR356W NUF1 10.38 2.80 n.d. n.d. May be involved in connecting nuclear microtubules to the spindle pole body Microtubule nucleation 
YLR146C SPE4 3.03 n.d. n.d. n.d. Spermine Synthase Spermine biosynthesis 
YLR045C STU2 5.70 n.d. n.d. 2.09 
May play a role in attachment, organization, 
and/or dynamics of microtubule ends at the 
spindle pole body 
Microtubule nucleation 
YPR004C   11.80 3.74 n.d. n.d. Electron transfer flavoprotein complex subunit ETF alpha; contains a FAD binding domain  Biological_process unknown 
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Table 6. ORFs whose transcripts are repressed in FF18984 strain by 3-fold by 0.0125% MMS in F1 and/or YPD media (n=69) 
F1 
0.0125% 
YPD 
0.0125% 
F1 
0.0125% 
YPD 
0.0125% Down-regulated  
ORFs 
Gene  
short name 
30 min 30 min 1h 1h 
Molecular function Biological process 
DNA synthesis/repair (3 ORFs) 
YJR057W CDC8 n.d. n.d. n.d. -3.13 Thymidylate kinase DNA repair 
YHR164C DNA2 n.d. n.d. -3.8 -2.17 DNA replication helicase DNA repair 
YLR265C NEJ1 n.d. n.d. n.d. -3.85 Mating-type regulated component of NHEJ DNA repair 
Amino acid metabolism (2 ORFs) 
YLR158C ASP3C n.d. n.d. n.d. -3.21 Nitrogen catabolite-regulated cell-wall L-asparaginase II Asparagine catabolism 
YLR160C ASP3D n.d. n.d. -2.12 -4.00 Nitrogen catabolite-regulated cell-wall L-asparaginase II Asparagine catabolism 
Protein biosynthesis (15 ORFs) 
YKL191W DPH2 n.d. n.d. -3.45 n.d. 
Protein required for synthesis of diphthamide, 
which is a modified histidine residue of Eft1p or 
Eft2p 
Peptidyl-diphthamide biosynthesis from peptidyl-
histidine 
YLR172C DPH5 n.d. n.d. -2.07 -3.19 Diphthamide biosynthesis Peptidyl-diphthamide biosynthesis from peptidyl-histidine 
YGL195W GCN1 -2.61 n.d. n.d. -3.24 Translational activator of GCN4 through activation of GCN2 in response to starvation Regulation of translational elongation 
YEL034W HYP2 n.d. -3.87 n.d. n.d. Translation initiation factor eIF-5A Protein synthesis initiation 
YGL099W LSG1 n.d. n.d. n.d. -4.33 Putative GTPase involved in 60S ribosomal subunit biogenesis Ribosome export from nucleus 
YCR024C PMP1 -3.07 n.d. n.d. n.d. Asparagine-tRNA ligase Protein biosynthesis 
YHR141C RPL41B n.d. n.d. n.d. -4.22 Ribosomal protein L42B (YL27) (L41B) (YP44) Protein biosynthesis 
YDL184C RPL47A n.d. n.d. n.d. -5.09 Ribosomal protein L41A (YL41) (L47A) Protein biosynthesis 
YKR057W RPS25A n.d. n.d. n.d. -3.72 Ribosomal protein S21A (S26A) (YS25) Protein biosynthesis 
YKL156W RPS27A n.d. n.d. n.d. -3.44 Ribosomal protein S27A (rp61) (YS20) Protein biosynthesis 
YGR027C RPS31A n.d. n.d. n.d. -3.06 Ribosomal protein S25A (S31A) (rp45) (YS23) Protein biosynthesis 
YLR333C RPS31B n.d. n.d. n.d. -3.77 Ribosomal protein S25B (S31B) (rp45) (YS23) Protein biosynthesis 
YLR264W RPS33B n.d. n.d. n.d. -4.56 Ribosomal protein S28B (S33B) (YS27) Protein biosynthesis 
YJR007W SUI2 -2.06 n.d. n.d. -3.90 Translation initiation factor eIF-2 alpha subunit Protein synthesis initiation 
YIL052C   n.d. n.d. -2.11 -3.18 Ribosomal protein L34B Protein biosynthesis 
Regulation of transcription, RNA metabolism and processing (6 ORFs) 
YER045C ACA1 -2.34 -3.11 -2.66 n.d. Basic leucine zipper (bZIP) transcription factor of the ATF/CREB family 
Transcription initiation from RNA polymerase II 
promoter 
YOR046C DBP5 n.d. n.d. n.d. -3.09 RNA helicase mRNA-nucleus export 
YEL015W EDC3 n.d. n.d. -2.20 -3.06 Plays a role in mRNA decapping by specifically affecting the function of Dcp1p Deadenylylation-independent decapping 
YMR129W POM152 n.d. n.d. n.d. -3.34 Membrane glycoprotein, nuclear pore complex subunit mRNA-nucleus export 
YOR294W RRS1 n.d. n.d. n.d. -6.64 Regulator for ribosome synthesis Ribosome biogenesis 
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F1 
0.0125% 
YPD 
0.0125% 
F1 
0.0125% 
YPD 
0.0125% Down-regulated  
ORFs 
Gene  
short name 
30 min 30 min 1h 1h 
Molecular function Biological process 
YIL143C SSL2 n.d. n.d. n.d. -3.79 DNA helicase, human XPBC, ERCC3 homolog Transcription initiation from Pol II promoter 
Cell wall biosynthesis and organisation (5 ORFs) 
YLR342W FKS1 n.d. n.d. n.d. -3.19 1,3-beta-D-glucan synthase Cell wall organization and biogenesis 
YDL049C KNH1 n.d. n.d. n.d. -3.69 Protein with similarity to Kre9p, which is involved in cell wall beta 1,6-glucan synthesis Beta-1,6 glucan biosynthesis 
YLR332W MID2 n.d. n.d. n.d. -3.33 
O-glycosylated plasma membrane protein that acts 
as a sensor for cell wall integrity signaling and 
activates the pathway 
Cell wall organization and biogenesis 
YOR010C TIR2 -3.26 n.d. n.d. n.d. Putative cell wall mannoprotein of the Srp1p/Tip1p family of serine-alanine-rich proteins Cell wall organization and biogenesis 
YHL028W WSC4 n.d. n.d. -2.35 -7.59 Integral membrane protein (putative)|similar to SLG1 (WSC1), WSC2 and WSC3 Cell wall organization and biogenesis 
Protein folding, degradation and translocation (4 ORFs) 
YDL143W CCT4 n.d. n.d. n.d. -4.00 Cytoplasmic chaperonin subunit  Protein folding 
YOR020C HSP10 n.d. n.d. n.d. -3.03 Heat shock protein 10 Protein folding 
YJR143C PMT4 -3.05 -2.32 n.d. n.d. Dolichyl phosphate-D-mannose:protein O-D-mannosyltransferase O-linked glycosylation 
YLL039C UBI4 n.d. n.d. n.d. -5.99 Ubiquitin, becomes conjugated to proteins Stress response 
Membrane transport (1 ORF) 
YGL255W ZRT1 -3.45 n.d. n.d. n.d. High-affinity zinc transport protein High-affinity zinc ion transport 
Protein sorting (7 ORFs) 
YLR078C BOS1 n.d. n.d. n.d. -3.29 necessary for vesicular transport from the ER to the Golgi complex ER to Golgi transport 
YLR093C NYV1 n.d. n.d. n.d. -3.51 Vacuolar v-SNARE Non-selective vesicle fusion 
YLR026C SED5 n.d. n.d. n.d. -5.17 Sed5p is a t-SNARE (soluble NSF attachment protein receptor) required in ER to Golgi transport. ER to Golgi transport 
YGL104C VPS73 n.d. n.d. n.d. -3.52 Mitochondrial protein of unknown function involved in vacuolar protein sorting  Protein targeting to vacuole 
YER072W VTC1 n.d. n.d. n.d. -3.11 Involved in distributing V-ATPase and other membrane proteins Vacuole fusion (non-autophagic) 
YHR161C YAP1801 n.d. n.d. n.d. -3.42 Yeast Assembly Polypeptide, member of AP180 protein family Endocytosis 
YGL198W YIP4 n.d. n.d. n.d. -4.63 Protein that interacts with Rab GTPases; a possible role in vesicle-mediated transport  Vesicle-mediated transport 
Stress response/detoxification (1 ORF) 
YDR032C PST2 n.d. n.d. n.d. -3.25 
similarity to members of a family of flavodoxin-
like proteins; induced by oxidative stress in a 
Yap1p dependent manner 
Biological_process unknown 
Chromatin arrangement, chromosomes maintenance (4 ORFs) 
YLR318W EST2 n.d. n.d. n.d. -3.14 Telomerase catalytic subunit Telomere maintenance 
YBR010W HHT1 -3.14 n.d. n.d. n.d. Histone H3 (HHT1 and HHT2 code for identical proteins) Chromatin assembly/disassembly 
YNL031C HHT2 -3.76 n.d. n.d. n.d. Histone H3 (HHT1 and HHT2 code for identical proteins) Hhromatin assembly/disassembly 
YLR357W RSC2 n.d. n.d. n.d. -3.36 RSC complex member Chromatin modeling 
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F1 
0.0125% 
YPD 
0.0125% 
F1 
0.0125% 
YPD 
0.0125% Down-regulated  
ORFs 
Gene  
short name 30 min 30 min 1h 1h 
Molecular function Biological process 
Cell cycle (2 ORFs) 
YDL132W CDC53 n.d. n.d. n.d. -4.97 
Acts together with Cdc4p and Cdc34p to control 
the G1-S phase transition, assists in mediating the 
proteolysis of the Cdk inhibitor Sic1p in late G1 
G1/S and G2/M transition of mitotic cell cycle 
YGR238C KEL2 n.d. n.d. -2.18 -6.42 Negatively regulate mitotic exit, interacts with Tem1p and Lte1p Negative regulation of exit from mitosis 
Mitochondrial biogenesis, maintance and aerobic respiration (4 ORFs) 
YHR051W COX6 n.d. n.d. n.d. -3.48 Cytochrome c oxidase subunit Mitochondrial electron transport, cytochrome c to oxygen 
YJR048W CYC1 n.d. n.d. -2.51 -3.87 Iso-1-cytochrome c Oxidative phosphorylation 
YGR028W MSP1 n.d. n.d. n.d. -4.77 40 kDa membrane-spanning ATPase Mitochondrial translocation 
YHR050W SMF2 n.d. n.d. n.d. -3.41 
Suppressor of Mitochondria import Function, 
divalent metal ion transporter involved in 
manganese homeostasis 
Manganese ion transport 
Others (15 ORFs) 
YOR198C BFR1 n.d. n.d. n.d. -3.54 
Multicopy suppressor of BFA (Brefeldin A)-
induced lethality; implicated in secretion and 
nuclear segregation 
Meiosis 
YHR055C CUP1B -2.57 n.d. n.d. -3.20 Copper binding metallothionein Copper sensitivity/resistance 
YLR206W ENT2 n.d. n.d. -2.63 n.d. 
Epsin-like protein required for endocytosis and 
actin patch assembly and functionally redundant 
with Ent1p 
Actin filament organization 
YDR437W GPI19 -2.32 -3.41 n.d. n.d. 
Subunit of GPI-GlcNAc transferase involved in 
synthesis of N-acetylglucosaminyl 
phosphatidylinositol (GlcNAc-PI) 
GPI anchor biosynthesis 
YDL227C HO n.d. n.d. n.d. -4.00 Homothallic switching endonuclease Mating-type switching/recombination 
YDR017C KCS1 n.d. n.d. n.d. -4.82 
Inositol hexaphosphate kinase, phosphorylates 
inositol hexakisphosphate (InsP6) to 
diphosphoinositol polyphosphates 
Vacuole organization and biogenesis 
YGL197W MDS3 n.d. n.d. n.d. -5.30 Mck1 Dosage Suppressor 3; negative regulator of early meiotic gene expression Meiosis 
YGL211W NCS6 n.d. n.d. n.d. -3.14 Protein with a role in urmylation and in invasive and pseudohyphal growth Biological_process unknown 
YER009W NTF2 n.d. n.d. n.d. -3.58 Nuclear transport factor, similar to mammalian cytosolic nuclear import factor NTF2 Protein-nucleus import 
YDL090C RAM1 n.d. n.d. n.d. -3.40 Farnesyltransferase beta subunit Protein amino acid farnesylation 
YHL024W RIM4 n.d. n.d. n.d. -3.36 Putative RNA-binding protein required for the expression of early and middle sporulation genes Meiosis 
YPR007C SPO69 n.d. n.d. n.d. -3.05 Meiosis-specific component of sister chromatid cohesion complex Meiosis 
YER046W SPO73 -3.68 n.d. n.d. n.d. 
Meiosis-specific protein of unknown function, 
required for spore wall formation during 
sporulation 
Spore wall assembly  
YOL154W ZPS1 n.d. n.d. -5.05 n.d. 
Putative GPI-anchored protein; transcription is 
induced under low-zinc conditions, as mediated by 
the Zap1p transcription factor, and at alkaline pH  
Biological_process unknown 
YGL160W   -3.52 n.d. n.d. n.d. 
Protein with sequence similarity to iron/copper 
reductases (FRE1-8), possibly involved in iron 
homeostasis  
Biological_process unknown 
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The results obtained from transcriptional profiling after treatment with very low doses 
of MMS revealed a possible important role of metabolic adaptation in response to DNA 
damage and oxidative stress conditions. Expression of genes encoding enzymes involved in 
the glycolysis/gluconeogenesis (reactions between ethanol and pyruvate, and between 
pyruvate and glucose-6-phosphate) was similarly induced in YPD medium after 1h of 
incubation with both concentrations of MMS (Fig.9). Fold-induction by two MMS 
concentrations is compared in Table 7.  
 
Figure 9. Genes of the glycolysis/gluconeogenesis pathway induced by MMS. Outline of the 
glycolysis/gluconeogenesis pathway. Genes significantly induced after 1 and 4h of MMS treatment are marked 
with arrows. 
 
Dumond et al. (2000) demonstrated a link between oxidative stress and carbohydrate 
metabolism. They showed that carbohydrate metabolism is up-regulated by Yap1p and 
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concluded that under oxidative stress preferential utilization of the pentose phosphate 
pathway leads to a more efficient generation of the redox reaction cofactor NADPH. To check 
if a shift towards gluconeogenesis occurred after MMS treatment, we analyzed the expression 
of the key enzyme of gluconeogenesis fructose-1,6-bisphosphatase (FBP1), although its 
expression and regulation was not detectable on the gene expression array. The more sensitive 
RT-PCR showed a clear induction for FBP1 after 30 min and 1h in F1 medium and - albeit 
much weaker - after 1h in YPD with both concentration of MMS (Fig.10). Together with the 
earlier notion that genes of the carbohydrate metabolism are part of ESR in yeast (Godon et 
al., 1998; Dumond et al., 2000; Gasch et al., 2000), our result indicates that under oxidative 
stress and DNA damage caused by MMS, the carbohydrate metabolism is shifted towards an 
“anti-oxidative-stress” condition, requiring a slight adjustment of balance between 
glycolisis/gluconeogenesis, energy storage and the pentose phosphate pathway. 
 1h 1h
Gene/ORF 0.00125% 0.0125% 
HXK1 2.3 2.4
PGI1 3.7 4.8
FBA1 4.0 4.3
TDH1 3.5 6.4
TDH2 0.0 2.5
TDH3 4.9 4.3
PGK1 11.4 25.3
ENO1 6.1 9.7
ENO2 2.4 3.2
PDC1 0.0 2.8
PDC5 6.2 6.9
PDC6 3.0 3.0
ADH1 4.5 5.6
ADH2 11.1 17.9
 
Table 7 Fold induction of genes of the glycolysis/gluconeogenesis pathway induced after 1h treatment 
with 0.00125% and 0.0125% MMS in YPD medium. 
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Figure 10. Induction of FBP1 expression upon MMS treatment. (A) Expression of FBP1 in wild-
type after treatment with MMS in minimal (F1) and full medium (YPD). RT-PCR from 5-fold serial dilutions of 
cDNA preparations was performed and FBP1 was amplified for 30 cycles. (B) RT-PCR expression analysis of 
ACT1 amplified for 25 cycles. 
 
The absence of transcriptional induction of genes involved in carbohydrate 
metabolism by MMS in cells grown in F1 medium could be a consequence of an already high 
basal expression of these genes in the cells.  The same explanation can stand for the induction 
of different genes from the same functional group in F1 and YPD media. To confirm these 
data, we performed RT-PCR analysis of the stress-induced genes YAP1 and YCF1. YAP1 and 
YCF1 are characterized as oxidative stress responsive genes (Gounalaki and Thireos, 1994; 
Jungwirth et al., 2000). In all cases RT-PCR results showed a significantly higher basal 
expression in cells grown in F1 medium which was only slightly increased upon induction by 
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MMS. In YPD these genes were lower expressed and clearly induced already after 30 min by 
both MMS concentrations (Fig.11). The same effect is visible for FBP1 discussed above 
(Fig.10). This observation correlates with hybridization data for other members of the heat 
shock and stress response gene families, membrane transporters (HSC, HSP, SSA and SSB; 
Fig.12) and genes involved in the carbohydrate metabolism, which also showed elevated basal 
expression in cells grown in minimal medium.  
 
Figure 11. Elevated basal expression of ESR genes in F1 medium. Comparative RT-PCR for YAP1 
and YCF1, which is regulated by Yap1p, was performed from 10-fold serial dilutions of cDNA. For both genes a 
30-cycle PCR protocol was used. Corresponding control RT-PCR for ACT1 is presented in Fig. 10B. 
 
Therefore, although the cultivation in F1 did not induce changes in cell morphology 
and growth rate (data not shown), the limited amount of nutrients produced stress conditions, 
which are reflected in the expression profiles. In given conditions metabolic reorganization is 
not necessary, as well as the induction of many genes involved in detoxification and 
maintenance of cellular homeostasis. In this case cells can further activate more specific and 
stronger transcriptional response to MMS. 
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Figure 12. Elevated basal expression of ESR genes in F1 medium. Expression level of some ESR 
genes in non-treated YPD or F1 cultures. The data represent hybridisation signal intensity obtained from the 
DNA arrays.  
 
3.3. Differences in transcriptional profiles after low level MMS treatment between 
strains 
The transcription profile of cells grown in media with different nutrient availability 
showed that in F1 medium MMS triggers the expression of more specific groups involved in 
defense against this drug. In YPD medium the adjustment in the basic cellular processes like 
metabolic pathways, proteins biosynthesis or regulation of internal homeostasis is a 
prerequisite for a further specific response. By analyzing changes in the transcriptional profile 
of BY4742 in response to a 1h treatment with 0.0125% MMS we wanted to see how strain 
background influences this basic cellular response.  
Selecting for genes regulated at least 3 fold in BY4742 we found 44 up-regulated 
genes and 11 down-regulated genes (Table 8, Table 9). Only 2 ORF2 were also induced in the 
FF18984 strain: RNR2 involved in DNA damage repair and SHM1 involved in amino acids 
metabolism. In the group of down-regulated genes there were no similarly regulated genes as 
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in the FF18984 strain. Although some of the functional groups regulated in the FF18984 
strain are also present in the response of the BY4742 strain, many of them are represented 
with only one to tree genes. This is especially the case for the groups of carbohydrate 
metabolism and fermentation, amino acid metabolism, protein biosynthesis, regulation of 
transcription, RNA metabolism and processing, as well as for membrane transporters. All of 
these groups are strongly induced in the FF18984 strain, in which they are represented with 
more than tree ORFs. Notably up-regulated in this experiment were genes involved in protein 
folding, degradation and sorting which implicates high protein damage caused by applied 
MMS concentrations. The group of genes involved in chromatin rearrangement and 
chromosomes maintenance was also strongly up-regulated and presented with four ORFs all 
required for maintaining the chromosome stability. The groups of stress response, cell cycle 
regulation, mitochondrial biogenesis and aerobic respiration were also not included in the 
response of the BY4742 strain with significant number of genes. Two genes were highly up-
regulated exclusively in this strain, DNA damage-induced RAD9 required for G2 arrest in 
mitosis and glutathione reductase TRR1. Both of them are hallmarks of DNA damage and 
oxidative stress response. What could be even more important is that the transcription 
response of the BY4742 strain did not include significant down-regulation of any specific 
functional groups. Transcription of only 11 ORFs was down-regulated for more than 3-fold, 
but no functional group was represented with more than 2 ORFs (Table 9). These results 
implicate that the higher sensitivity of the BY4742 strain to MMS could be a result of 
inefficient induction of genes involved in the protection of critical aspects of the internal 
milieu, like energy conservation, cell wall integrity or export of drugs from the cells.   
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Table 8. ORFs whose transcripts are induced in BY4742 strain by 3-fold by 0.0125% MMS in F1 
and/or YPD media (n=44) 
YPD 
0.0125% Up-regulated  
ORFs 
Gene  
short name 
1h 
Molecular function Biological process 
Carbohydrate metabolism and fermentation, pentose-phosphate shunt (3 ORFs) 
YBR149W ARA1 3.53 D-arabinose dehydrogenase Carbohydrate metabolism 
YGR256W GND2 3.33 
6-phosphogluconate dehydrogenase 
(decarboxylating), catalyzes an NADPH regenerating 
reaction in the pentose phosphate pathway 
Glucose metabolism 
YOL136C PFK27 4.25 6-phosphofructo-2-kinase, has negligible fructose-2,6-bisphosphatase activity Regulation of glycolysis 
DNA synthesis/repair (3 ORFs) 
YDR408C ADE8 6.15 
Phosphoribosyl-glycinamide transformylase, catalyzes 
a step in the 'de novo' purine nucleotide biosynthetic 
pathway  
Purine nucleotide biosynthesis 
YDR217C RAD9 3.91 
Required for DNA damage-induced G2 arrest in 
mitosis, required for ionizing radation-induced G1 
arrest, and other cdc13-induced G2 arrest in meiosis 
DNA repair 
YJL026W RNR2 5.53 Small subunit of ribonucleotide reductase DNA replication 
Signaling/kinases/phosphatases (1 ORF) 
YHR030C SLT2 3.24 
Serine/threonine MAP kinase involved in regulating 
the maintenance of cell wall integrity and progression 
through the cell cycle; regulated by the PKC1-
mediated signaling pathway  
Signal transduction 
Amino acid metabolism (2 ORFs) 
YDR037W KRS1 3.79 
Lysyl-tRNA synthetase; also identified as a negative 
regulator of general control of amino acid 
biosynthesis 
 Lysyl-tRNA aminoacylation 
YBR263W SHM1 3.76 Serine hydroxymethyltransferase, mitochondrial One-carbon compound metabolism 
Protein biosynthesis (1 ORF) 
YPR163C TIF3 3.15 Translation initiation factor eIF-4B Protein synthesis initiation 
Regulation of transcription, RNA metabolism and processing (3 ORFs)  
YLR117C CLF1 3.03 
Essential splicesome assembly factor; contains 
multiple tetratricopeptide repeat (TPR) protein-
binding motifs and interacts specifically with many 
spliceosome components, may serve as a scaffold 
during splicesome assembly  
Nuclear mRNA splicing, via 
spliceosome 
YLR266C PDR8 3.11 
Transcription factor; targets include ATP-binding 
cassette (ABC) transporters, major facilitator 
superfamily transporters, and other genes involved in 
the pleiotropic drug resistance  
Positive regulation of transcription 
from RNA polymerase II promoter 
YGR006W PRP18 3.99 RNA splicing factor associated with U5 snRNP mRNA splicing 
Cell wall biosynthesis and organisation (3 ORFs) 
YOR382W FIT2 3.34 
Mannoprotein that is incorporated into the cell wall 
via a glycosylphosphatidylinositol (GPI) anchor, 
involved in the retention of siderophore-iron in the 
cell wall 
Siderophore transport 
YOR383C FIT3 7.87 
Mannoprotein that is incorporated into the cell wall 
via a glycosylphosphatidylinositol (GPI) anchor, 
involved in the retention of siderophore-iron in the 
cell wall  
Cell wall protein involved in iron 
transport 
YBR205W KTR3 4.25 Putative alpha-1,2-mannosyltransferase Cell wall organization and biogenesis 
     
Protein folding, degradation and translocation (6 ORFs) 
YGL038C OCH1 3.32 Initiates the polymannose outer chain elongation of N-linked glycans N-linked glycoprotein maturation 
YDR313C PIB1 3.42 
RING-type ubiquitin ligase of the endosomal and 
vacuolar membranes, binds phosphatidylinositol(3)-
phosphate; contains a FYVE finger domain  
Protein ubiquitination 
YMR297W PRC1 3.49 
Vacuolar carboxypeptidase Y (proteinase C), involved 
in protein degradation in the vacuole and required for 
full protein degradation during sporulation  
Vacuolar protein catabolism 
YGL048C SUG1 3.90 Member of the 26 S proteasome Ubiquitin-dependent protein degradation 
YEL002c WBP1 3.09 
Beta subunit of the oligosaccharyl transferase (OST) 
glycoprotein complex; required for N-linked 
glycosylation of proteins in the endoplasmic reticulum  
Protein amino acid N-linked 
glycosylation 
YBR075W   4.55 Putative metalloprotease Proteolysis 
Membrane transport (1 ORF) 
YKR050W TRK2 3.11 Membrane protein; low affinity potassium transport Potassium ion homeostasis 
Protein sorting (5 ORFs) 
YGL002W ERP6 3.49 
Protein with similarity to Emp24p and Erv25p, 
member of the p24 family involved in ER to Golgi 
transport  
Secretory pathway 
YDL226C GCS1 4.70 
Zn-finger-containing protein that functions as ADP-
ribosylation factor GTPase-activating protein and is 
involved in regulating vesicle transport 
ER to Golgi transport 
YDL100c GET3 3.39 
ATPase, subunit of the GET complex; required for the 
retrieval of HDEL proteins from the Golgi to the ER 
in an ERD2 dependent fashion 
Retrograde transport, Golgi to ER 
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F1 
0.0125% Up-regulated  
ORFs 
Gene  
short name 30 min 
Molecular function Biological process 
YGL257C MNT2 3.88 MaNnosylTransferase; involved in adding the 4th and 5th mannose residues of O-linked glycans O-linked glycosylation 
YJR033C RAV1 3.22 
Subunit of the RAVE complex (Rav1p, Rav2p, 
Skp1p), which promotes assembly of the V-ATPase 
holoenzyme 
Early endosome to late endosome 
transport 
Stress response/detoxification (1 ORF) 
YDR513W TTR1 3.31 Glutaredoxin (thioltransferase) (glutathione reductase) Oxidative stress response 
Chromatin arrangement, chromosomes maintenance (4 ORFs) 
YDR254W CHL4 3.27 
Outer kinetochore protein required for chromosome 
stability, interacts with kinetochore proteins Ctf19p, 
Ctf3p, and Iml3p 
Chromosome segregation 
YBL002W HTB2 5.53 Histone H2B (HTB1 and HTB2 code for nearly identical proteins) Chromatin assembly/disassembly 
YLR033W RSC58 5.50 Remodels the structure of chromatin complex 58KDa subunit Chromatin remodeling 
YDR082w STN1 3.27 Involved in telomere length regulation, function in telomere metabolism during late S phase Telomere capping 
Cell cycle (1 ORF) 
YKL203C TOR2 4.48 
Putative protein/phosphatidylinositol kinase involved 
in signaling activation of translation initiation, 
distribution of the actin cytoskeleton, and meiosis 
Regulation of cell cycle 
Mitochondrial biogenesis, maintenance and aerobic respiration (2 ORFs) 
YPR020W ATP20 3.36 Protein associated with mitochondrial ATP Synthase; essential for dimeric state of ATP synthase ATP synthesis coupled proton transport 
YPL078C ATP4 3.52 ATP synthase F0 sector subunit 4; analogous to the bovine b subunit ATP synthesis coupled proton transport 
Others (8 ORFs) 
YER026c CHO1 3.02 Phosphatidylserine synthase Phosphatidylserine biosynthesis 
YJL196C ELO1 3.42 
Elongation enzyme 1, required for the elongation of 
the saturated fatty acid tetradecanoic acid (14:0) to 
that of hexadecanoic acid (16:0) 
Fatty acid metabolism 
YDR174W HMO1 7.44 High mobility group (HMG)-like protein Plasmid maintenance 
YDR142C PEX7 3.04 
Peroxisomal signal receptor for the N-terminal 
nonapeptide signal (PTS2) of peroxisomal matrix 
proteins 
Peroxisome organization and 
biogenesis 
YLR084C RAX2 3.25 Involved in the maintenance of bipolar pattern Maintenance of cell polarity (sensu Saccharomyces) 
YIL016W SNL1 3.07 
Protein of unknown function proposed to be involved 
in nuclear pore complex biogenesis and maintenance 
as well as protein folding 
Nuclear pore organization and 
biogenesis 
YER024w YAT2 3.20 
The Yat2p protein shows significant homology with 
the known carnitine acetyltransferase associated with 
the outer-mitochondrial membrane, Yat1p, and also 
functions as a carnitine acetyltransferase. 
Carnitine metabolism 
YDL124w   3.07 
NADPH-dependent alpha-keto amide reductase; 
reduces aromatic alpha-keto amides, aliphatic alpha-
keto esters, and aromatic alpha-keto esters 
Metabolism 
 
Table 9. ORFs whose transcripts are repressed in BY4742 strain by 3-fold by 0.0125% MMS in 
F1 and/or YPD media (n=11) 
YPD 
0.0125% Down-regulated  
ORFs 
Gene  
short name 
1h 
Molecular function Biological process 
Signaling/kinases/phosphatases (1 ORF) 
YNR031C SSK2 -4.89 MAP kinase kinase kinase of the HOG1 mitogen-activated signaling pathway Protein amino acid phosphorylation 
Amino acid metabolism (1 ORF) 
YOR108W LEU9 -3.06 
Alpha-isopropylmalate synthase II (2-isopropylmalate 
synthase), catalyzes the first step in the leucine 
biosynthesis pathway 
Lleucine biosynthesis 
Protein biosynthesis (2 ORFs) 
YPL179W PPQ1 -4.75 
Putative protein serine/threonine phosphatase; null 
mutation enhances efficiency of translational 
suppressors  
Regulation of translation 
YNL178W RPS3 -4.76 Ribosomal protein S3 (rp13) (YS3) Protein biosynthesis 
Cell wall biosynthesis and organisation (1 ORF) 
YMR307W GAS1 -4.40 Beta-1.3-glucanosyltransferase, required for cell wall assembly Cell wall organization and biogenesis 
Protein folding, degradation and translocation (1 ORF) 
YIL046W MET30 -3.15 F-box protein involved in sulfur metabolism and protein ubiquitination 
Ubiquitin-dependent protein 
degradation 
Membrane transport (2 ORFs) 
YHR175W CTR2 -4.72 Putative low-affinity copper transport protein Transport 
YGL008C PMA1 -3.05 Major regulator of cytoplasmic pH Regulation of pH 
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YPD 
0.0125% Down-regulated  
ORFs 
Gene  
short name 1h 
Molecular function Biological process 
Chromatin arrangement, chromosomes maintenance (1 ORF) 
YKL049C CSE4 -6.99 Centromere protein that resembles histones, required for proper kinetochore function Mitotic sister chromatid segregation 
Others (2 ORFs) 
YCL050c APA1 -3.10 Diadenosine 5',5'''-P1,P4-tetraphosphate phosphorylase I Nucleotide metabolism 
YOR190W SPR1 -3.72 Glucan 1,3-beta-glucosidase  Sporulation  
 
3.4. Induction of gluconeogenesis and oxidative metabolism has a direct influence 
on DNA damage response 
Taking all aforementioned results into consideration, sensitivity to MMS seems to be 
dependent on the ability of the cells to induce genes of the ESR and the carbohydrate 
metabolism. Many of these genes are higher expressed when cells are grown in minimal 
medium. To check if pre-induction of these genes would decrease sensitivity to MMS we 
performed survival tests under MMS after pre-incubation in three media: full medium (YPD), 
synthetic minimal medium (SD), and oxidative metabolism induced medium (YPKG). Both 
strains, FF18984 and BY4742, were incubated in parallel in these media and aliquots from log 
phase, early stationary phase (1 day culture) and six days old cultures were spotted in serial 
dilutions on YPD agar plates with 0.018%-0.0225% MMS. The optical density of all cultures 
measured after 4h, 1 day and 6 days of cultivation showed no differences between the two 
strains cultivated in the same medium. The highest optical density was reached in YPD, 
growth was slower in YPKG and slowest in SD (Fig.13). These results correlate with the 
availability of nutrients.  
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Figure 13. Growth rate of FF18984 and BY4742 strains cultivated in different media. Pre-cultures 
were grown overnight in full (YPD), minimal (SD) or respiratory induced (YPKG) medium. Cultures were 
prepared in the same medium by inoculation with pre-cultures, and grown for 6 days. Optical density of the 
cultures (OD600) was measured after 4h, 24h and 6 days. 
 
After being spotted on MMS plates the BY4742 cells were again more sensitive to 
MMS than the FF18984 cells. Cells from both strains taken from 1 day or 6 day stationary 
cultures were less sensitive to MMS than cells taken from the log phase (Fig.14). Although 
the difference was more striking for BY4742, this increase is also visible for the FF18984 
cells. This shows that replicating cells are more sensitive to DNA damage than cells in 
stationary phase that ceased dividing and already induced ESR. Interestingly, for both strains, 
cells cultivated in SD or YPKG media were less sensitive to MMS compared with the cells 
cultivated in YPD. Cells cultivated in YPKG medium, in which genes involved in 
gluconeogenesis and oxidative metabolism were highly expressed, showed the lowest 
sensitivity to MMS. This effect is better visible in young cells from mid-log phase and again 
more striking in BY4742. It also should be noted, that the FF18984 strain showed reduced 
viability when pre-cultured in SD for six days.  
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Figure 14. MMS sensitivity of cells pre-cultivated in different media. Pre-cultures were grown 
overnight in full (YPD), minimal (SD) or respiratory induced (YPKG) medium. Cultures were prepared in the 
same medium by inoculation with pre-cultures, and grown for 6 days. Aliquots of cultures were taken after 4h, 
24h and 6 days. Serial 5-fold dilutions were prepared and spotted onto YPD, YPD + 0.018% MMS, YPD + 
0.02% MMS or YPD + 0.0225% MMS and incubated for 48h at 30°C. Reduced growth at higher dilutions 
reflects higher sensitivity to MMS. 
 
These results show that pre-induction of genes involved in ESR, gluconeogenesis and 
oxidative metabolism by changing the availability of nutrients decreases sensitivity to MMS 
and allows more cells to survive the treatment with the toxic agent.  
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3.5. Deletion of FBP1 influences sensitivity of S.cerevisiae to DNA damage caused 
by MMS 
 The results obtained from expression profiling and sensitivity assays with cells grown in 
different media revealed that metabolic adaptation could play an important role in defence 
against DNA damage. To test how the deletion of some important regulators of oxidative 
metabolism and gluconeogenesis influence sensitivity of yeast cells to DNA damage, we 
constructed the following deletion mutants: Δfbp1, Δhap4 and Δmig1. Fbp1 is the key 
regulator of gluconeogenesis and its transcription is known to be strongly repressed in the 
presence of glucose (Polakis and Bartley, 1965; Eraso and Gancedo, 1984). Hap4p enhances 
transcription of a large set of mitochondrial protein genes during transition from fermentative 
to non-fermentative metabolism (Lascaris et al., 2002), while Mig1p is a transcription factor 
that negatively regulates transcription of genes involved in gluconeogenesis and energy 
generation. Mig1 binds to the promoter of FBP1 and represses its transcription under high 
glucose conditions (Zaragoza et al., 2001), although additional Mig1p-independent FBP1 
repression by glucose is described (Balciunas and Ronne, 1995). First we tested sensitivity of 
these strains to various DNA damaging agents: MMS, 4-nitroquinolin-N-oxide (4-NQO) and 
phleomycin and their vitality on non-fermentable carbon sources. The test was done by 
spotting serial 5-fold dilutions of cells from mid-log phase onto YPD plates containing 
different toxic substances (as indicated in the figures) or SD plates containing ethanol and 
glycerol (Fig.15). In addition, the Δrad9 mutant was again used as a positive control to detect 
a substance specific genotoxic effect. 
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Figure 15. Deletion of FBP1 influences cellular sensitivity to MMS, but does not have any effect 
on sensitivity to 4-NQO or phleomycin. (A) MMS sensitivity on full medium (YPD) and viability on non-
fermentable carbon sources (SDEG). Wild-type strain (WT) and deletion strains Δfbp1, Δhap4, Δmig1 and 
Δrad9 were grown in YPD until mid-log phase at 30°C.  5-fold dilutions (starting OD600 = 0.5) were spotted onto 
plates with YPD, YPD + MMS or SDEG (EG indicates ethanol and glycerol) and incubated for 48h at 30°C. (B) 
Sensitivity of deletion strains to 4-NQO and phleomycin. Cells were grown and diluted as described above for 
Fig. 15A.  
 
 On non-fermentable carbon sources, both Δfbp1 and Δhap4 mutants as well as Δrad9 
mutant display impaired growth, while the growth of wild-type and Δmig1 was not changed 
(Fig.15A). Low viability of the Δrad9 mutant strain on non-fermentable carbon sources can 
be explained by inability of the strain to slow down proliferation and adapt to conditions with 
limited nutrients. Deletion of FBP1 has already been characterised to yield petite or pet 
mutants (Dimmer et al., 2002; Steinmetz et al., 2002). The reason for such mutant phenotype 
is the fact that growth of yeast cells on non-carbohydrate substrates as sole carbon sources 
necessitates the synthesis of sugars which are required for macromolecular biosynthesis. As 
expected, Δrad9 mutant cells did not survive any MMS or 4-NQO treatment and had a very 
low viability on plates with phleomycin (Fig.15A, 15B). In response to increasing MMS 
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concentrations, the Δfbp1 mutant showed much lower sensitivity to MMS than the wild-type 
strain. However, in the treatment with the two other DNA-damaging agents, – 4-NQO and 
phleomycin, the Δfbp1 mutant did not show a comparable reduction of sensitivity (Fig. 15A, 
15B). 4-NQO is considered to be a UV-mimetic agent that produces single strand DNA 
breaks and pyrimidine dimers (Mirzayans et al., 1999), while phleomycin reacts with 
deoxyribose to cleave phosphodiester bonds, generates 3´-phosphoglycolate and oxidizes AP 
sites what block DNA polymerase and cause cleavage of DNA leading to double strand DNA 
breaks (Bennett, 1999). Thus, reduced sensitivity to MMS in absence of functional Fbp1p 
appears to be specific for this genotoxic agent. Remarkably, Δmig1 was more sensitive to 
MMS and only slightly more sensitive to phleomycin (Fig. 15A, 15B). Deletion of HAP4 also 
caused higher sensitivity to the MMS (Fig. 15A) what is in consistence with previous reports 
that increased antioxidant status after respiratory adaptation contributes to an increased 
oxidative-stress tolerance (reviewed in Moradas-Ferreira et al., 1996).  
The reduced sensitivity of cells lacking Fbp1p to MMS could be a result of direct 
influences of mutation on cellular damage and accumulation of dead cells or an impact on the 
proliferation potential of damaged cells. To address this question we scored the number of 
viable cells and screened for colony formation ability after both short- and-long term 
treatment with MMS. MMS was used in the concentration of 0.03% that on plates caused no 
colony formation in wild-type and large number of colonies produced in the Δfbp1 mutant. 
Viability staining of wild-type and the Δfbp1 mutant cells was performed by fluorescein 
diacetate (FDA) and propidium iodide (PI) staining during a 48h time-course of MMS 
treatment. The results revealed that after a short-term treatment with 0.03% of MMS (after 2h, 
4h of treatment) there are still more than 95% of metabolically active cells in both strains, 
while this number is reduced to app. 80% after long-term treatment (24h and 48h of 
treatment) (Fig.16). The ratio of dead versus viable cells was determined by flow cytometry 
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analysis. There were no differences in the amount of PI positive cells in wild-type and the 
Δfbp1 cells over 48h of MMS treatment (data not shown).  
 
Figure 16. Cell viability after the long-term treatment with MMS. Wild-type (WT) and Δfbp1 
mutant cells were grown in YPD until mid-log phase. The cultures were divided, one part was used as control 
(untreated sample) and the other part was treated with 0.03% MMS for 24h or 48h. Samples from indicated time-
points were stained in parallel with PI and FDA and cells were visualised with fluorescence microscope. 
 
In contrast, when we analysed the ability to proliferate and form colonies we found 
remarkable differences between wild-type and the Δfbp1 mutant. A 2h MMS treatment 
reduced the number of cells that were able to proliferate for approximately 43% in wild-type 
and 70% in the Δfbp1 strain. (Fig.17). After 4h of treatment the number of wild-type colonies 
further reduced to only 14% of control one, while in Δfbp1 further decrease was not observed 
(36% of proliferating cells).  The fast decrease in the percentage of MMS treated cells able to 
form colonies is in consistence with previous results obtained after treatment with lower 
concentrations of this agent. The results show that treatment with MMS reduces cellular 
proliferation which probably gives enough time to cells to repair damage. Interestingly, after 
long term treatment with MMS (24h and 48h) we observed a significant recovery of the Δfbp1 
mutant, but not of wild-type. Also, the number of non-treated cells from the 24h culture that 
are able to form colonies was significantly higher in the Δfbp1 mutant.  
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Figure 17. The Δfbp1 mutant cells are able to proliferate after release from long-term treatment 
with MMS. Wild-type (wt) and Δfbp1 mutant cells were grown in YPD until mid-log phase. The cultures were 
divided, one part was used as control (untreated sample; con) and the other part was treated with 0.03% MMS. 
Samples were taken at indicated time-points, plated in triplicate on YPD and incubated at 30°C. After 48h 
numbers of colonies were counted. The results are presented as logarithmic mean values ± SEM.  
 
Therefore, deletion of FBP1 seems to have impact on the ability of cells to recover 
after MMS treatment which could be a consequence of reduced toxic effect of this agent or 
more efficient repair mechanism. 
 
3.6. Overproduction of Fbp1p has a toxic effect on cells 
In order to prove that the observed results are caused by the absence of the FBP1 gene, 
and not by secondary mutations in the deletion strain, we overexpressed FBP1 in wild-type 
and in Δfbp1. All transformants were tested for viability on non-fermentable carbon sources 
(ethanol and glycerol) and for MMS-sensitivity (Fig.18).  
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Figure 18. Sensitivity of strains overexpressing FBP1 to MMS and their viability on selective 
medium (SD-URA) and on non-fermentable carbon sources (SDEG). Wild-type (WT) and Δfbp1 were 
transformed with the empty plasmid pRS426 (e), or with the plasmid pRS426 containing the FBP1 cassette 
under the control of the GPD promoter (+ FBP1). Cells were grown in SD-URA until mid-log phase at 30°C. 5-
fold dilutions (starting OD600 = 0.5) were spotted onto indicated media and incubated for 48h at 30°C. SDEG 
+URA or SDEG –URA represent selective or non-selective ethanol/glycerol medium, correspondingly and 
+0.1% GLU or -GLU indicate plates with or without glucose. 
 
Viability of the strains on non-fermentable carbon sources was tested under non-
selective or plasmid selective conditions in presence or absence of limited amounts of 
glucose. Results confirmed that the Δfbp1 mutant strain is not viable on medium without 
glucose while limited amounts of glucose (0.1%) are sufficient to support growth. 
Overexpression of FBP1 completely restored the mutant to wild-type phenotype on non-
fermentable carbon sources and restored wild-type sensitivity to MMS (Fig.18). In wild-type 
overexpression of FBP1 increased sensitivity to MMS leading to lower viability of this strain. 
FBP1 overexpression slowed down the growth rate resulting in production of smaller colonies 
in both, wild-type and Δfbp1. These results confirm that sensitivity to DNA-damage caused 
by MMS depends, at least in part, on FBP1 expression. Also, the increased sensitivity of 
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wild-type cells overexpressing FBP1 to MMS implicated that the high intracellular level of 
this protein could be actually toxic for the cells. 
 
Figure 19. Effect of FBP1 overexpression on cell sensitivity to MMS. Survival test of cells lacking 
or overexpressing FBP1 after 24h treatment with 0.02% MMS. Cells carrying control plasmid (e) or plasmid 
overexpressing FBP1 (+FBP1) were mock-treated (control) or treated with 0.02% MMS for 24h and plated in 
triplicate on SD-URA medium. Data represents mean value ± SEM. 
 
Similar results were obtained when we analysed the ability of colony formation of 
wild-type and the Δfbp1 mutant overexpressing FBP1 after 2h and 24h of treatment with 
MMS. This time, we used a lower MMS concentration (0.02%) that in the survival test on 
solid medium with MMS showed only slight cytotoxicity (Fig.7). Results showed that in both 
wild-type and Δfbp1 mutant cells the overexpression of FBP1 reduced the amount of cells 
able to form colonies even in untreated cells (Fig.19). This effect was visible only in 24h old 
stationary phase cultures while in young cells from mid-log phase there was no effect of 
FBP1 overexpression on cellular ability to form colonies on solid medium (data not shown). 
Interestingly, 24h non-treated stationary phase cultures of the Δfbp1 mutant again showed that 
many more cells were able to continue proliferation and form colonies, although during 
exponential growth in full and minimal media, similar growth rate in both wild-type and 
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Δfbp1 strain were found (Fig.20). Total biomass yield after 24h of culturing was only slightly 
lower (88.3 % of wild-type density) for the Δfbp1 strain. Therefore, better viability of mutant 
cells in stationary culture and more colonies produced can not be explained by faster growing 
of the Δfbp1 strain. 
 
Figure 20. Growth curve of wild-type (WT) and Δfbp1 mutant in YPD medium. Cultures were 
prepared in YPD medium by inoculation with pre-cultures, and grown for 24h. Optical density of the cultures 
(OD600) was measured after 1h, 2h, 3h, 4h, 5h, 6h, 7h and 24h. Experiment was repeated three times showing 
similar results at every repetition.  
 
When we transformed cells with FBP1 fused with yEGFP to its C-terminus Fbp1-
GFPp showed mostly a vacuolar localisation of the protein in control and MMS-treated cells 
in glucose rich conditions (Fig.21). This is in accordance with the observation that under 
glucose-rich conditions Fbp1p is transported from the cytosol to the vacuole for degradation 
(Shieh and Chiang, 1998). The test for growth on ethanol and glycerol without glucose proved 
that the C-terminally GFP-tagged Fbp1p restored the lack of Fbp1p in the Δfbp1 strain. In 
contrast to this, it was not possible to restore wild-type MMS-sensitivity in Δfbp1 cells with 
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this fusion protein, although slightly higher sensitivity of the Δfbp1 cells overexpressing 
FBP1-GFP in comparison to the Δfbp1 strain could be observed (Fig.22). This indicates that 
the function of FBPase in cellular growth on media with alternative carbon sources (e.g. 
ethanol and glycerol) could be independent, at least in part, from its role in response to MMS 
treatment. 
 
 
Figure 21. Fbp1p fused with GFP on its C-terminus is targeted to the vacuole. Representative 
images of wild-type (WT) and Δfbp1 mutant cells transformed with plasmid overexpressing FBP1-GFP. For 
control an aliquot of each sample was stained with the vacuolar marker FM 4-64, a dye specific for vacuolar 
membranes. DIC: differential interference contrast microscopy. 
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Figure 22.  Overexpression of Fbp1-GFPp complements the lack of Fbp1p in growing on non-
fermentable carbon sources, but its function in conferring MMS-sensitivity is impaired. MMS sensitivity 
and viability on ethanol-glycerol medium (SDEG) of the wild-type (WT) transformed with empty plasmid 
pRS426 (e), or with the plasmid pRS426 containing the FBP1 cassette under the control of the GPD promoter 
(+FBP1) and Δfbp1 mutant transformed with empty pRS426 (e), pRS426 containing FBP1 cassette (+FBP1), or 
plasmid overexpressing FBP1-GFP under control of actin promoter (+FBP1-GFP). Cells were grown in SD-
URA until mid-log phase at 30°C. 5-fold dilutions (starting OD600 = 0.5) were spotted onto indicated media and 
incubated for 48h at 30°C. 
 
3.7. Fbp1p overproduction influences the level of DNA damage caused by MMS  
One of the main DNA damage-induced pathways goes from the transcriptional 
activator Mec1/Tel1 via activation of Rad9p that in turn activates both Rad53p and Chk1p 
pathways (Blankley and Lydall, 2004). The induction of this pathway results in activation of a 
large group of genes necessary for DNA repair via Rad53p and cell cycle arrest via Chk1p. 
One of the proteins downstream from Rad53p is Rnr2p. Induction of RNR2 is necessary for 
DNA repair (Chabes et al., 2003).  
To check if the lack of Fbp1p alters the impact of MMS on the Mec1/Tel1 pathway we 
used an RNR2-GFP reporter system (Affanasiev et al., 2000) to measure the induction of the 
RNR2 after MMS damage in wild-type, Δfbp1 and Δrad9 mutant cells. Induction of the RNR2 
gene is a very good indicator of a genotoxic effect of various toxic agents (Affanasiev et al., 
2000). Considering that transcriptional induction of RNR2 is Rad9p-dependent (Blankley and 
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Lydall, 2004) Δrad9 mutant transformed with the reporter plasmid served as additional 
negative control along with wild-type cells without RNR2-GFP reporter plasmid. 
 
Figure 23. Deletion of FBP1 does not influence the level of DNA damage after treatment with 
MMS. MMS induction of yEGFP expression from the RNR2 promoter in wild-type (WT) and deletion strains, 
Δfbp1 and Δrad9. Wild-type (wt), Δfbp1 and Δrad9 were transformed with RNR2 reporter plasmid (RNR2 RP)  
and intensity of GFP-fluorescence was measured after 16h of treatment with different MMS concentrations 0% - 
0.045%. The Δrad9 mutant was used as negative control. The values present fold induction of RNR2 expression 
± SEM, calculated as mean fluorescence signal for MMS treated samples, normalised for cell density and 
divided by mean signal for non-treated samples. 
 
Induction of the RNR2-GFP reporter after MMS treatment, calculated as change in 
fluorescence intensity per cell number, showed that in the Δfbp1mutant induction of the RNR2 
was similar as in wild-type, whereas it was absent in the Δrad9 mutant (Fig.23). However, 
overexpression of FBP1 significantly increased fold-induction of the RNR2 in comparison 
with strains transformed with a control plasmid (pRS425 e) where RNR2 induction was again 
similar in the wild-type and Δfbp1 mutant (Fig.24).  The facts that deletion of FBP1 shows no 
effect on RNR2 induction, while overexpression increase it suggests that the increased 
intracellular level of Fbp1p after DNA damage caused by MMS probably acts as a signal that 
mediate cellular response to this toxic agent. 
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Figure 24. Overexpression of FBP1 increases the level of DNA damage after treatment with 
MMS. Wild-type (wt) and Δfbp1 were transformed with two plasmids: empty plasmid pRS425 GPD (GPDe) and 
RNR2 reporter plasmid (RNR2 RP) or pRS425 containing the FBP1 cassette under the control of the GPD 
promoter (FBP OE) and RNR2 RP. Intensity of GFP-fluorescence was measured after 16h of treatment with 
different MMS concentrations 0%-0.045%. The values present fold induction of RNR2 expression ± SEM, 
calculated as mean fluorescence signal for MMS treated samples, normalised for cell density and divided by 
mean signal for non-treated samples. 
 
3.8. Influence of Fbp1p on ROS production and aging 
Salmon and colleagues (2004) showed that DNA damage can trigger an increase in 
ROS production suggesting that ROS may function as a signal mediating cellular response to 
unrepared DNA damage. Therefore, increase in ROS and oxidative stress caused by MMS 
treatment could be a consequence of DNA damage. 
To investigate if Fbp1p influences ROS accumulation in MMS treated cells, we 
measured ROS production after MMS treatment in Δfbp1  mutant cells using 
dihydroethidium, which can be oxidized by ROS to fluorescent ethidium. Results showed that 
0.03% MMS triggered ROS production in wild-type cells after 1h of treatment (Fig.25, 
Fig.26). Under the same conditions in mutant cells there was no significant increase in ROS 
level. 
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Figure 25. Lack of Fbp1p influences generation of ROS after treatment with 0.03% MMS. 
Quantification of ROS production by LSC. Y-axes: number of cells. X-axes: relative fluorescence intensity 
(orange chanel). Light blue line presents wild-type before MMS treatment, dark blue Δfbp1 mutant before MMS 
treatment, green wild-type after 1h treatment with 0.03% of MMS and orange Δfbp1 mutant after 1h treatment 
with 0.03% of MMS. 
 
That the high intracellular accumulation of ROS is one of the reasons of cellular death 
after MMS treatment we proved with survive test on plates treated with MMS and TMPO. 
TMPO is an oxygen radical scavenger (Knecht and Mason, 1993) that was added on the 
surface of plates with MMS 15 min before dropping the cellular serial dilution. Results 
showed protective effect of the TMPO on cellular viability after MMS treatment. In both 
wild-type and Δfbp1 mutant ROS scavenging decreased sensitivity to MMS (Fig.27). 
However, the effect was weaker in the Δfbp1 mutant strain because this mutant has already 
very low intracellular accumulation of ROS. 
 High accumulation of ROS was also observed in chronologically aged yeast cells 
(Herker et al., 2004). Therefore, we investigated the production of ROS and the life span of 
chronologically aged cells in the wild-type and in the Δfbp1 mutant strain. Considering that 
Fbp1p is induced by the diauxic shift in nutrient deprived medium (DeRisi et al., 1997), 
including minimal medium (Fig.10), chronological aging experiments were performed in full 
(YPD) as well as minimal medium (SD). 
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Figure 26. Lack of Fbp1p influences generation of ROS after treatment with 0.03% MMS. 
Representative images of ROS production in wild-type (WT) and Δfbp1 cells treated for 1h with 0.03% MMS. 
DIC: differential interference contrast microscopy. ROS: staining with DHE. 
 
Figure 27. Protective effect of the TMPO on cellular viability after MMS treatment. Sensitivity of 
wild-type (WT) and Δfbp1 mutant to MMS in presence and absence of ROS scavenger TMPO was tested. 5 mM 
TMPO was added on top of plates 15 min before cell spotting. Cells were grown in YPD until mid-log phase at 
30°C. 5-fold dilutions (starting OD600 = 0.5) were spotted onto indicated media and incubated for 48h at 30°C. 
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Surprisingly, we found a significantly increased survival rate of the Δfbp1 mutant cells 
during first 15 days in stationary culture in full medium (Fig.28). Looking at ROS production, 
in wild-type, the number of ROS-accumulating cells significantly increased with aging, 
showing 60% of ROS-accumulated cells already after 6 days in stationary culture (Fig.29A, 
Fig.29B). Aged Δfbp1 mutant cells started to accumulate ROS after 15 days. 
 
Figure 28. Chronological aged Δfbp1 mutant cells survive better in the first 15-th days of aging in 
full medium. Survival of chronologically aged wild-type (WT) and Δfbp1 mutant cells in full medium (YPD). 
The number of colonies on day 3 is considered to denote 100% survival. The results are presented as logarithmic 
mean values ± SEM. 
 
This correlated with a fast loss of viability after 18 days. In minimal medium the lack 
of Fbp1p was no advantage for cellular survival. Aged Δfbp1 mutants survived even less 
(Fig.30) and accumulated similar level of ROS (data not shown). Overexpression of FBP1 
caused faster aging in both wild-type and Δfbp1 mutant cells (Fig.30), but did not have any 
influence on ROS accumulation (data not shown). These results show that Fbp1p directly 
influences aging in S.cerevisiae. Fbp1p seems to be an important factor that modulates ROS 
production in response to MMS treatment and aging. However, in the media where nutrients 
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become limited (minimal medium or full medium after 15 days of aging) Fbp1p is a critical 
factor for cellular survive and its lack is rather disadvantage. 
 
 
 
Figure 29. Chronological aged Δfbp1 mutant cells delay ROS production. (A) Representative 
images of ROS production in 6 days aged cells. DIC: differential interference contrast microscopy. ROS: 
staining with DHE. (B) ROS production of chronologically aged wild-type (WT) and Δfbp1 mutant cells 
measured by flow cytometry. Data represent the percentage of cells that showed induced ROS production. This 
experiment was performed three times independently with similar results. 
 
That Fbp1p is rather involved in induction of ROS production as a cellular response to 
DNA damage and not a factor that directly modify sensitivity to oxidative stress could be 
proved with the fact that the sensitivity of the Δfbp1 mutant to external sources of ROS, like 
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inorganic peroxide (hydrogen peroxide-H2O2), or organic peroxide (tert-butyl hydroperoxide-
tBHP) did not differ from wild-type sensitivity. Both, H2O2 and tBHP treatment led to 
accumulation of ROS and a low viability of the Δfbp1 mutant strain (data not shown). 
 
Figure 30. FBP1 overexpression leads to faster aging. Survival of chronologically aged wild-type 
(WT) and Δfbp1 mutant cells transformed with pRS426 GPD empty plasmid (p426 GPD e) or pRS426 
containing the FBP1 cassette under the control of the GPD promoter (FBP1 OE GPD). The number of colonies 
on day 0 is considered to denote 100% survival. The results are presented as mean values ± SEM. 
 
The main source of ROS are mitochondria. However, the observed phenotype of the 
Δfbp1 mutant in response to MMS and aging, especially the decreased ROS accumulation, is 
not a consequence of Fbp1p-dependent changes in mitochondrial metabolism. ATP 
production, mitochondrial membrane potential and mitochondria biomass (rhodamine 123 and 
nonyl acridine orange staining) of cells lacking or overproducing Fbp1p in mock- and MMS-
treated cultures showed no significant differences from wild-type (data not shown). 
Therefore, it seems that FBP1 influences the connection between DNA damage, aging and 
oxidative stress through either direct signalling or an intricate adaptation in energy 
metabolism, but has no detectable impact on mitochondrial metabolism. 
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4. Discussion 
 
4.1. Cellular sensitivity to MMS – strain background differences 
Cellular sensitivity to treatment with MMS strongly depends on the strain background. 
Treatment with the same MMS concentrations had a much stronger cytotoxic effect in the 
BY4742 strain than in the FF18984 strain. Measured as sensitivity on plates with MMS or as 
optical density in liquid cultures treated with MMS, the BY4742 strain in both cases showed 
higher reduction in biomass yield. When the number of cells capable to proliferate was 
measured at different time points of MMS treatment, results revealed reduced colony 
formation in the FF18984 strain already after 2h. The first drop in number of cells able to 
form colonies in the BY4742 strain was observed just after 24h of treatment. It should be 
underlined that vitality staining of the cells treated with MMS revealed that more than 95% of 
cells were still detected as metabolically active even after 24h of treatment (data not shown). 
Thus, reduced ability of cells to form colonies after treatment with MMS is the result of cell 
cycle arrest that prevents reproduction of damaged or mutated cells. Slow response of the 
BY4742 strain and persistent proliferation at the first hours of MMS treatment, most probably 
leads to a higher accumulation of mutations, conversion of primary lesions to DSB and thus a 
higher sensitivity to the toxic agent. In long-term MMS treatment reduced number of cells 
forming colonies due to the effect of toxic agent is combined with reproductive aging of cells 
when cells reach finite number of division, stop proliferation and enter chronological aging 
what results in the fast drop in vitality after 24h of treatment in both strains. 
 
4.2. First line response to low doses of DNA damaging agent MMS – influence of 
growth conditions 
Transcriptional response of cells treated with low doses of MMS showed that the 
magnitude of cellular response is proportional to the dose of the toxic agent applied and 
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nutrient availability. Significant differences in the response of cells grown in restricted 
nutrient conditions were observed. With already elevated expression of many ESR genes 
these cells could respond to MMS treatment much faster and with induction of more specific 
genes directly involved in DNA damage response. However, this response in F1 medium 
occurred only in the treatment with the higher MMS dose. This was particularly the case for 
genes encoding proteins involved in DNA damage repair, stress response/detoxification, cell 
cycle control and mitochondrial function. For example, MAG2 encoding a protein involved in 
DNA dealkylation, GSH1 encoding gamma glutamylcysteine synthetase involved in 
glutathione biosynthesis, or YBP1 required for oxidation of specific cysteine residues of 
transcription factor Yap1 were up-regulated only in F1 medium. Transcriptional response of 
cells cultivated in nutrient rich medium, was however, characterised with an induction of 
general, stereotypical genes involved in ESR. ESR was first reported by Gasch and colleagues 
(2000) as the orchestrated machinery that protects critical functions within the cell during 
times of stress and includes the proteins involved in carbohydrate metabolism, protein folding 
and degradation, cytoskeletal reorganization, amino acid metabolism, protein biosynthesis, 
RNA metabolism and processing, cell wall organisation and membrane transport. In YPD 
medium ESR characterised the response to MMS treatment with both concentrations after 1h, 
while no changes in transcription were observed after 30 min.  
In many cases genes from the same functional groups up-regulated in YPD medium 
had already elevated basal transcription in F1 medium. This observation could be especially 
important for genes encoding proteins involved in cellular stress response and membrane 
transport required for transport of drugs from the cells. Indeed, basal transcriptions of two 
transcription factors HAC1 and IKI1, many chaperones like HSC82, HSP82, SSA1 and SSA2, 
or membrane transporters CTR2, PMA1 and PMA2, were higher in cells cultivated in F1 
medium. Moreover, in many functional groups that belong to ESR, up-regulation of 
additional genes was detected in F1 medium. The observation that the transcription of large 
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number of yeast genes in minimal medium is higher than in complex medium is consistent 
with previous observation by Wodicka et al. (1997). These results, therefore, indicate that 
induction of ESR could be the most important prerequisite for the proper and fast cellular 
response to the DNA damage and stress conditions. If the ESR machinery is active, cells are 
able to regulate transcription of more specific genes necessary for DNA damage repair, cell 
cycle arrest or detoxification. In a case of treatment with lower MMS concentration ESR 
seems to be only important factor in cellular defence. In the F1 medium this requirement is 
already fulfilled and the large transcription alteration is omitted.  
 
4.3. Differences in transcriptional response between strains 
Expression profiling of the BY4742 strain after 1h treatment with 0.0125% MMS 
suggested that sensitivity to MMS is directly correlated with the extent of the transcriptional 
response. This strain is more sensitive to MMS than FF18984 and shows a much lower 
induction of ESR genes. Except for the groups of chromosome maintenance, protein 
degradation and protein sorting, other functional groups did not show up-regulation of more 
than three genes. Especially the large group of carbohydrate metabolism was notably absent 
from the response in the BY4742 strain. Even if the same groups were involved in the 
response of both strains, they were represented with different genes. What could be even more 
important, the response of the BY4742 strain did not include significant decrease in the 
transcription of many genes, particularly those involved in protein biosynthesis, mRNA 
processing and regulation of transcription. Taking into consideration that in survival 
experiments BY4742 also did not show significant reduction in number of cells able to form 
colonies after short-term MMS treatment, these results contribute to the theory that fast and 
strong induction of the ESR machinery is the first factor that ensures accurate cellular defence 
against many cytotoxic and genotoxyc substances. The first role of ESR seems to be 
transcription modulation of metabolic and stress response pathways in order to preserve 
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energy and redirect transcription into “stress program”. This was seen in the response of cells 
grown in YPD medium to the lower MMS concentration. If the level of DNA and cellular 
damage is elevated by higher doses of the toxic substance used or extended time of treatment, 
the first line response is followed with induction of additional ESR genes whose products 
contribute to the basic cellular defence and detoxification: degradation and replacement of 
damaged proteins, regulation of cellular redox potential, export of toxic substances from the 
cell and reorganisation of cell wall in order to make it less porous. Finally, when the “stress 
program” is switched on, as seen in the F1 medium, cells can further respond with a more 
specific program involved in the repair of damaged DNA, control of cell cycle progression 
and elimination of the toxic agent. However, this response did not include transcription 
induction of many genes involved in DNA damage repair, especially those that belong to the 
Mec1/Tel1 pathway. Birrell and colleagues (2002) showed that many genes encoding proteins 
involved in protection against DNA damage are actually not regulated by DNA damage. 
These genes are rather constantly expressed at a relatively high level, so there is always 
sufficient amount of proteins required for an initial fast activation of the repair process. The 
results obtained with BY4742 point to the conclusion that this strain is not able to activate this 
“stress program” in the first hours of treatment. Because more time is needed for the similar 
response in the BY4742 strain (which should be exanimated in the future) it simply may be 
too late to cope with existing DNA and protein damage.   
 
4.4. Influence of nutrient availability and metabolic adaptation on cellular 
sensitivity to MMS 
The modulation in energy metabolism, as a part of ESR, seems to play an important 
role in cellular response to DNA damage. Previous gene expression studies of other or similar 
stress conditions reported - or contained in their supplementary data sets - similar regulations 
of genes involved in glycolysis/gluconeogenesis (DeRisi et al., 1997; Godon et al., 1998; 
            4. Discussion                             
 96
Dumond et al., 2000; Jelinsky et al., 2000; Causton et al., 2001; Gasch et al., 2001). A 
potential effect of these changes could be a shift from glycolysis to the pentose-phosphate 
pathway, as suggested by Dumond and colleagues (2000), what could lead to a generation of 
reducing equivalents (NADH, NADPH) required for cellular antioxidant systems. As already 
mentioned in the introduction, growth arrest and efficient utilization of nutrients could save 
ATP and NADPH/NADH for macromolecular stabilization and repair processes which 
require energy and reducing equivalents (Kültz, 2005). We observed that nutrient deprivation 
mediated pre-induction of ESR and metabolic adaptation by changes in nutrient availability 
helps to cope better with the toxic effect of genotoxic agents applied later such as MMS. The 
lowest sensitivity to MMS was found in cells cultivated in respiratory induced medium. 
Slightly higher was the sensitivity of cells cultivated in minimal medium. The most sensitive 
were cells cultivated in full medium. The effect was visible in log phase as well as in early 
and late stationary phase. The effect is more pronounced in case of BY4742 and weaker in 
FF18984. An explanation could be that the MMS triggered transcriptional response is faster 
and stronger in FF18984, activating many more genes involved in ESR, so the response 
triggered by nutrient lack does not play such an important role as observed for BY4742. The 
strain BY4742 responds to MMS more slowly and the adaptive response, induced by nutrient 
depleted media, protects these cells against subsequent challenge with genotoxic agent like 
MMS.  
We obtained the best cellular resistance to MMS just by changing the carbon source in 
the medium, e.g. reducing the glucose concentration. Moreover, in F1 medium we could also 
prove higher basal expression of genes involved in gluconeogenesis and respiratory 
metabolism. Therefore, seems that the major stimulus that triggers the adaptive response and 
induction of ESR genes is actually alteration in glucose utilization. It was shown earlier that 
yeast cells grown on non-fermentable substrates (e.g. ethanol and glycerol) express higher 
levels of antioxidant activity and display higher oxidative stress tolerances (reviewed in 
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Moradas-Ferreira et al., 1996). Many of primary antioxidant defence genes are repressed by 
glucose and their derepression occurs with respiratory adaptation that follows glucose 
exhaustion (Krems et al., 1995). This transcriptional adaptation that occurs in diauxic shift is 
an important factor that contributes to the increased oxidative-stress tolerance of stationary-
phase yeast cells (Jamieson et al., 1994; Steels et al., 1994). In our experiments this primary 
antioxidant program was induced by MMS even in the cells grown in medium with high 
glucose concentration showing that the modulation of major pathways of energy metabolism 
is inevitable part of minimal stress response. Presumably, energy metabolism and antioxidant 
defence genes are under control of the same transcriptional mechanisms involving glucose, 
transcription factors or secondary messengers. There are ample evidences showing that 
changes in cAMP levels are important in regulation of growth arrest at the diauxic shift 
(Russell et al., 1993). A reduction in cAMP level is essential for traversing the diauxic shift 
while transcription of many genes involved in this process is directly or indirectly controlled 
by the cAMP level (Boy-Marcotte et al., 1996). Other evidences showed that STRE-regulated 
genes are also under negative regulation by cAMP (Marchler et al., 1993). Therefore, energy 
metabolism and stress proteome are inseparably intertwined in cellular response to 
environmental changes, nutrient depletion or DNA damage.  
Taken together, yeast cells seem to utilize a common response to cope with diverse 
stress conditions, nutrient starvation or DNA damage which includes: modulation in basic 
metabolic pathways, induction of environmental, especially oxidative stress response (ESR) 
and energy conservation. Those cells that are able to induce alterations in cellular energy 
homeostasis and adjust to calorie restriction are also better prepared to survive treatment with 
toxic agents. Our results show an important correlation between metabolic pathways and the 
ability of living organisms to cope with adverse conditions. 
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4.5. The role of Fbp1p in cellular response to DNA damage 
The importance of respiratory metabolism and gluconeogenesis for proper response to 
DNA damage was also supported by results obtained from the sensitivity assays of various 
yeast mutants. Deletion of the HAP4, encoding a subunit of the heme-activated, glucose-
repressed Hap2p/3p/4p/5p CCAAT-binding complex which serves as a transcriptional 
activator and global regulator of respiratory gene expression (Lascaris et al., 2002), slightly 
increased cellular sensitivity to MMS. The sensitivity of this mutant to phleomycin or 4-NQO 
did not differ from wild-type one. Although the effect is not so striking, this result supports 
the conclusion that induction of respiratory metabolism is not just a consequence of having 
the similar regulatory elements, as found in stress response genes, but is an active counterpart 
in cellular defence to DNA damage. On the other hand, the deletion of the key enzyme in 
gluconeogenesis, Fbp1, or its transcriptional repressor, Mig1, showed some surprising results. 
Lack of Fbp1p in the cells drastically increased cellular resistance to MMS, while the Δmig1 
mutant had higher sensitivity to MMS and phleomycin. The reduced sensitivity of the Δfbp1 
mutant was specific for MMS treatment. Deletion of FBP1 did not confer resistance to other 
DNA damaging agents such as 4-NQO or phleomycin. Even 4-NQO, which reacts with DNA 
and forms stable quinoline-purine monoadducts (Galiegue-Zouitina et al., 1986), and which is 
known to undergo redox cycling and produce substantial amounts of ROS in the cell (Biaglow 
et al., 1977), did not have the same effect as MMS on the Δfbp1 mutant. These results suggest 
that the gluconeogenesis pathway and its key regulator Fbp1p must have some additional role 
in DNA damage and stress response other than just energy conservation and higher 
production of glucose-6-phosphate, the key substrate for the pentose phosphate pathway. 
NADPH synthesis in this pathway is an important factor for reduction of oxidized glutathione. 
In this case FBP1 deletion could lead to an increased MMS-sensitivity due to reduced 
NADPH production. 
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That the lack of Fbp1p is responsible for increased resistance to MMS was proved by 
reintroduction of FBP1 into Δfbp1 mutant cells.  The wild-type MMS sensitivity was restored. 
Moreover, overexpression of FBP1 in wild-type led to a slightly higher sensitivity to MMS in 
comparison with the Δfbp1 mutant cells overexpressing FBP1. How can this be explained 
considering that induction of genomic FBP1 by MMS should only contribute marginally due 
to the higher copy number of the transformed gene? One explanation could be that additional 
control mechanisms post-transcriptional and on protein level, such as degradation and 
vacuolar targeting, significantly contribute to the regulation of protein activity. Thus, upon 
stress caused by MMS, a marginal increase in transcription without adaptation of degradation 
could lead to a significant higher level of active Fbp1p, which could mediate the higher 
sensitivity to MMS in wild-type overexpressing FBP1. In addition, we showed that FBP1 is 
induced not only in response to glucose deprivation, but also by MMS treatment and under 
limited nutrient conditions in the presence of glucose, like in F1 medium. Induction of FBP1 
can also be found in the results of genome wide gene expression studies in response to H2O2 
(0.32 mM; Gasch et al., 2000); to oligomycin (Epstein et al., 2001); to a temperature shift 
from 30°C to 25°C (Causton et al., 2001) and after treatment with griseofulvin, an antifungal 
agent that disrupts mitotic spindle structure leading to metaphase arrest (Savoie et a., 2003). 
In the work from Schaus and colleagues (2001) FBP1 is listed among the genes 
transcriptionally controlled by phosphorylated Sip4p. Sip4p mediates the response to 
neocarzinostatin, which has an antiproliferative effect (Schaus et al., 2001). Therefore, under 
many stress conditions FBP1 expression could be induced even in the medium with the high 
glucose concentration. Considering that MIG1 deletion caused an opposite effect to this seen 
with lack of FBP1, it seems that Mig1p plays an important role in transcription control of 
FBP1 in such conditions. 
The role of Fbp1p in DNA damage response mechanisms seems to be connected with 
the better recovery of this strain after a long-term treatment with MMS. In the Δfbp1 mutant 
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prolonged treatment with MMS, e.g. 24h or 48h strongly reduced the number of cells able to 
form colonies after plating them on medium without the toxic agent. The first drop was 
observed in both strains already after 2h of treatment while a maximal reduction occurred 
after 24h. The Δfbp1 mutant, however, was able to recover and continue proliferation, what 
was detected as an increased colony formation unit starting from 24h of MMS treatment. On 
the other hand, the same experiment with cells that overexpress FBP1 led to exactly the 
opposite effect. This time high level of FBP1 expression decreased the number of 
proliferating cells even in the non-treated culture. The results obtained from measuring the 
induction of the RNR2 after DNA damage revealed that increased transcription of FBP1 led to 
stronger induction of this essential gene in DNA repair. The effect, of course, could be 
connected with a stronger activation of the pentose-phosphate pathway and subsequently a 
more efficient production of nucleotides through redirection of energy metabolism into 
gluconeogenesis. In this case, a similar effect of FBP1 deletion should be observed if any 
other DNA damaging agent is applied. Hence, Fbp1p must have an additional role in response 
to DNA damage, most probably by mediating the DNA damage response between damage 
sensors and effectors. Consistent with this assumption is the observation that C-terminally 
GFP-tagged Fbp1p restores the lack of this protein in utilization of non-fermentable carbon 
sources, but has impaired function in response to MMS. 
 
4.6. Fbp1p delays the onset of ROS production in DNA damage or aged cells 
Looking at ROS production we found that cells lacking Fbp1p did not generate 
substantial amounts of ROS after MMS treatment or in chronologically aged cells, both 
treated in full medium. Both the stationary phase cultures as well as MMS treated cultures are 
characterised by an accumulation of endogenously produced intracellular ROS in response to 
DNA damage or aging. In contrast, in case of 4-NQO, H2O2 or tBHP treatment, the strong 
oxidative stress and high ROS accumulation, which is not influenced by the deletion of FBP1, 
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is generated by these agents directly and is not the result of induced ROS production. 
Therefore, we conclude that Fbp1p does not modify sensitivity to oxidative stress, but rather 
participates in or modulates the production of ROS induced by DNA damage or in aged cells. 
Thus, rather than influencing MMS toxicity directly, Fbp1p plays a role in connecting DNA 
damage with ROS production. 
Various evidences suggest that some factors that influence aging are linked to 
oxidative damage of DNA (reviewed in von Zglinicki et al., 2001). As yeast cells grow older 
they cease dividing and enter a postdiauxic, hypometabolic state, where they can remain 
viable for weeks (Bitterman et al., 2003). Maclean and colleagues (2003) showed that the 
longest S.cerevisiae life spans are obtained by adaptation of cells to efficient respiratory 
maintenance, achieved by growth to stationary phase on a respiratory carbon source. 
Moreover, they proved the vital importance of base excision repair (BER) in the prevention of 
mutation accumulation and the attainment of a full yeast chronological life span. Aged wild-
type cells or cells treated with MMS for 24 h display metabolic activity and are negative for 
PI staining, but their ability to replicate and form colonies is impaired. These cells show a 
very high level of intracellular ROS accumulation. Without FBP1 the amount of ROS 
produced after MMS treatment or in aged cells is much lower, and the cells maintain their 
reproduction capability and continue proliferation. In addition, treatment with a ROS 
scavenger resulted in a similar increase in the number of wild-type cells able to form colonies 
after MMS treatment as was obtained by deletion of FBP1. This shows that ROS contributes 
to the reduced vitality seen in MMS treated or aged cells which can be compensated by 
preventing ROS accumulation. The link between aging process and FBP1 expression is also 
confirmed by overexpression of FBP1. Cells that produce high amounts of this protein age 
faster. This is an interesting point, showing that high level of Fbp1p present in the cell is 
cytotoxic. Therefore, precise metabolic regulation, especially tight control of the key 
metabolic proteins level, seems to be very important for the aging process and cellular 
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viability after DNA damage. Taken together, our results lead to the hypothesis that Fbp1p 
could serve as a signalling molecule involved in mediating the cellular response to such 
conditions.  
What is the role of Fbp1p in those processes? A shift toward increased energy 
metabolism and gluconeogenesis in aged cells or in response to DNA damage leads to higher 
oxidative stress resistance and more efficient DNA damage repair, but also causes shorter 
lifespan and faster maturation (Lin et al., 2001). These two, at the first glance opposite 
effects, may be explained by the recently published work of Herker and colleagues (2004). 
They found that chronological aging leads to apoptosis in yeast. It is suggested that in a 
monoclonal population of cells it can be evolutionarily advantageous to spare most of the 
dwindling resources for healthier cells. Looking for ROS production in aged cell populations 
we found that deletion of FBP1 significantly delays the onset of ROS production. Thus, 
induction of FBP1 could contribute to mediate the apoptotic signal in aged cells, selectively 
enabling younger cells to survive in adverse environmental conditions. Taken together, our 
results clearly show that FBP1 influences the connection between DNA damage, aging and 
oxidative stress through either direct signalling or an intricate adaptation in energy 
metabolism. As was already observed by Lin and colleagues (2001), enhanced 
gluconeogenesis and increased energy storage are hallmarks of aging in S.cerevisiae. In 
consequence, the tight regulation of FBP1 expression and age-associated changes in glucose 
metabolism are not only crucial for the control of gluconeogenesis, but also for an appropriate 
response to aging and DNA damage.  
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 5. Conclusions 
 
1. Induction of ESR is the most important prerequisite for the proper and fast cellular 
response to DNA damage and stress conditions. This response is induced under many 
stress conditions and serves to protect the basic cellular functions and integrity of 
intracellular structures. If the ESR machinery is already active, cells are able to 
regulate transcription of more specific genes necessary for DNA damage repair, cell 
cycle arrest or detoxification. Fast induction of the ESR program contributes to the 
higher resistance of the FF18984 strain to MMS treatment. 
2. The most important genes directly involved in protection against DNA damage are 
constantly expressed at the high level. Therefore, there is always sufficient amount of 
proteins required for an initial fast activation of the repair process. 
3. Nutrient availability can modify transcription profile of the cells and induce activation 
of the cellular “stress program”. The elevated transcription of many genes involved in 
this program is the molecular base of cross-tolerance of cells to the other stress 
conditions or agents applied later. In both FF18984 and BY4742 strains pre-induction 
of ESR by minimal or glucose depleted media increases cellular resistance to MMS 
and allows more cells to continue proliferation.  
4. The modulation in energy metabolism, as a part of ESR, seems to play an important 
role in cellular response to DNA damage. The major stimulus that triggers the 
adaptive response and induction of ESR genes is alteration in glucose utilization. 
Being under control of the same transcriptional mechanisms, energy metabolism and 
stress proteome are inseparably intertwined in cellular response to environmental 
changes, nutrient depletion or DNA damage.  
5. The key enzyme in gluconeogenesis fructose-1,6-bisphosphatase plays an important 
role in mediating cellular responses to DNA damage and aging in yeast cells. Its 
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transcription is clearly up-regulated upon MMS treatment, while deletion of this gene 
confers resistance to MMS by increasing the number of cells able to proliferate after 
the treatment and prolong life-span in nutrient rich medium.  
6. Overproduction of Fbp1p has a toxic effect on cells. High level of Fbp1p in the cells 
increases cellular sensitivity to MMS, reduces the number of cells able to proliferate 
even in non-treated cultures, increases RNR2 induction upon MMS treatment and 
causes faster aging. 
7. Both in MMS treated or chronologically aged cells, deletion of FBP1 significantly 
delays the onset of ROS production. A similar effect is obtained in wild-type cells by 
treatment with the ROS scavenger, TMPO, which confirms that ROS contributes to 
the reduced vitality seen in MMS-treated or aged cells. 
8. Induction of FBP1 could contribute to mediate the apoptotic signal in aged and 
seriously damaged cells, selectively enabling younger and better adapted cells to 
survive in adverse environmental conditions 
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7. Appendix 
 
Abbreviations (without gene names) 
 
4-NQO  4-nitroquinoline 1-oxide  
ALL   acute lymphoblastic leukaemia 
AP   apurinic/apyrimidinic sites 
A–T   Ataxia–telangiectasia 
ATP  adenosine 5’triphosphate 
BCNU   1,3-bis(2-chloroethyl)-1-nitrosourea  
BER   base excision repair 
BSA  bovine serum albumin 
cDNA   complementary DNA 
CML   chronic myelogenous leukemia  or  
DHE  dihydroethidium 
DMSO dimethylsulfoxide 
dNTP  deoxynucleotide triphosphate 
DR   direct repair 
DSB   double strand DNA brake  
dsDNA double strand DNA 
DTT  dithiothreitol 
EDTA  ethylenediamine-tetraacetic acid 
ESR  environmental stress response 
EtBr  ethidium bromide 
FACS  fluorescent activated cell sorter 
FADH- Flavin-Adenin-Dinucleotid 
FDA  fluorescein diacetate 
GSH  glutathione (reduced glutathione) 
HR   homologous recombination  
IR   ionizing radiation  
LSC  laser-scanning cytometer  
MMS   methyl methanesulfonate  
MNNG  N-methyl-N´-nitro-N-nitrosoguanidine 
MR   mismatch repair  
NADH reduced nicotinamide adenine dinucleotide 
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NADPH reduced nicotinamide adenine dinucleotide phosphate 
n.d.  non-defined 
NER   nucleotide excision repair  
NHEJ   nonhomologous end-joining mechanisms 
OD  optical density 
ORF  open reading frames 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PEG   polyethylene glycol 
PI  propidium iodide 
RNS  reactive nitrogen species 
ROS  reactive oxygen species  
RT-PCR reverse transcriptase polymerase chain reaction 
SDS  sodiumdodecylsulfate 
SSA   single-strand annealing repair mechanism 
ssDNA single strand DNA 
TBS   translation bypass synthesis  
TMPO  3,3,5,5,-tetramethyl-pyrroline N-oxide 
UV   ultraviolet radiation  
XP   Xeroderma pigmentosum  
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